<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74636</article-id><article-id pub-id-type="doi">10.7554/eLife.74636</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Cytotoxic CD4<sup>+</sup> T cells driven by T-cell intrinsic IL-18R/MyD88 signaling predominantly infiltrate <italic>Trypanosoma cruzi</italic>-infected hearts</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-257805"><name><surname>Barbosa</surname><given-names>Carlos-Henrique D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7644-7034</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-257804"><name><surname>Canto</surname><given-names>Fábio B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7574-2613</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-257806"><name><surname>Gomes</surname><given-names>Ariel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="pa3">#</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257810"><name><surname>Brandao</surname><given-names>Layza M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257807"><name><surname>Lima</surname><given-names>Jéssica R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257808"><name><surname>Melo</surname><given-names>Guilherme A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84195"><name><surname>Granato</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa4">¶</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257809"><name><surname>Neves</surname><given-names>Eula GA</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149212"><name><surname>Dutra</surname><given-names>Walderez O</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7586-9996</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84192"><name><surname>Oliveira</surname><given-names>Ana-Carolina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0036-3720</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97084"><name><surname>Nóbrega</surname><given-names>Alberto</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9840-0103</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-83996"><name><surname>Bellio</surname><given-names>Maria</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3360-2740</contrib-id><email>mariabellioufrj@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03490as77</institution-id><institution>Department of Immunology, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ)</institution></institution-wrap><addr-line><named-content content-type="city">Rio de Janeiro</named-content></addr-line><country>Brazil</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0176yjw32</institution-id><institution>Laboratório de Biologia das Interações Celulares, Universidade Federal de Minas Gerais</institution></institution-wrap><addr-line><named-content content-type="city">Belo Horizonte</named-content></addr-line><country>Brazil</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03490as77</institution-id><institution>Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ)</institution></institution-wrap><addr-line><named-content content-type="city">Rio de Janeiro</named-content></addr-line><country>Brazil</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0145znz58</institution-id><institution>Walter Reed Army Institute of Research</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00djv2c17</institution-id><institution>Indian Institute of Science Education and Research (IISER)</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Microbiology &amp; Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, IL, United States</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense (UFF), Niterói, Brazil</p></fn><fn fn-type="present-address" id="pa3"><label>#</label><p>Faculdade de Medicina da Universidade Estácio de Sá, Angra dos Reis, RJ, Brazil</p></fn><fn fn-type="present-address" id="pa4"><label>¶</label><p>The Hospital for Sick Children - Genetics and Genome Biology, Toronto, ON, Canada</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>07</day><month>06</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e74636</elocation-id><history><date date-type="received" iso-8601-date="2021-10-12"><day>12</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-06-04"><day>04</day><month>06</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-10-22"><day>22</day><month>10</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.10.21.465260"/></event></pub-history><permissions><copyright-statement>© 2022, Barbosa, Canto, Gomes et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Barbosa, Canto, Gomes et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74636-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-74636-figures-v2.pdf"/><abstract><p>Increasing attention has been directed to cytotoxic CD4<sup>+</sup> T cells (CD4CTLs) in different pathologies, both in humans and mice. The impact of CD4CTLs in immunity and the mechanisms controlling their generation, however, remain poorly understood. Here, we show that CD4CTLs abundantly differentiate during mouse infection with the intracellular parasite <italic>Trypanosoma cruzi</italic>. CD4CTLs display parallel kinetics to Th1 cells in the spleen, mediate specific cytotoxicity against cells presenting pathogen-derived antigens and express immunoregulatory and/or exhaustion markers. We demonstrate that CD4CTL absolute numbers and activity are severely reduced in both <italic>Myd88<sup>-/-</sup></italic> and <italic>Il18ra<sup>-/-</sup></italic> mice. Of note, the infection of mixed-bone marrow chimeras revealed that wild-type (WT) but not <italic>Myd88<sup>-/-</sup></italic> cells transcribe the CD4CTL gene signature and that <italic>Il18ra<sup>-/-</sup></italic> and <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells phenocopy each other. Moreover, adoptive transfer of WT CD4<sup>+</sup>GzB<sup>+</sup> T cells to infected <italic>Il18ra<sup>-/-</sup></italic> mice extended their survival. Importantly, cells expressing the CD4CTL phenotype predominate among CD4<sup>+</sup> T cells infiltrating the infected mouse cardiac tissue and are increased in the blood of Chagas patients, in which the frequency of CD4CTLs correlates with the severity of cardiomyopathy. Our findings describe CD4CTLs as a major player in immunity to a relevant human pathogen and disclose T-cell intrinsic IL-18R/MyD88 signaling as a key pathway controlling the magnitude of the CD4CTL response.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cytotoxicity</kwd><kwd>CD4 T cells</kwd><kwd>infectious disease</kwd><kwd>myocarditis</kwd><kwd>Chagas disease</kwd><kwd>MyD88</kwd><kwd>IL-18R</kwd><kwd><italic>Trypanosoma cruzi</italic></kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004586</institution-id><institution>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</institution></institution-wrap></funding-source><award-id>CNE E-26/202.603/2019</award-id><principal-award-recipient><name><surname>Bellio</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003593</institution-id><institution>Conselho Nacional de Desenvolvimento Científico e Tecnológico</institution></institution-wrap></funding-source><award-id>PQ Award 312143/2018-4</award-id><principal-award-recipient><name><surname>Bellio</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003593</institution-id><institution>Conselho Nacional de Desenvolvimento Científico e Tecnológico</institution></institution-wrap></funding-source><award-id>INCT -V 465293/2014-0</award-id><principal-award-recipient><name><surname>Bellio</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002322</institution-id><institution>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</institution></institution-wrap></funding-source><award-id>Finance Code 001</award-id><principal-award-recipient><name><surname>Bellio</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004586</institution-id><institution>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</institution></institution-wrap></funding-source><award-id>CNE E26/202.942/2016</award-id><principal-award-recipient><name><surname>Nóbrega</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004901</institution-id><institution>Fundação de Amparo à Pesquisa do Estado de Minas Gerais</institution></institution-wrap></funding-source><award-id>Universal 2018</award-id><principal-award-recipient><name><surname>Dutra</surname><given-names>Walderez O</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004586</institution-id><institution>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</institution></institution-wrap></funding-source><award-id>APQ1 Manutenção da Unidade de Citometria. E26/210.986/2016</award-id><principal-award-recipient><name><surname>Nóbrega</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Cytotoxic CD4 T lymphocytes are abundantly generated in <italic>T. cruzi-</italic>infected mice, predominantly infiltrate infected hearts, depend on T-cell intrinsic IL-18R/MyD88 signaling for expansion and their blood frequency correlates with the severity of chronic myocarditis in patients with Chagas disease.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Cytotoxic CD4<sup>+</sup> T cells (CD4CTLs) are present in viral infections, cancer and autoimmune diseases (<xref ref-type="bibr" rid="bib18">Cheroutre and Husain, 2013</xref>; <xref ref-type="bibr" rid="bib44">Juno et al., 2017</xref>; <xref ref-type="bibr" rid="bib84">Takeuchi and Saito, 2017</xref>). Although more frequently found in chronic conditions, CD4CTLs have also been described during acute viral infection (<xref ref-type="bibr" rid="bib11">Brien et al., 2008</xref>; <xref ref-type="bibr" rid="bib13">Brown et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Fang et al., 2012</xref>; <xref ref-type="bibr" rid="bib42">Jellison et al., 2005</xref>; <xref ref-type="bibr" rid="bib87">Wilkinson et al., 2012</xref>). At present, however, there are few studies on the CD4CTL response to infection with non-viral intracellular pathogens (<xref ref-type="bibr" rid="bib14">Burel et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Canaday et al., 2001</xref>; <xref ref-type="bibr" rid="bib48">Kotov et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Krueger et al., 2021</xref>). The role of CD4CTLs in immunity against intracellular parasites and the mechanisms operating in the generation and maintenance of this cell subset are poorly understood.</p><p>Following the recognition of the cognate antigen-MHC complex and under the influence of cytokines secreted by antigen presenting cells (APCs), naïve CD4<sup>+</sup> T cells proliferate and differentiate into diverse subsets, including Tfh, Th1, Th2, or Th17, with varied effector functions. Different pathogen-derived molecular patterns (PAMPs) elicit distinct innate immune pathways, resulting in tailored Th responses against the infectious agent (<xref ref-type="bibr" rid="bib45">Kara et al., 2014</xref>). Interestingly, single-cell heterogeneity in the transcriptional profile of effector CD4<sup>+</sup> T cells, dictated in a microbe-specific manner, has been recently found in the gut (<xref ref-type="bibr" rid="bib47">Kiner et al., 2021</xref>). Additionally, tissue-derived factors can also be involved in defining CD4<sup>+</sup> T cell phenotypes (<xref ref-type="bibr" rid="bib69">Poholek, 2021</xref>). In this context, the mechanism regulating the differentiation of CD4CTLs remains an open and relevant question. Although some authors consider CD4CTLs functional variants of Th1 cells, there is also evidence that CD4CTLs might constitute a Th1-independent subset, directly differentiating from naïve CD4<sup>+</sup> T cell precursors or even a heterogeneous population congregating cytolytic lymphocytes that originate from different T-cell subsets, such as Treg, Th1, and Th2 cells (reviewed in <xref ref-type="bibr" rid="bib18">Cheroutre and Husain, 2013</xref> and <xref ref-type="bibr" rid="bib84">Takeuchi and Saito, 2017</xref>).</p><p>Receptors belonging to the TLR and IL-1R families are upstream of the MyD88 adaptor molecule and are expressed both in myeloid and lymphoid cell lineages. MyD88-dependent signaling in innate cells can influence Th1 cell differentiation by inducing the release of IL-12 or IFN-γ (<xref ref-type="bibr" rid="bib43">Joffre et al., 2009</xref>; <xref ref-type="bibr" rid="bib82">Takeda et al., 1998</xref>). The T-cell intrinsic MyD88 adaptor function was also shown to be essential for the Th1 response in different contexts. The identity of the receptor acting upstream of MyD88 on T cells, however, was not always determined (<xref ref-type="bibr" rid="bib31">Frazer et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">LaRosa et al., 2008</xref>) and remains a matter of debate. Early in vitro studies have shown that IL-18 synergizes with IL-12 in the induction of IFN-γ production and T-bet expression by CD4<sup>+</sup> T cells and, therefore, impacts Th1 development (<xref ref-type="bibr" rid="bib74">Robinson et al., 1997</xref>). Intriguingly, the IL-18 contribution for a robust Th1 response in vivo has not always been confirmed (<xref ref-type="bibr" rid="bib37">Haring and Harty, 2009</xref>; <xref ref-type="bibr" rid="bib60">Monteforte et al., 2000</xref>). ST2 (IL-33 receptor) and IL-1R have also been implicated in the establishment of Th1 responses to viral infection (<xref ref-type="bibr" rid="bib6">Baumann et al., 2015</xref>) and immunization (<xref ref-type="bibr" rid="bib8">Ben-Sasson et al., 2009</xref>; <xref ref-type="bibr" rid="bib77">Schenten et al., 2014</xref>), respectively. Previously, our group identified the crucial role of T cell-intrinsic IL-18R/MyD88 signaling for the reinforcement and maintenance of the Th1 program in vivo, in response to mouse infection with <italic>Trypanosoma cruzi,</italic> in which Th1 cells have a key protective function (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Rodrigues et al., 2012</xref>).</p><p><italic>T. cruzi</italic> is an intracellular protozoan parasite and the etiologic agent of Chagas disease (<italic>American trypanosomiasis</italic>), one of the most important parasitic diseases in the Western Hemisphere. Chagas disease is an important cause of heart failure, stroke, arrhythmia, and sudden death, being the leading cause of cardiomyopathy among younger individuals in Latin America (<xref ref-type="bibr" rid="bib9">Bern, 2015</xref>; <xref ref-type="bibr" rid="bib64">Nunes et al., 2018</xref>). Here we showed that CD4<sup>+</sup> T lymphocytes with a CTL phenotype are abundantly present in the spleen of mice infected with <italic>T. cruzi</italic> and display in vitro and in vivo Ag-specific cytotoxicity against APCs. Of note, we found that cells with a CTL phenotype predominate among CD4<sup>+</sup> T lymphocytes infiltrating infected cardiac tissue. Using mixed bone marrow (mix-BM) chimeras, we show that T cell-intrinsic IL-18R/MyD88 signaling plays a crucial role for the expansion/survival of CD4<sup>+</sup> T cells expressing the CTL gene signature in vivo. In accordance with results obtained in mix-BM chimeras, we found that absolute numbers of CD4 T cells displaying cytotoxic markers and activity were severely reduced in <italic>Myd88<sup>-/-</sup></italic> and <italic>Il18ra<sup>-/-</sup></italic> mouse lineages. Moreover, adoptive transfer of wild-type (WT) CD4<sup>+</sup>GzB<sup>+</sup> T cells to <italic>Il18ra<sup>-/-</sup></italic> mice increase survival of this susceptible mouse strain to infection. Interestingly, the majority of CD4<sup>+</sup>GzB<sup>+</sup> T cells in WT infected mice express high levels of immunoregulatory molecules such as, Tim-3, Lag-3, CD39, and PD-1. Finally, and importantly, we detected the presence of CD4<sup>+</sup> T cells expressing perforin in the blood of patients with the severe cardiac form of Chagas disease and correlation analyses point to a possible pathogenic role of these cells in the chronic phase of Chagas myocarditis. To our knowledge, the present study is the first to extensively characterize CD4CTLs generated in response to a protozoan pathogen in a murine model and to elucidate a central mechanism that accounts for their expansion/survival.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>CD4<sup>+</sup> T cells with cytolytic phenotype are abundantly present in the spleen of mice infected with <italic>T. cruzi</italic></title><p>CD4CTLs express granzyme B (GzB) and perforin (PRF), which are major constituents of CD8CTL and NK cell-granules that promote target cell death in a number of ways (<xref ref-type="bibr" rid="bib1">Afonina et al., 2010</xref>). Here, we reveal the presence of a TCRαβ<sup>+</sup>CD8α<sup>-</sup>NK1.1<sup>-</sup>CD4<sup>+</sup>GzB<sup>+</sup> T cell population, which represents around 30% of the CD4<sup>+</sup> T cells in the spleen of C57BL/6 (B6) mice, in the acute phase of infection with <italic>T. cruzi</italic> (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Equivalent percentages of CD4<sup>+</sup>PRF<sup>+</sup> T cells were found (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) and the majority of CD4<sup>+</sup>GzB<sup>+</sup> T cells express PRF and the cytolytic marker 2B4 (CD244) (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). Of note, most CD4<sup>+</sup>GzB<sup>+</sup> T cells (&gt;80%) do not express IFN-γ at day 14 post-infection (pi), the peak time-point of the T cell response, and although CD4GzB<sup>+</sup> and CD4IFN-γ<sup>+</sup> cells follow similar kinetics in the spleen, the absolute number of CD4<sup>+</sup>GzB<sup>+</sup> T cells was superior to that of CD4<sup>+</sup>IFN-γ<sup>+</sup> cells, at every time point of the infection (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>). It is known that intracellular parasitism by <italic>T. cruzi</italic> Y strain in the spleen is at its highest point between day 12 and 15 pi, concomitant with the histologically observed massive destruction of parasitized splenic macrophages (<xref ref-type="bibr" rid="bib20">Cordeiro et al., 1997</xref>). Therefore, there is a coincidence between parasite titers in the spleen and the frequency and absolute numbers of CD4<sup>+</sup>GzB<sup>+</sup> T cells. We also observed an increase in the percentage of degranulating CD4<sup>+</sup> T cells at day 14 pi, comparable to the CD8<sup>+</sup> T cells, as inferred by staining with anti-CD107a (LAMP-1) mAb, (<xref ref-type="fig" rid="fig1">Figure 1H</xref>), although CD8CTLs are present at higher percentage (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B-E and G</xref> ) and absolute number (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F and H</xref>). In summary, these data show the remarkable induction of CD4<sup>+</sup> T cells with cytolytic potential during infection with <italic>T. cruzi</italic>, an effector subpopulation whose appearance in the spleen parallels and largely outnumbers that of classic GzB<sup>-</sup> IFN-γ<sup>+</sup> Th1 cells.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>CD4<sup>+</sup>GzB<sup>+</sup>PRF<sup>+</sup> T cells are present at high frequency in the spleen of mice infected with <italic>T. cruzi.</italic></title><p>(<bold>A</bold>) CD4<sup>+</sup> T cell gating strategy. (<bold>B and C</bold>) Representative flow-cytometry dot plots of granzyme B (GzB) (<bold>B</bold>) or perforin (PRF) (<bold>C</bold>) staining, gated on CD4<sup>+</sup> T cells from non-infected (naïve) or infected B6 mice (left) and mean frequency of CD4<sup>+</sup>GzB<sup>+</sup> (or CD4<sup>+</sup>PRF<sup>+</sup>) T cells in the spleen (right). (<bold>D</bold>) Representative dot plots of PRF and GzB expression in CD4<sup>+</sup> T cells gated as in (<bold>A</bold>) and mean frequencies of PFR<sup>+</sup> among GzB<sup>+</sup> CD4<sup>+</sup> T cells (isotype controls on <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). (<bold>E</bold>) Representative histogram of 2B4 (CD244) expression on CD8<bold><sup>+</sup></bold> (blue), CD4<sup>+</sup>GzB<sup>+</sup> (red) or CD4<sup>+</sup>GzB<sup>-</sup> T cells (pink), and correspondent mean fluorescence intensity (mean MFI) values; (<bold>F</bold>) Representative dot plots of GzB and IFN-γ staining in gated CD4<sup>+</sup> T splenocytes (left), mean frequencies of GzB<sup>+</sup>IFN-γ<sup>-</sup> (red), GzB<sup>+</sup>IFN-γ<sup>+</sup> (purple) and GzB<sup>-</sup>IFN-γ<sup>+</sup> (blue) subsets among total CD4<bold><sup>+</sup></bold> (center) or gated on CD4<sup>+</sup>GzB<sup>+</sup> T cells (right). (<bold>G</bold>) Kinetics of the mean frequency of CD4<sup>+</sup>IFN-γ<sup>+</sup> (purple) and CD4<sup>+</sup>GzB<sup>+</sup> (red; left), and corresponding absolute numbers (right). (<bold>H</bold>) Frequency of LAMP-1<sup>+</sup>(CD107a<sup>+</sup>) cells among CD4<sup>+</sup>GzB<sup>+</sup> (red) or CD8<sup>+</sup>GzB<sup>+</sup> (blue) T cells in the infected spleen. Data obtained from individually analyzed mice (n=4), at indicated or 14 day post-infection (pi). Error bars = SEM. ND = non-detected. ns = non-significant; **p≤0.01 (Student’s t-test). Data are representative of three or more independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Comparative percentages and absolute numbers of granzyme B-positive (GzB<sup>+</sup>) and perforin-positive (PRF<sup>+</sup>) T cell subsets.</title><p>(<bold>A</bold>) Isotype control staining of CD4<sup>+</sup> T cells, gated as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>, from infected mice. (<bold>B</bold>) Gating strategy for (<bold>C</bold> and <bold>D</bold>) plots. (<bold>C</bold>) Representative dot plots of GzB staining (on the left) and mean frequency of GzB<sup>+</sup>CD8<sup>+</sup>T cells (on the right). (<bold>D</bold>) Representative dot plots of PRF and GzB staining in CD8<sup>+</sup> T cells. (<bold>E</bold>) Mean frequency and (<bold>F</bold>) absolute numbers of CD4<sup>+</sup> and CD8<sup>+</sup> T cells in the spleen of non-infected (ctr) and infected mice. (<bold>G</bold>) Mean frequency and (<bold>H</bold>) absolute numbers of GzB<sup>+</sup>CD4<sup>+</sup> and GzB<sup>+</sup>CD8<sup>+</sup> T cells. Mice individually analyzed at day 14 post-infection (pi) (n=4); error bars = SEM. Data are representative of 6 independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>CD4<sup>+</sup> T cells from infected spleen exert Ag-specific cytotoxicity</title><p>To ascertain the presence of CD4<sup>+</sup> T lymphocytes with cytolytic function, we performed a redirected cytotoxicity assay, with anti-CD3 mAb–coated B cell blasts as target cells that were co-incubated with either highly purified effector (CD44<sup>hi</sup>) CD4 T cells sorted from the spleen of infected mice or naive (CD44<sup>lo</sup>) CD4 T cells from non-infected controls. The CTL activity was observed only when effector CD4<sup>+</sup> T cells were employed (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In order to determine if the CD4CTL killing capability is dependent on GzB- and PRF-mediated killing, we performed the cytotoxic assays in the presence of the GzB and PRF inhibitors, Z-AAD-CMK and Concamycin A, respectively. As shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>, the killing of target cells was abolished in this condition, demonstrating that the cytolysis mediated by CD4CTLs in <italic>T. cruzi-</italic>infected mice depends on GzB and PRF, as previously shown for tumor-specific CD4CTLs (<xref ref-type="bibr" rid="bib70">Quezada et al., 2010</xref>). Antigen-specific cytotoxicity, using highly purified CD4<sup>+</sup> T cells, was also assayed in vitro against an I-A<sup>b+</sup> macrophage cell line (IC-21), loaded or not with <italic>T. cruzi</italic> amastigote total protein extract. Results shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref> demonstrate that CD4CTLs with cognate cytotoxic activity are present in the spleen of infected mice. FasL is expressed on CD8<sup>+</sup> and CD4<sup>+</sup> T cells at the immunological synapse following Ag-triggered degranulation and participates in CD4CTL-mediated lysis of target cells (<xref ref-type="bibr" rid="bib10">Bossi and Griffiths, 1999</xref>; <xref ref-type="bibr" rid="bib12">Brown et al., 2009</xref>; <xref ref-type="bibr" rid="bib48">Kotov et al., 2018</xref>). As shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref>, addition of anti-FasL mAb significantly inhibited the specific lysis of the target cells, demonstrating the involvement of the FasL/Fas pathway in the killing process.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>CD4 T cell-mediated Ag-specific cytotoxicity and transcription factor (TF) expression by CD4<sup>+</sup>GzB<sup>+</sup> T cells.</title><p>(<bold>A</bold>) Mean frequencies of dead target cells (LPS-induced B blasts) in redirected cytotoxicity assay employing sorted naïve (blue) or in vivo activated (red) CD4<sup>+</sup> T cells as effectors, at different E:T ratios, in triplicates. (<bold>B</bold>) Specific lysis of IC-21 macrophages (T) loaded with amastigote antigens, co-incubated with highly purified effector CD4<sup>+</sup> T cells, at the indicated E:T ratios, in the presence of anti-FasL mAb (red) or isotype control mAb (blue). Mean values of triplicates ± SEM are shown in (<bold>A</bold>) and (<bold>B</bold>); *p≤0.05 (two-tailed Student’s t-test). Data are representative of three independent experiments. Gating strategy on <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>. (<bold>C and D</bold>) Percentages of Ag-specific cytotoxicity in vivo; bars represent mean values + SEM (error bars) of individually analyzed mice (n=3) infected with <italic>T. cruzi</italic> Y in (<bold>C</bold>) or ovalbumin (OVA)-expressing Y strain trypomastigotes (Y-OVA) strain in (<bold>D</bold>); class I-restricted (PA8 or OVA<sub>257-264</sub>) and class II-restricted (SA851.1c+d or OVA<sub>323-339</sub>) peptides were employed. Data are representative of two independent experiments. Cell survival was measured by flow cytometry (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>) and specific lysis calculated as described in Methods. (<bold>E and F</bold>) Representative dot plots of CD4<sup>+</sup> T cells (gated as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>) and corresponding mean frequencies of gated subpopulations: (<bold>E</bold>) granzyme B (GzB) and FoxP3 staining and (<bold>F</bold>) GzB and T-bet staining. (<bold>G</bold>) Representative histogram of Eomes expression in CD4<sup>+</sup> T splenocytes of non-infected mice (ctr, gray) and in GzB<sup>-</sup> (black) and GzB<sup>+</sup> (red) CD4<sup>+</sup> T cells from infected mice, gated as in <xref ref-type="fig" rid="fig1">Figure 1A and B</xref> (left) and mean frequencies of Eomes<sup>+</sup> cells among these different subpopulations (right). All experiments were done at day 14 post-infection (pi). Bars represent mean values of non-infected ctr group n=3 or infected group, n=3–5, individually analyzed mice. Error bars = SEM. (<bold>H</bold>) Runx3d and ThPOK (<italic>Zbtb7b</italic>) mRNA expression estimated by qRT-PCR in CD4<sup>+</sup>EYFP<sup>+</sup> T cells sorted from infected and tamoxifen-treated GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP mice, as described in Methods and shown in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>; ND = not detected. Mean values of triplicates + SEM are shown. Data are representative of three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cytotoxicity assays.</title><p>(<bold>A</bold>) Cytotoxic assays were performed as in <xref ref-type="fig" rid="fig2">Figure 2A</xref> (black line and symbols) or in the presence of granzyme B (GzB) (Z-AAD-CMK, 10 μM) and perforin (PRF) (Concamycin A, 0.5 μM) inhibitors (red line and symbols) or DMSO (blue line and symbols). Mean values of triplicates ± SEM are shown. (<bold>B–C</bold>) Gating strategy of cytotoxic assays: (<bold>B</bold>) gating strategies and PI staining of IC-21 macrophages loaded with total amastigote protein extract (CFSE<sup>lo</sup>) or not (CFSE<sup>hi</sup>) and co-cultured with 4 × 10<sup>5</sup> purified CD4<sup>+</sup> T cells (right), or not (left); specific cytotoxicity values are shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref>; (<bold>C</bold>) gating strategies for CTV-stained target splenocytes, loaded with the indicated antigenic peptides or not (ctr), 20 hr after iv injection in non-infected or Y strain-infected mice. The <italic>T. cruzi</italic>-derived PA8 (class I-restricted) and SA85 (class II-restricted) peptides were employed. Specific cytotoxicity values for the in vivo assay are shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>The majority of CD4<sup>+</sup> T lymphocytes (GzB<sup>+</sup> or GzB<sup>-</sup>) in the spleen of infected mice are non-naïve (activated effectors and memory) cells.</title><p>Representative dot plots and gating strategy of staining for granzyme B (GzB), CD44 and CD62L (on the left) and mean frequency of naive (CD44<sup>lo</sup>) and non-naive (CD44<sup>hi</sup>) CD4<sup>+</sup> T cells (on the right) in: (<bold>A</bold>) non-infected (ctr) mice and gated on total CD4<sup>+</sup>TCRβ<sup>+</sup> and (<bold>B</bold>) infected mice and gated on GzB<sup>+</sup> (top) or GzB<sup>-</sup> (bottom) CD4<sup>+</sup>TCRβ<sup>+</sup> cells, at day 14 post-infection (pi). Bars represent mean values of cell frequency of individually analyzed mice; n=4; Error bars = SEM. Data are representative of three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Expression of <italic>Tbx21</italic> and <italic>Cd8a</italic> in sorted GzB<sup>+</sup>CD4<sup>+</sup> T cells.</title><p>(<bold>A</bold>) Sorting gate and frequency of CD4<sup>+</sup>GzB<sup>+</sup> (EYFP)<sup>+</sup> T cells obtained from infected and tamoxifen-treated GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP mice. CD4<sup>+</sup> cells were enriched by negative selection with magnetic beads, as described in Methods, and then submitted to FACS-sorting. Pre-sorting CD4<sup>+</sup> T cell frequency is shown on the left panel and post-sorting on the right. (<bold>B</bold>) Sorted cells had RNA extracted and <italic>Tbx21</italic>, <italic>Runx3d</italic>, <italic>Zbtb7b</italic> and <italic>Cd8a</italic> expression tested by qRT-PCR, as described in Methods. Results for <italic>Runx3d</italic> and <italic>Zbtb7b</italic> expression are shown in <xref ref-type="fig" rid="fig2">Figure 2H</xref>. ND = not detected. Mean values of triplicates + SEM are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig2-figsupp3-v2.tif"/></fig></fig-group><p>We tested the in vivo killing of target splenocytes loaded with class II-restricted peptides (SA85-1.1c and d), derived from a protein of the <italic>T. cruzi</italic> transialidase superfamily (<xref ref-type="bibr" rid="bib58">Millar and Kahn, 2000</xref>; <xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). The detailed Ag-specific repertoire of CD4CTLs could not be further assessed because of the scarce definition of parasite-derived CD4 epitopes in the literature. To circumvent this, we infected mice with ovalbumin (OVA)-expressing Y strain trypomastigotes (Y-OVA) (<xref ref-type="bibr" rid="bib34">Gomes-Neto et al., 2018</xref>) and compared the in vivo cytotoxic response against known OVA-derived CD4 and CD8 epitopes: OVA<sub>323-339</sub> and OVA<sub>257-264</sub>, respectively. As shown in <xref ref-type="fig" rid="fig2">Figure 2D</xref>, the same level of specific killing was attained against targets loaded with class I- or class II-restricted OVA peptides. Together, these experiments confirmed the presence of a CD4<sup>+</sup> T cell population with Ag-specific cytolytic function against MHC class II-restricted epitopes in the spleen of mice infected with <italic>T. cruzi</italic>.</p></sec><sec id="s2-3"><title>CD4<sup>+</sup>GzB<sup>+</sup> T cells express transcription factors typical of CTLs</title><p>We then investigated the expression of transcription factors (TFs) typical of cytotoxic CD8 T cells. T-bet and Eomesodermin (Eomes) are known to bind to the promoters of <italic>Gzmb</italic> and <italic>Prf1</italic> (<xref ref-type="bibr" rid="bib33">Glimcher et al., 2004</xref>; <xref ref-type="bibr" rid="bib40">Intlekofer et al., 2005</xref>; <xref ref-type="bibr" rid="bib68">Pearce et al., 2003</xref>) and were shown to be expressed in CD4CTLs (<xref ref-type="bibr" rid="bib22">Curran et al., 2013</xref>; <xref ref-type="bibr" rid="bib27">Eshima et al., 2012</xref>; <xref ref-type="bibr" rid="bib71">Qui et al., 2011</xref>). <xref ref-type="fig" rid="fig2">Figure 2E and F</xref> show that the vast majority of CD4<sup>+</sup>GzB<sup>+</sup> T cells express T-bet, but not FoxP3, the master gene of Treg cells. In accordance with the cytolytic potential of CD4<sup>+</sup>GzB<sup>+</sup> T cells in our model, 60% of the CD4<sup>+</sup>GzB<sup>+</sup> T cells express Eomes, while only a small percentage of GzB<sup>-</sup> CD4<sup>+</sup> T cells are Eomes<sup>+</sup> (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Of note, at day 14 pi, the vast majority of both GzB<sup>+</sup> and GzB<sup>-</sup> CD4<sup>+</sup> T lymphocytes are CD44<sup>hi</sup>CD62L<sup>lo</sup> effector/memory cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><p>CD4CTLs that migrate to the gut, gradually stop expressing ThPOK, while upregulating the expression of RUNX3 (<xref ref-type="bibr" rid="bib61">Mucida et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Reis et al., 2013</xref>), which is known to drive the CTL gene program in CD8<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib21">Cruz-Guilloty et al., 2009</xref>; <xref ref-type="bibr" rid="bib26">Egawa et al., 2007</xref>). The long-form transcript encoding RUNX3 (<italic>Runx3d</italic>) is also expressed in Th1 cells, but not in Th2 or naïve cells (<xref ref-type="bibr" rid="bib23">Djuretic et al., 2007</xref>). As shown in <xref ref-type="fig" rid="fig2">Figure 2H</xref>, besides <italic>Runx3d</italic> mRNA, we found that CD4<sup>+</sup>GzB<sup>+</sup> T cells, sorted from the spleen of tamoxifen-treated infected GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP reporter mice (<xref ref-type="bibr" rid="bib5">Bannard et al., 2009</xref>; <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>), express ThPOK (<italic>Zbtb7b gene</italic>)-coding RNA comparable to naive CD4<sup>+</sup> T cells, at day 14 pi, when their number and frequency are at the highest levels in this organ (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). The absence of CD8α-coding transcripts confirms the purity of sorted CD4<sup>+</sup>GzB<sup>+</sup> T cells (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>). Since a large fraction of CD4<sup>+</sup>GzB<sup>+</sup> T cells do not express EYFP in the infected reporter mice and, as a consequence, we could not sort bona-fide GzB<sup>-</sup> CD4<sup>+</sup> T cells, it was not possible to compare the levels of <italic>Runx3d</italic> expression between GzB<sup>+</sup> and other subsets of activated CD4<sup>+</sup> T cells. These data show that CD4<sup>+</sup>GzB<sup>+</sup> T cells generated in response to infection with <italic>T. cruzi,</italic> besides expressing cytolytic markers, also express T-bet, Eomes and RUNX3, typical TFs found in cytotoxic T cells.</p></sec><sec id="s2-4"><title>CD4<sup>+</sup>GzB<sup>+</sup> T cells express cytotoxic markers and immunoregulatory molecules</title><p>Tr1 cells are a subset of IL-10-producing CD4<sup>+</sup>FoxP3<sup>-</sup> T cells that express GzB and PRF and exert a potent suppressive function both in humans and mice (<xref ref-type="bibr" rid="bib76">Roncarolo et al., 2018</xref>). Since a high percentage of CD4<sup>+</sup>GzB<sup>+</sup> T cells in our system express Eomes, which drives the development of Tr1 cells (<xref ref-type="bibr" rid="bib89">Zhang et al., 2017</xref>), we investigated whether <italic>T. cruzi</italic>-induced CD4<sup>+</sup>GzB<sup>+</sup> T cells would share other phenotypic characteristics with Tr1 cells. We detected a very low frequency of IL-10-producing TCRαβ<sup>+</sup>CD4<sup>+</sup> T cells in the spleens of mice infected with <italic>T. cruzi</italic>, in agreement with previous data (<xref ref-type="bibr" rid="bib41">Jankovic et al., 2007</xref>), although IL-10<sup>+</sup> cells were found to be more frequent among CD4<sup>+</sup>GzB<sup>+</sup> T cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>). The co-expression of Lag-3 and CD49b defines both human and mouse Tr1 cells (<xref ref-type="bibr" rid="bib32">Gagliani et al., 2013</xref>). Although most splenic CD4<sup>+</sup>GzB<sup>+</sup> T cells express Lag-3, only a minor percentage of these cells co-express CD49b (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). On the other hand, a substantial fraction of splenic CD4<sup>+</sup>GzB<sup>+</sup> T cells express the immunoregulatory molecule Tim-3 and downregulate CD27 (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>), indicating that these might be terminally differentiated cells, as suggested in other models (<xref ref-type="bibr" rid="bib3">Anderson et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Takeuchi and Saito, 2017</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Expression of IL-10, immunoregulatory molecules and cytotoxic markers by CD4<sup>+</sup>GzB<sup>+</sup> T cells.</title><p>(<bold>A</bold>) Representative dot plots of IL-10 staining and mean frequencies of IL-10<sup>+</sup> cells among non-infected (ctr, gray) or granzyme B-negative (GzB<sup>-</sup>, black) and GzB<sup>+</sup> (red) CD4<sup>+</sup> T cells from infected mice. (<bold>B</bold>) Representative histogram of Lag-3 staining and mean frequency of Lag-3<sup>+</sup> cells. (<bold>C</bold>) Representative dot plots of Lag-3 and CD49b staining and mean frequency of different cells subsets. (<bold>D</bold>) Representative histogram of Tim-3 staining and mean frequency of Tim-3<sup>+</sup> cells among different cells subsets. (<bold>E</bold>) Representative histogram of CD27 staining and mean frequency of CD27<sup>+</sup> cells. (<bold>A–E</bold>) CD4<sup>+</sup>GzB<sup>+</sup> T cells gated as in <xref ref-type="fig" rid="fig1">Figure 1A, B</xref>; staining controls in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. (<bold>F–H</bold>) Representative dot plots and mean frequencies of (<bold>F</bold>) NKG2A/C/E, (<bold>G</bold>) NKG2D, and (<bold>H</bold>) CRTAM expression among gated CD4<sup>+</sup> T splenocytes. All experiments were done at day 14 post-infection (pi). Non-infected ctr group, n=3; infected group, n=3–5 mice, individually analyzed. Error bars = SEM; *p≤0.05; **p≤0.01; ***p≤0.001; ****p≤0.0001 (two-tailed Student’s t-test). Data are representative of three independent experiments. Staining controls are shown on <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>IL-10, Lag-3 and CD49b expression.</title><p>(<bold>A</bold>) Representative dot plots and gating strategy for IL-10 expression. Total spleen cells (left) and gated CD4<sup>+</sup> T cells (middle and right panels) of non-infected control mice. (<bold>B</bold>) Representative dot plot of IL-10 staining in total splenocytes of infected mice. Dot plot and mean frequencies of IL-10<sup>+</sup> cells among CD4<sup>+</sup>GzB<sup>-</sup> and CD4<sup>+</sup>GzB<sup>+</sup> T cells in infected mice are shown in <xref ref-type="fig" rid="fig3">Figure 3A</xref>. (<bold>C</bold>) Representative dot plot of Lag-3 and CD49b expression on gated B220<sup>+</sup>, NK1.1<sup>+</sup> or total CD4<sup>+</sup> T cells from the spleen of non-infected mice (left, middle and right panels, respectively). Mean frequencies of Lag-3<sup>+</sup>CD49b<sup>+</sup> and Lag-3<sup>+</sup>CD49b<sup>-</sup> cells among CD4<sup>+</sup>GzB<sup>-</sup> and CD4<sup>+</sup>GzB<sup>+</sup> T splenocytes of infected mice are shown in <xref ref-type="fig" rid="fig3">Figure 3C</xref>. Data are representative of two independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Representative dot plots and gating strategies for NKG2A/C/E, NKG2D and CRTAM staining on CD4<sup>+</sup> and CD8<sup>+</sup> GzB<sup>+</sup> T cells.</title><p>Staining of spleen cells from non-infected controls (right panels) and Fluorescence Minus One (FMO) and isotype controls of spleen cells from B6 infected mice (left panels) are shown. Representative dot plots and mean frequencies of CD4<sup>+</sup>GzB<sup>+</sup> and CD8<sup>+</sup>GzB<sup>+</sup> T cells expressing these cytotoxic markers are shown in <xref ref-type="fig" rid="fig3">Figure 3F–H</xref> and <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Most CD4<sup>+</sup>GzB<sup>+</sup>NKG2D<sup>+</sup> T cells express the CRTAM cytotoxic marker while only a minority of CD4<sup>+</sup>GzB<sup>+</sup> T cells co-expresses CRTAM and NKG2A/C/E molecules.</title><p>(<bold>A and B</bold>) Representative dot plots of CRTAM and NDG2D (<bold>A</bold>) or CRTAM and NKG2A/C/E (<bold>B</bold>) staining of spleen cells from non-infected and infected mice, gated on total CD4<sup>+</sup> or on CD4<sup>+</sup>GzB<sup>+</sup> T cells, respectively, as indicated. Bars graphs on the right represent mean values of individually analyzed infected mice; n=6; error bars = SEM; Data are representative of three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Expression of NKG2A/C/E, NKG2D, and CRTAM cytotoxic markers by CD8<sup>+</sup>GzB<sup>+</sup> T cells.</title><p>Representative dot plots and gating strategies of spleen cells from B6 infected mice (left panels). Graphs on the right: bars represent mean values of cell frequency of each indicated cell subpopulation in individually analyzed mice; n=4; error bars = SEM; ns = non-significant; *p≤0.05; **p≤0.01; ****p≤0.0001 (two-tailed Student’s t-test). Data are representative of three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>Frequency of CRTAM-expressing cells among splenic granzyme B-positive (GzB<sup>+</sup>) and GzB<sup>-</sup> CD4<sup>+</sup> T cells, gating or not on CD44<sup>hi</sup> cells.</title><p>Bars represent mean values of the frequency of CRTAM<sup>+</sup> cells among: CD4 naïve cells of non-infected (ctr) mice (white bar) and CD4<sup>+</sup>GzB<sup>-</sup> (gray bar), CD4<sup>+</sup>GzB<sup>+</sup> (orange bar), CD4<sup>+</sup>CD44<sup>hi</sup>GzB<sup>-</sup> (black bar) or CD4<sup>+</sup>CD44<sup>hi</sup>GzB<sup>+</sup> (red bars) of infected mice at day 14 post-infection (pi); Gating as shown in <xref ref-type="fig" rid="fig1">Figures 1A–B</xref>–<xref ref-type="fig" rid="fig3">3H</xref> and <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>. Mice were individually analyzed, n=4; error bars = SEM; ns = non-significant, Student’s t-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig3-figsupp5-v2.tif"/></fig></fig-group><p>Natural killer group 2 (NKG2) members A, C, D, and E are C-type lectin-like receptors and cytotoxic markers expressed by NK, NKT, γδ, and activated CD8<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib35">Gunturi et al., 2004</xref>; <xref ref-type="bibr" rid="bib80">Stojanovic et al., 2018</xref>). NKG2C/E and NKG2D molecules identify a CD4CTL population, present in mouse lungs during influenza A virus (IAV) infection (<xref ref-type="bibr" rid="bib54">Marshall et al., 2017</xref>). As shown in <xref ref-type="fig" rid="fig3">Figure 3F and G</xref> , the fraction of cells expressing NKG2A/C/E and NKG2D was increased among splenic CD4<sup>+</sup>GzB<sup>+</sup> T cells, when compared to either GzB<sup>-</sup> CD4<sup>+</sup> T cells of infected mice or to naive CD4<sup>+</sup> T cells of non-infected controls (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>). The class I-restricted T cell associated molecule (CRTAM) was described as being critical for the differentiation of CD4CTLs (<xref ref-type="bibr" rid="bib83">Takeuchi et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Takeuchi and Saito, 2017</xref>). <xref ref-type="fig" rid="fig3">Figure 3H</xref> shows that the frequency of CRTAM-expressing cells was also increased among splenic CD4<sup>+</sup>GzB<sup>+</sup> T cells of <italic>T. cruzi</italic>-infected mice, when compared with GzB<sup>-</sup> CD4<sup>+</sup> T cells. We then analyzed whether CRTAM and NKG2X cytotoxic markers were co-expressed on GzB<sup>+</sup>CD4<sup>+</sup> T cells. As shown in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>, while most NKG2D<sup>+</sup> cells also express the CRTAM cytotoxic marker, only a minority of CD4<sup>+</sup>GzB<sup>+</sup> T cells co-express CRTAM and NKG2A/C/E molecules. The frequencies of CRTAM<sup>+</sup>, NKG2A/C/E<sup>+</sup> and NKG2D<sup>+</sup> CD8<sup>+</sup>GzB<sup>+</sup> T cells in infected mice are shown in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>. Since, as shown in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, both GzB<sup>-</sup> and GzB<sup>+</sup> CD4<sup>+</sup> T cells are in their majority effector/memory cells at day 14 pi, equivalent results were obtained gating on CD44<sup>hi</sup> cells or not (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>). Together, these results show that a significant fraction of the CD4<sup>+</sup>GzB<sup>+</sup> T cell subpopulation found in this unicellular parasite infection model complies with the general phenotype of CD4CTLs and CD4CTL-precursors reported in response to viral infection.</p></sec><sec id="s2-5"><title>CD4CTLs are present in lower numbers in <italic>Myd88</italic><sup><italic>-/-</italic></sup> infected mice</title><p>To extend our understanding on the requirements for the differentiation of CD4CTLs and their relationship to Th1 cells, we next investigated the role of IL-12, IFN-γ and MyD88 in their generation. IL-12 and IFN-γ are the major cytokines driving Th1 differentiation and T-bet expression, but their requirement for CD4CTL generation is controversial (<xref ref-type="bibr" rid="bib12">Brown et al., 2009</xref>; <xref ref-type="bibr" rid="bib19">Cooper et al., 2004</xref>; <xref ref-type="bibr" rid="bib22">Curran et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Hua et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Kotov et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Krueger et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Tagawa et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Xie et al., 2010</xref>). Here, we observed that <italic>Il12p40<sup>-/-</sup></italic> mice infected with <italic>T. cruzi</italic> displayed lower percentages of T-bet<sup>+</sup>CD4<sup>+</sup> and IFN-γ<sup>+</sup>CD4<sup>+</sup> T cells and exhibited very low levels of CD4<sup>+</sup>GzB<sup>+</sup> T cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Interestingly, in infected <italic>Ifng<sup>-/-</sup></italic> mice, despite the lower frequency of T-bet<sup>+</sup>CD4<sup>+</sup> T cells, CD4<sup>+</sup>GzB<sup>+</sup> T cells attained the same frequencies as observed in the spleens of WT animals (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). However, absolute numbers of both total CD4<sup>+</sup> and CD4<sup>+</sup>GzB<sup>+</sup> T cells were lower in <italic>Ifng<sup>-/-</sup></italic> mice when compared to WT controls. Thus, both IL-12p40 and IFN-γ play important but distinct roles in the differentiation and expansion/survival of CD4<sup>+</sup>GzB<sup>+</sup> T cells.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Cytotoxic CD4<sup>+</sup> T cells (CD4CTLs) are severely reduced in <italic>Myd88<sup>-/-</sup></italic> mice.</title><p>(<bold>A–B</bold>) Representative dot plots of granzyme B (GzB) and T-bet staining on gated CD4<sup>+</sup> T splenocytes (left panels) and mean frequencies of T-bet<sup>+</sup>, IFN-γ<sup>+</sup> and GzB<sup>+</sup> CD4<sup>+</sup> T cells and absolute numbers of GzB<sup>+</sup>CD4<sup>+</sup> T cells (on the right) from (<bold>A</bold>) wild-type (B6) and <italic>Il12p40<sup>-/-</sup></italic> mice on day 14 post-infection (pi) and (<bold>B</bold>) wild-type (WT) and <italic>Ifng</italic><sup>-/-</sup> mice on day 11 pi. (<bold>C</bold>) Representative dot plots and gating strategy. (<bold>D</bold>) Mean frequencies and (<bold>E</bold>) absolute numbers of GzB<sup>+</sup> or NKG2A/C/E<sup>+</sup>, NKG2D<sup>+</sup> and CRTAM<sup>+</sup> cells among GzB<sup>+</sup>CD4<sup>+</sup> T cells in the spleen of WT (blue) and <italic>Myd88<sup>-/-</sup></italic> (red) mice at day 13 pi. Bars represent mean values in each group; n=5 individually analyzed mice. Error bars = SEM; ns = non-significant; *p≤0.05; **p≤0.01; ****p≤0.0001 (Student’s t-test). Representative dot plots of GzB, NKG2A/C/E, NKG2D and CRTAM staining on CD4<sup>+</sup> T cells from non-infected animals are shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>. (<bold>F–G</bold>) Frequencies (left) and absolute numbers (right) of perforin-positive (PRF<sup>+</sup>) cells among CD4<sup>+</sup> T cells (<bold>F</bold>) and of PRF<sup>+</sup> cells among GzB<sup>+</sup>CD4<sup>+</sup> T cells (<bold>G</bold>) in the spleen of non-infected (ctr) or infected (inf.) WT (blue bars) and <italic>Myd88<sup>-/-</sup></italic> (red bars) mice. GzB<sup>+</sup>CD4<sup>+</sup> T cells were gated as shown in <xref ref-type="fig" rid="fig1">Figure 1A-D</xref>. Data in (<bold>F</bold>) and (<bold>G</bold>) are compiled from four independent experiments with n=3 animals in each group, each symbol represents an individual analyzed mice. ****p≤0.0001 (Student’s t-test). (<bold>H</bold>) Frequency of dead target cells (LPS-induced B cell blasts) in cytotoxic assay, after 14 hr of co-culture with CD4<sup>+</sup>CD44<sup>hi</sup> T cells sorted from WT (blue line) or <italic>Myd88<sup>-/-</sup></italic> (red line) infected mice at day 13 pi. B cells were coated with anti-CD3 (left) or not (right). Mean of triplicates +/- SEM for each E:T ratio point are shown. Data are representative of three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Equivalent frequencies and absolute numbers of total CD4<sup>+</sup> and CD8<sup>+</sup> T cells and equivalent frequencies and absolute numbers of CD8<sup>+</sup> T cells expressing cytotoxic markers in the spleens of infected <italic>Myd88<sup>-/-</sup></italic> and wild-type (WT) mice.</title><p>(<bold>A</bold>) Mean frequencies and absolute numbers of total CD4<sup>+</sup> and CD8<sup>+</sup> T cells in the spleens of non-infected (ctr) and infected (inf.) <italic>Myd88<sup>-/-</sup></italic> and WT (B6) mice, at day 13 post-infection (pi). (<bold>B</bold>) Representative dot plots and gating strategies for granzyme B (GzB), CRTAM, NKG2D and NKG2A/C/E staining of CD4<sup>+</sup> T splenocytes from non-infected (ctr) WT (B6) and <italic>Myd88<sup>-/-</sup></italic> mice. Staining results obtained with infected mice are shown on <xref ref-type="fig" rid="fig4">Figure 4C–E</xref>. (<bold>C</bold>) Mean frequencies and (<bold>D</bold>) absolute numbers of GzB<sup>+</sup>, GzB<sup>+</sup>CRTAM<sup>+</sup>, GzB<sup>+</sup>NKG2D<sup>+</sup> and GzB<sup>+</sup>NKG2A/C/E<sup>+</sup> cells among CD8<sup>+</sup> T cells in the spleen of WT and <italic>Myd88<sup>-/-</sup></italic> infected mice at day 13 pi, gated as in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>. Bars represent mean values in each group; error bars = SEM; n=5 individually analyzed mice. Results are representative of two independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Equivalent frequency and absolute number of activated/memory (CD44<sup>hi</sup>) CD4<sup>+</sup> T cells in wild-type (WT) and <italic>Myd88<sup>-/-</sup></italic> mice infected with <italic>T. cruzi</italic>.</title><p>Representative dot plots (top) and mean frequencies and absolute numbers (bottom) of CD4<sup>+</sup>CD44<sup>hi</sup> T cells in the spleens of non-infected (ctr) and infected (inf.) WT (B6) and <italic>Myd88<sup>-/-</sup></italic> mice, at day 14 post-infection (pi). Mice were individually analyzed; n=4; error bars = SEM. Representative of two independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig4-figsupp2-v2.tif"/></fig></fig-group><p>The above results obtained in <italic>Il12p40<sup>-/-</sup></italic> and <italic>Ifng<sup>-/-</sup></italic> mice, together with the fact that <italic>Myd88<sup>-/-</sup></italic> mice have lower levels of Th1 cells and are highly susceptible to infection with <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="bib15">Campos et al., 2004</xref>; <xref ref-type="bibr" rid="bib65">Oliveira et al., 2010</xref>), prompted us to address the role of MyD88-dependent pathways in the generation of CD4CTLs. Although infected <italic>Myd88<sup>-/-</sup></italic> mice displayed equivalent absolute numbers and percentages of total splenic CD4<sup>+</sup> T cells when compared to WT mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), the frequencies and absolute numbers of CD4<sup>+</sup>GzB<sup>+</sup> T cells were significantly lower in this mouse strain (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>). Furthermore, absolute numbers of CRTAM<sup>+</sup>, NKG2D<sup>+</sup> and NKG2A/C/E<sup>+</sup> CD4<sup>+</sup>GzB<sup>+</sup> T cells were severely diminished in <italic>Myd88<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>). This picture does not result from lower numbers of total activated CD4<sup>+</sup> T cells in infected <italic>Myd88<sup>-/-</sup></italic> mice, as shown by the percentages and absolute numbers of CD44<sup>hi</sup> cells, which are equivalent to those observed in WT animals (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). On the other hand, absolute numbers of CRTAM<sup>+</sup>, NKG2D<sup>+</sup> and NKG2A/C/E<sup>+</sup> CD8<sup>+</sup>GzB<sup>+</sup> T cells were not affected in <italic>Myd88<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C-D</xref>). Concerning the expression of perforin, both the percentages and absolute numbers of PRF<sup>+</sup>CD4<sup>+</sup> T cells were also severely decreased in <italic>Myd88<sup>-/-</sup></italic> compared to WT mice (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). The same was observed when analyzing the frequency and absolute numbers of PRF<sup>+</sup>CD4<sup>+</sup> T cells among GzB-expressing cells (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). In order to establish to what extent the absence of MyD88 expression would impact on cytotoxicity mediated by CD4<sup>+</sup> T splenocytes, we sorted activated CD4<sup>+</sup>CD44<sup>hi</sup> T cells from both WT and <italic>Myd88<sup>-/-</sup></italic> infected mice to a high purity level and performed redirected cytotoxicity assay. Lower levels of cytotoxicity were observed when sorted <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup>CD44<sup>hi</sup> T cells were employed, as compared to assays using equal numbers of sorted WT CD4<sup>+</sup>CD44<sup>hi</sup> T cells (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Together, these results demonstrate the important role of MyD88 signaling for the establishment of a robust cytotoxic response mediated by CD4CTLs.</p></sec><sec id="s2-6"><title>T cell-intrinsic IL-18R/MyD88 signaling plays a crucial role in the establishment of a CD4<sup>+</sup> T cell subpopulation bearing the CD4CTL gene signature</title><p>MyD88 deficiency results in lower IL-12 production by APCs (<xref ref-type="bibr" rid="bib15">Campos et al., 2004</xref>) and this could explain the diminished numbers of CD4CTLs found in infected <italic>Myd88<sup>-/-</sup></italic> mice. However, we have recently shown that IL-18R/MyD88 signaling intrinsic to CD4<sup>+</sup> T cells is critical for Th1 cell proliferation and resistance to apoptosis in response to infection with <italic>T</italic>. cruzi (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>). If CD4CTLs herein described share a common early differentiation process with (or derive from) Th1 cells, it is reasonable to expect that besides IL-12 and IFN-γ, T-cell-intrinsic MyD88-dependent signaling would also be important for the generation of a robust CD4CTL response. In order to test this hypothesis, we constructed mix-BM chimeras in which WT (B6 × B6.SJL) F1 mice were irradiated and reconstituted with a 1:1 mix of WT and <italic>Myd88<sup>-/-</sup></italic> BM cells. After reconstitution, mix-BM chimeras were infected with <italic>T. cruzi</italic> and, at day 14 pi, we sorted WT (CD45.1) and <italic>Myd88<sup>-/-</sup></italic> (CD45.2) CD44<sup>+</sup>CD4<sup>+</sup> T cells to a high purity level for transcriptome analysis. We then investigated whether the transcriptional signature of CD4CTLs (<xref ref-type="bibr" rid="bib24">Donnarumma et al., 2016</xref>) was present in sorted CD4<sup>+</sup> T splenocytes and to what extent the absence of T-cell intrinsic MyD88-dependent signaling would impact the acquirement of this transcriptional program. This signature, previously described in the experimental model of Friend virus infection, distinguishes CD4CTLs from other CD4<sup>+</sup> T cell subsets, including Th1 and Tfh cells (<xref ref-type="bibr" rid="bib24">Donnarumma et al., 2016</xref>). Importantly, gene set enrichment analysis (GSEA), comparing the transcriptome of sorted WT and <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells, revealed that 51 genes of the CD4CTL signature were upregulated in WT CD4<sup>+</sup> T cells, while 78 were downregulated in <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). We confirmed, by flow cytometry, the upregulation of Blimp-1 (<italic>Prdm1</italic> gene) TF and of the ecto-nucleotidase CD39 (<italic>Entpd1</italic>) in WT CD4<sup>+</sup>GzB<sup>+</sup> T cells (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>). Of note, Blimp-1 is required for the cytotoxic function of CD4CTLs (<xref ref-type="bibr" rid="bib38">Hua et al., 2013</xref>) and CD39 expression level was found to be higher in CD4<sup>+</sup>GzB<sup>+</sup> T cells than in Tregs (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The cytotoxic CD4<sup>+</sup> T cells (CD4CTL) gene program is absent in MyD88-deficient CD4<sup>+</sup> T cells.</title><p>(<bold>A</bold>) GSEA performed using pre-ranked list of genes expressed in wild-type (WT) or <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells sorted from mixed bone marrow (mix-BM) chimeras using the CD4CTL gene signature previously described as gene set (<xref ref-type="bibr" rid="bib24">Donnarumma et al., 2016</xref>). (<bold>B</bold>) Venn diagram of CD4CTL genes upregulated in WT and downregulated in <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells sorted from chimeric mice. (<bold>C</bold>) Heat map of normalized CD4CTL-signature gene expression in WT or <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells sorted from chimeric mice: values indicate mean Z-score, upregulated genes in red and downregulated genes in blue. (<bold>D</bold>) Representative histograms of Blimp-1 expression (right) and mean frequency of Blimp-1<sup>+</sup> splenocytes (left) among total gated CD4<sup>+</sup> T cells from non-infected mice (ctr, gray shaded area and bar) or among CD4<sup>+</sup>GzB<sup>+</sup> (red line and bar) or CD4<sup>+</sup>GzB<sup>-</sup> (black line and bar) from WT infected mice at day 14 post-infection (pi). Individually analyzed mice, n=4. Error bars = SEM, data are representative of two independent experiments. (<bold>E</bold>) Representative histograms (left and central panel) and mean mean fluorescence intensity (MFI) values of CD39 expression (right panel) on gated FoxP3<sup>-</sup> (gray shaded area and bar) or FoxP3<sup>+</sup> (blue line and bar) CD4<sup>+</sup> T cells from non-infected (ctr) mice (left); GzB<sup>-</sup>FoxP3<sup>-</sup> (black line and bar), GzB<sup>-</sup>FoxP3<sup>+</sup> (purple line and bar) or GzB<sup>+</sup>FoxP3<sup>-</sup> (red line and bar) CD4<sup>+</sup> T cells from infected WT mice (center), at day 14 pi; individually analyzed mice (n=4), error bars = SEM; data are representative of four independent experiments. (<bold>F</bold>) Mean frequency (left) and absolute numbers (right) of GzB-expressing cells among CD45.1<sup>+</sup> (B6.SJL WT) or CD45.2<sup>+</sup> (B6 WT or KO) CD4<sup>+</sup> T splenocytes in mix-BM chimeric mice, at day 14 pi; WT:WT control chimera group, n=3; other chimera groups, n=6 or 7. Error bars = SEM, ns = non-significant, ***p≤0.001,****p≤0.0001 (paired Student’s t-test). Gating strategy and representative dot plots are shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. Data are representative of three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>GzB expression in CD4<sup>+</sup> T cells of mixed bone marrow (mixed-BM) chimeric mice.</title><p>Gating strategy and representative dot plots of (<bold>A</bold>) CD45.1<sup>+</sup> and CD45.2<sup>+</sup> cells (on the right) gated CD4<sup>+</sup>CD8<sup>-</sup> T lymphocytes (on the left) from the spleens of mixed-BM chimeric mice. (<bold>B</bold>) GzB expression in CD4<sup>+</sup>CD45.1<sup>+</sup> (wild-type; WT) and CD4<sup>+</sup>CD45.2<sup>+</sup> (WT or KO) T cells from the spleens of non-infected and infected chimeric mice at day 14 post-infection (pi), gated as in (<bold>A</bold>). Mean frequencies and absolute numbers of CD4<sup>+</sup>GzB<sup>+</sup> in each group are shown in <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig5-figsupp1-v2.tif"/></fig></fig-group><p>In order to identify the receptor signaling upstream MyD88 responsible for the establishment of a robust CD4CTL response, we further constructed three groups of mix-BM chimeras, by mixing 1:1 WT and (i) <italic>Il1r1<sup>-/-</sup></italic>, (ii) <italic>Il18ra<sup>-/-</sup></italic> or (iii) <italic>Myd88<sup>-/-</sup></italic> BM cells. A fourth group of mix-BM chimeras, 1:1 WT(B6):WT (B6.SJL) control was also generated. After infection with <italic>T. cruzi</italic>, the percentages and absolute numbers of GzB<sup>+</sup> cells among CD4<sup>+</sup> T lymphocytes were analyzed in each chimeric group (gate strategy in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). <xref ref-type="fig" rid="fig5">Figure 5F</xref> shows that the lack of IL-18R signaling in T cells, but not of IL-1R, phenocopied the absence of T cell-intrinsic MyD88 signaling, revealing that IL-18R is a critical pathway upstream MyD88 necessary for the establishment of the CD4<sup>+</sup>GzB<sup>+</sup> T cell population.</p><p>In order to further consolidate the role of IL-18R signaling in the generation of a strong CD4CTL response, we analyzed the expression of PRF as well as of CRTAM, NKG2D and NKG2A/C/E cytotoxic markers on CD4<sup>+</sup>GzB<sup>+</sup> T cells from the spleens of <italic>Il18ra<sup>-/-</sup></italic> mice. <xref ref-type="fig" rid="fig6">Figure 6A</xref> shows that both the frequency and absolute number of PRF<sup>+</sup>CD4<sup>+</sup> T cells were significantly diminished in the spleens of infected <italic>Il18ra<sup>-/-</sup></italic> compared to WT mice. The same was true for PRF-expressing cells among GzB<sup>+</sup>CD4<sup>+</sup> T lymphocytes (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). As observed in infected <italic>Myd88<sup>-/-</sup></italic> mice, the frequency of GzB<sup>+</sup>CD4<sup>+</sup> T cells and their absolute number were also decreased in infected <italic>Il18ra<sup>-/-</sup></italic> compared to WT mice (<xref ref-type="fig" rid="fig6">Figure 6C–E</xref>). Absolute numbers of CRTAM<sup>+</sup>, NKG2D<sup>+</sup> and NKG2A/C/E<sup>+</sup> GzB<sup>+</sup>CD4<sup>+</sup> T cells were significantly diminished in <italic>Il18ra<sup>-/-</sup></italic> mice as well, again phenocopying results obtained in <italic>Myd88<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig6">Figure 6C–E</xref>). The cytotoxic potential of CD4<sup>+</sup> T splenocytes from <italic>Il18ra<sup>-/-</sup></italic> infected animals was also evaluated by performing redirected cytotoxicity assays with equal numbers of CD4<sup>+</sup>CD44<sup>hi</sup> T cells purified from infected <italic>Il18ra<sup>-/-</sup></italic> or WT mice. Again, as shown for <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells, lower levels of target killing were observed when employing purified <italic>Il18ra<sup>-/-</sup></italic> CD4<sup>+</sup>CD44<sup>hi</sup> T cells as effectors (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Collectively, the present data demonstrate that T-cell intrinsic IL-18R/MyD88 signaling support the generation and/or survival of CD4<sup>+</sup> T cells with cytotoxic potential in response to parasite infection, revealing a parallel between the requirements for the development of robust Th1 and CD4CTL responses.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Cytotoxic CD4<sup>+</sup> T cells (CD4CTLs) are severely reduced in <italic>Il18ra<sup>-/-</sup></italic> mice.</title><p>(<bold>A and B</bold>) Frequencies and absolute numbers of perforin-positive (PRF<sup>+</sup>) cells among CD4<sup>+</sup> T cells (<bold>A</bold>) and of PRF<sup>+</sup> cells among GzB<sup>+</sup>CD4<sup>+</sup> T cells (<bold>B</bold>) in wild-type (WT) (blue bars) and <italic>Il18ra<sup>-/-</sup></italic> (red bars) spleens of non-infected (ctr) or infected (inf.) mice. Data are compiled from two independent experiments with n=4–5 animals in each group, each symbol represents an individual mouse. (<bold>C</bold>) Representative dot plots of GzB, CRTAM, NKG2D and NKG2A/C/E staining in WT and <italic>Il18ra<sup>-/-</sup></italic> mice. (<bold>D</bold>) Mean frequencies and (<bold>E</bold>) absolute numbers of GzB<sup>+</sup> or CRTAM<sup>+</sup>, NKG2D<sup>+</sup> and NKG2A/C/E<sup>+</sup> cells among CD4<sup>+</sup> and CD4<sup>+</sup>GzB<sup>+</sup> T cells, respectively. (<bold>A–E</bold>) CD4<sup>+</sup> T cells gated as in <xref ref-type="fig" rid="fig1">Figure 1A–D</xref>; n=4 individually analyzed mice in each group; error bars = SEM, *p≤0.05, **p≤0.01, ***p≤0.001, ns = non-significant (Student’s t-test). Data are representative of two independent experiments. (<bold>F</bold>) Frequency of dead target cells (LPS-induced B cell blasts) in cytotoxic assay, after 14 hr of co-culture with CD4<sup>+</sup>CD44<sup>hi</sup> T cells sorted from WT (blue line) or <italic>Il18ra<sup>-/-</sup></italic> (red line) infected mice at day 13 post-infection (pi). B cells were coated with anti-CD3 (left) or not (right). Mean of triplicates +/- SEM for each E:T ratio point are shown. (<bold>G</bold>) Survival curve (left) and parasite load in the heart (right) of infected <italic>Il18ra<sup>-/-</sup></italic> mice, adoptively transferred with CD4<sup>+</sup>GzBYFP<sup>+</sup> cells at day 7 pi (red curve and bar), or not (black curve and bar); time-line in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>; n=10 mice in each group; p=0.0277 Log-rank (Mantel-Cox) test; survival data are compiled from two independent experiments; ns = non-significant (Student’s t-test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Time-line of the adoptive transfer experiment shown on <xref ref-type="fig" rid="fig6">Figure 6G</xref>.</title><p>Description of the protocol is available in the Methods and materials section.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>The adoptive transfer of <italic>Ifng<sup>-/-</sup></italic> CD4<sup>+</sup> T cells increased survival to infection.</title><p>Survival curve of <italic>Il18ra<sup>-/-</sup></italic> mice, infected with 1 × 10<sup>3</sup> trypomastigotes of the Y strain and adoptively transferred with sorted (&gt;98% pure) <italic>Ifng<sup>-/-</sup></italic> CD4<sup>+</sup> T cells (green curve) or not (phosphate-buffered saline [PBS] group, black curve); n=6 mice in each group; p=0.0295 Log-rank (Mantel-Cox) test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig6-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-7"><title>The adoptive transfer of CD4<sup>+</sup>GzB<sup>+</sup> T cells to <italic>Il18ra</italic><sup><italic>-/-</italic></sup> mice extended survival to infection</title><p>In vivo studies addressing the function of CD4<sup>+</sup>GzB<sup>+</sup> T cells have been hampered by the absence of a stable and abundantly expressed surface-marker of cytotoxicity, which would allow purifying these cells alive. To circumvent this, we employed infected and tamoxifen-treated GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP reporter mice, from whose spleens CD4<sup>+</sup>EYFP<sup>+</sup> (GzB<sup>+</sup>) cells were highly purified by flow cytometry and adoptively transferred to infected <italic>Il18ra<sup>-/-</sup></italic> mice, following the scheme shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>. The <italic>Il18ra<sup>-/-</sup></italic> mouse lineage was previously shown to be very susceptible to infection with <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>), and display lower numbers of CD4<sup>+</sup>GzB<sup>+</sup> and CD4<sup>+</sup>PRF<sup>+</sup> T cells with cytotoxic potential, as demonstrated above. The transfer of highly purified CD4<sup>+</sup>GzB<sup>+</sup>(EYFP<sup>+</sup>) T cells to <italic>Il18ra<sup>-/-</sup></italic> mice significantly extended their survival rate without, however, decreasing the parasite load in the hearts (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). In a previous work, we have demonstrated that the transfer of total WT CD4<sup>+</sup> T cells protects infected <italic>Il18ra<sup>-/-</sup></italic> mice, and this property was attributed to Th1 cells, which are also diminished in this mouse lineage (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>). Since infected <italic>Ifng<sup>-/-</sup></italic> mice have the same frequency of CD4<sup>+</sup>GzB<sup>+</sup> T cells as WT mice in their spleens (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), we tested whether adoptive transfer of CD4<sup>+</sup> T cells sorted from <italic>Ifng<sup>-/-</sup></italic> mice would also be able to extend the survival of recipient <italic>Il18ra<sup>-/-</sup></italic> mice. As shown in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>, this was indeed the case. Although IFN-γ expression by CD4<sup>+</sup> T cells is necessary for decreasing parasitemia (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>), the present result indicated that the secretion of IFN-γ by adoptively transferred CD4<sup>+</sup> T cells is not absolutely required for extending the survival time of infected <italic>Il18ra<sup>-/-</sup></italic> recipients. Together, these data demonstrate the beneficial function of the CD4<sup>+</sup>GzB<sup>+</sup> T cell subset against mortality caused by an intracellular parasite, which is independent of decreasing heart parasitism.</p></sec><sec id="s2-8"><title>The great majority of CD4<sup>+</sup> T cells in the infected myocardium express the CD4CTL phenotype and increased levels of immunoregulatory markers</title><p>Previous studies in viral infection models suggested that CD4CTLs are present in tissues where pathogen replication occurs (<xref ref-type="bibr" rid="bib54">Marshall et al., 2017</xref>; <xref ref-type="bibr" rid="bib83">Takeuchi et al., 2016</xref>). Since <italic>T. cruzi</italic> heavily infects the heart, we performed intravascular staining with anti-CD4 mAb and demonstrated that tissue-infiltrating CD4<sup>+</sup> T cells are abundant in the myocardium of infected mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, B</xref>). As shown in <xref ref-type="fig" rid="fig7">Figure 7A and B</xref> and <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>, CD4<sup>+</sup>GzB<sup>+</sup> T cells infiltrating the cardiac tissue constitute the vast majority of CD4<sup>+</sup>CD44<sup>hi</sup> T cells, indicating the enrichment of this subset among activated CD4<sup>+</sup> T cells in the heart compared to the spleen. At the peak time-point of parasite load in the heart, CD4<sup>+</sup>GzB<sup>+</sup> T cells in the myocardium express the LAMP-1 degranulation marker at levels comparable to those of CD8<sup>+</sup> T cells (<xref ref-type="fig" rid="fig7">Figure 7C and D</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>). Importantly, the great majority of heart-infiltrating CD4<sup>+</sup>GzB<sup>+</sup> T cells expresses PRF, as well as the CRTAM and NKG2D cytotoxic markers (<xref ref-type="fig" rid="fig7">Figure 7E and F</xref>). On the other hand, only few CD4<sup>+</sup>GzB<sup>+</sup> T cells express NKG2A/C/E in the myocardium (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D</xref>, left). These data indicate a selective migration to, or retention in, the infected heart of double positive CRTAM<sup>+</sup>NKG2D<sup>+</sup> CD4<sup>+</sup>GzB<sup>+</sup> T cells, although both NKG2A/C/E<sup>+</sup> and NKG2D<sup>+</sup> cells are present at a similar ratio among CD4<sup>+</sup>GzB<sup>+</sup> T cells in the spleen. (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). On the other hand, high percentages of NKG2A/C/E<sup>+</sup>CD8<sup>+</sup>GzB<sup>+</sup> T cells were found both in the heart (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D</xref>, right) and in the spleen (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4A</xref>) of infected mice.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Cells with cytotoxic CD4<sup>+</sup> T cell phenotype predominate in the cardiac tissue of infected mice and are at higher frequencies in patients with Chagas cardiomyopathy (CC).</title><p>(<bold>A</bold>) Representative dot plots (gated as in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>), and mean frequency of CD8<sup>+</sup> and CD4<sup>+</sup> T cells infiltrating the heart of B6 infected mice at day 14 post-infection (pi). (<bold>B and C</bold>) Representative dot plot and mean frequency of (<bold>B</bold>) granzyme B-positive (GzB<sup>+</sup>) and (<bold>C</bold>) LAMP-1<sup>+</sup> (CD107a<sup>+</sup>) cells, among gated CD4<sup>+</sup> T cells infiltrating the infected heart; ctr = non-infected, ND = non-detected. (<bold>D</bold>) Mean parasite load in the cardiac tissue at different time points pi, obtained by real-time PCR, of individually analyzed mice as described in Methods; data are representative of at least eight (<bold>A and B</bold>) or two (<bold>C and D</bold>) independent experiments. (<bold>E</bold>) Representative dot plots and mean frequency of CRTAM<sup>+</sup> and NKG2D<sup>+</sup> cells among gated intracardiac CD4<sup>+</sup>GzB<sup>+</sup> T cells. DN and DP=CRTAM and NKG2D double negative and doulbe positive cells, respectively. Individually analyzed mice, n=4; error bars = SEM; data are representative of four independent experiments. (<bold>F</bold>) Representative dot plots and mean frequency of perforin-positive (PRF<sup>+</sup>) and GzB<sup>+</sup>PRF<sup>+</sup> cells among intracardiac CD4<sup>+</sup> T cells; data are compiled from two independent experiments with n=4 or 5 animals in each group, each symbol represents an individual analyzed mice. (<bold>G</bold>) Intensity of PRF staining (mean fluorescence intensity [MFI]) and (<bold>H</bold>) Frequency of PRF<sup>+</sup> cells among CD4<sup>+</sup> T cells in PBMCs from patients with chronic Chagas disease cardiomyopathy (CC; n=10) and healthy donors (HD; n=4) cultured overnight in medium alone (ctr) or in the presence of trypomastigote antigens (+trypo); *p≤0.05, **p≤0.01, ns = non-significant; data analyzed by paired Student’s t test. (<bold>I</bold>) Frequency of PRF<sup>+</sup> cells among CD4<sup>+</sup> T cells in the peripheral blood of patients with chronic Chagas disease cardiomyopathy (CC; n=10) and healthy donors (HD; n=4) cultured ON in the presence of trypomastigote antigens. Error bars = SEM; *p≤0.05, Student’s t test. Gating strategy and representative dot plots are shown in <xref ref-type="fig" rid="fig7s5">Figure 7—figure supplement 5</xref>. (<bold>J</bold>) Correlation analysis between the percentage of CD4<sup>+</sup>PRF<sup>+</sup> T cells among CD4<sup>+</sup> T cells in PBMCs from CC patients and left ventricular ejection fraction (LVEF) (left panel) or left atrium diameter (right panel); indicated p and r values were calculated using Pearson correlation test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>CD4<sup>+</sup> and CD8<sup>+</sup> T cells in the heart of mice infected with <italic>T. cruzi.</italic></title><p>(<bold>A</bold>) Representative FSC × SSC dot plots and gating strategy of cells from the hearts of non-infected (left panel) and infected (right panel) wild-type (WT) mice, employed for data analysis shown on this figure and <xref ref-type="fig" rid="fig7">Figure 7</xref>. (<bold>B</bold>) Representative dot plots of blood samples from infected mice injected iv with anti-CD4-FITC mAb, 3 min before euthanasia, with no other staining (left panel) or after staining with anti-CD4-PECy7 mAb in vitro (right panel). Representative dot plots of cells from the heart of non-infected (ctr) and infected mice, injected iv with anti-CD4-FITC mAb and stained in vitro with anti-CD4-PECy7 (two panels on the right), and mean frequencies of intravenously stained CD4<sup>+</sup> T cells in the hearts of non-infected (ctr) and infected mice. Mice were individually analyzed; n=3; error bars = SEM. Representative of two independent experiments. (<bold>C</bold>) Representative dot plots and gating strategy of isotype and granzyme B (GzB; left panels) or LAMP1 (right panels) staining and corresponding mean frequencies of GzB<sup>+</sup>CD8<sup>+</sup> and LAMP1<sup>+</sup>CD8<sup>+</sup> cells among gated CD8<sup>+</sup> T cells infiltrating the infected myocardium at day 14 post-infection (pi). (<bold>D</bold>) Representative dot plots of isotype and NKG2A/C/E staining on gated CD4<sup>+</sup>GzB<sup>+</sup> (left panels) or GzB<sup>+</sup>CD8<sup>+</sup> (right panels) T cells and corresponding mean frequencies of NKG2A/C/E<sup>+</sup> cells among GzB<sup>+</sup>CD4<sup>+</sup> and GzB<sup>+</sup>CD8<sup>+</sup> T cells infiltrating the infected myocardium at day 14 pi. Individually analyzed mice, n=4; error bars = SEM; ND = not detected. Data are representative of two independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>GzB<sup>+</sup>CD4<sup>+</sup> T cells are enriched among activated/memory CD4<sup>+</sup> T cells in the heart compared to the spleen of mice infected with <italic>T. cruzi.</italic></title><p>(<bold>A</bold>) Representative dot plots of granzyme B (GzB) and CD44 staining of CD4<sup>+</sup> T cells in the spleen and in the heart, gated as in <xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig7">7A</xref>. (<bold>B</bold>) Frequencies of GzB<sup>+</sup> cells among activated/memory CD4<sup>+</sup> T cells in the spleen and in the heart of individually analyzed infected mice; n=9; error bars = SEM, <sup>***</sup>p≤0.001 Student’s t test. Data are compiled from three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig7-figsupp2-v2.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title>Cytotoxic CD4 +T cells express the higher levels of immunoregulatory molecules.</title><p>(<bold>A and B</bold>) Frequency of cells expressing. Lag-3, Tim-3, CD39 or PD-1 molecules among naïve cells form non-infected mice (CD44<sup>lo</sup>, ctr) and naïve cells (CD44<sup>lo</sup>GzB<sup>-</sup>PRF<sup>-</sup>), activated non-cytotoxic (CD44<sup>hi</sup>GzB<sup>-</sup>PRF<sup>-</sup>) or activated cytotoxic (CD44<sup>hi</sup>GzB<sup>+</sup>PRF<sup>+</sup>) cells from infected mice, and (<bold>C and D</bold>) their respective levels of expression (mean fluorescence intensity, MFI), in the spleen and in the heart at day 14 post-infection (pi), as indicated. Bars represent mean frequency (<bold>A and B</bold>) or MFI (<bold>C and D</bold>) ± SEM of individually analyzed mice; n=7; ns = non-significant, <sup>*</sup>p≤0.05, <sup>**</sup>p≤0.01, <sup>***</sup>p≤0.001, <sup>****</sup>p≤0.0001 Student’s t test; ND = not detected. Data are compiled from two independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig7-figsupp3-v2.tif"/></fig><fig id="fig7s4" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 4.</label><caption><title>The expression of PD-1, CD39 and Tim-3, but not of Lag-3, is increased on cytotoxic CD4+ T cells (CD4CTLs) infiltrating the heart, compared to their levels in the spleen.</title><p>Graphs indicate the frequency of GZB<sup>+</sup>PRF<sup>+</sup> T cells expressing Lag-3, Tim-3, CD39 and PD-1 among CD4<sup>+</sup> and CD8<sup>+</sup> T cells (CD4TLs on the left and CD8CTLs on the right), and their corresponding mean fluorescence intensity (MFI), in the spleen (blue dots) and in the heart (red squares), at day 14 post-infection (pi). Symbols represent individually analyzed mice; n=7; ns = non-significant, <sup>*</sup>p≤0.05, <sup>**</sup>p≤0.01, <sup>***</sup>p≤0.001; paired Student’s t test. Data are compiled from two independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig7-figsupp4-v2.tif"/></fig><fig id="fig7s5" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 5.</label><caption><title>CD4<sup>+</sup> T cells expressing perforin (PRF) are found in the circulation of patients suffering from chronic Chagas cardiomyopathy (CC).</title><p>(<bold>A</bold>) Dot plot showing the gating strategy for CD4<sup>+</sup> T cell staining on PBMC. (<bold>B</bold>) Gating strategy and representative dot plots of perforin (PRF) staining, gated CD4<sup>+</sup> T cells as in (<bold>A</bold>), from CC patient incubated with medium (on the left), or with trypomastigote antigens (trypo) (on the right). Frequencies of PRF<sup>+</sup>CD4<sup>+</sup> T cells and mean fluorescence intensity (MFI) of PRF staining for CC patients and healthy donor controls are shown on <xref ref-type="fig" rid="fig7">Figure 7G–I</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig7-figsupp5-v2.tif"/></fig><fig id="fig7s6" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 6.</label><caption><title>Predicted model for the generation of cytotoxic CD4+ T cells (CD4CTLs) in response to <italic>T. cruzi</italic> infection.</title><p>This cartoon summarizes our results and hypothesis and also contains information from previous published studies, cited in this work. IL-12 produced during infection acts on TCR-triggered CD4<sup>+</sup> T cells, leading to T-bet expression, which promotes IFN-γ upregulation and induces <italic>Runx3d</italic> and <italic>Eomesodermin</italic> (<italic>Eomes)</italic> gene expression. In turn, IFN-γ- and IL-12-signaling induce IL-18R expression. T-bet, Eomes and Runx3d drive the expression of cytotoxic effector molecules, including granzyme B (GzB), perforin (PRF) and FasL. IL-10 expression can be induced by Blimp-1 and Eomes, although few IL-10<sup>+</sup> CD4<sup>+</sup>GzB<sup>+</sup> T cells were found in our infection model. As opposed to intraepithelial CD4CTLs of the gut, ThPOK expression is not downmodulated in splenic CD4<sup>+</sup>GzB<sup>+</sup> T cells, until day 14 pi. Only around 18% of CD4<sup>+</sup>GzB<sup>+</sup> T cells produce IFN-γ at the peak of the CD4<sup>+</sup> T cell response (14 dpi), and IFN-γ is necessary for CD4<sup>+</sup>GzB<sup>+</sup> T cell proliferation and/or survival. Most CD4<sup>+</sup>GzB<sup>+</sup> T cells express Lag-3, Tim-3, PD1 and CD39 immunoregulatory molecules, possible under the control of Blimp-1, while CD27 is downmodulated. Notably, the expansion and/or survival of CD4<sup>+</sup>GzB<sup>+</sup> T cells expressing CRTAM, NKG2D, and NKG2A/C/E cytotoxic markers depend on T-cell intrinsic IL-18R/MyD88 signaling.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74636-fig7-figsupp6-v2.tif"/></fig></fig-group><p>We next investigated the ratio of cells expressing the immunoregulatory markers Lag-3, Tim-3, CD39 and PD-1 among different CD4<sup>+</sup> T cell subsets of infected mice: naïve cells (CD44<sup>lo</sup>GzB<sup>-</sup>PRF<sup>-</sup>), activated non-cytotoxic (CD44<sup>hi</sup>GzB<sup>-</sup>PRF<sup>-</sup>) or activated cytotoxic (CD44<sup>hi</sup>GzB<sup>+</sup>PRF<sup>+</sup>) cells. The intensity of expression of these markers in each cell subpopulation was also analyzed. Results in <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>, show that CD44<sup>hi</sup>GzB<sup>+</sup>PRF<sup>+</sup> CD4<sup>+</sup> T cells compose the subset of activated cells among which the higher frequencies of cells expressing these markers are found, both in the spleen and in the heart, at day 14 pi. The only exception was the equal ratio of cells expressing PD-1, at equivalent levels, when comparing splenic CD44<sup>hi</sup>GzB<sup>-</sup>PRF<sup>-</sup> and CD44<sup>hi</sup>GzB<sup>+</sup>PRF<sup>+</sup> CD4<sup>+</sup> T cells. Similarly, equivalent percentages of cells expressing PD-1 among CD44<sup>hi</sup>GzB<sup>-</sup>PRF<sup>-</sup> and CD44<sup>hi</sup>GzB<sup>+</sup>PRF<sup>+</sup> CD4<sup>+</sup> T cells were found in the heart. However, the intensity of expression of the PD-1 marker was significantly higher among CD44<sup>hi</sup>GzB<sup>+</sup>PRF<sup>+</sup> (CD4CTLs) compared to CD44<sup>hi</sup>GzB<sup>-</sup>PRF<sup>-</sup> CD4<sup>+</sup> T cells infiltrating the cardiac tissue. Furthermore, we analyzed whether these parameters differ between CD4CTLs in the spleen and in the heart (<xref ref-type="fig" rid="fig7s4">Figure 7—figure supplement 4</xref>). Of note, while mean fluorescence intensity (MFI) values of Tim-3, CD39 and PD-1 expression were increased on CD4CTLs in the heart compared to CD4CTLs in the spleen, Lag-3 expression levels were decreased on CD4CTLs infiltrating the myocardium. Furthermore, only the expression of PD-1, but not of Lag-3, Tim-3 or CD39, is upregulated on CD8CTLs in the heart compared to the spleen (<xref ref-type="fig" rid="fig7s4">Figure 7—figure supplement 4</xref>), an indication that the <italic>T. cruzi-</italic>infected cardiac tissue is a less so-called exhaustion-inducing environment compared to certain tumors.</p></sec><sec id="s2-9"><title>The frequency of CD4<sup>+</sup>PRF<sup>+</sup> T cells correlates with cardiomyopathy in Chagas patients</title><p>Finally, we investigated the presence of PRF<sup>+</sup>CD4<sup>+</sup> T cells in the circulation of patients infected with <italic>T. cruzi</italic> and suffering from chronic Chagas cardiomyopathy (CC). In order to ascertain the specificity of CD4<sup>+</sup> T cells against <italic>T. cruzi</italic>, PBMC from CC patients or from healthy donors (HD) were incubated (or not) with trypomastigote-derived antigens (trypo) and analyzed for the expression of perforin by flow cytometry (<xref ref-type="fig" rid="fig7s5">Figure 7—figure supplement 5</xref>). As shown in <xref ref-type="fig" rid="fig7">Figure 7G and H</xref><bold>,</bold> after incubation with trypo, both the expression level of PRF (MFI) and the percentage of PRF<sup>+</sup>CD4<sup>+</sup> T cells increased among CD4<sup>+</sup> T cells from CC patients, but not from HD controls. Of note, CD4<sup>+</sup> T cells expressing PRF were found at higher frequency in CC patients than in HD (<xref ref-type="fig" rid="fig7">Figure 7I</xref>). We next performed correlative analyses between the frequency of PRF-expressing CD4<sup>+</sup> T cells in PBMC from CC patients and two echocardiographic parameters, usually employed to evaluate cardiac function in CC patients: left ventricular ejection fraction (LVEF) and left atrium diameter. As shown in <xref ref-type="fig" rid="fig7">Figure 7J and a</xref> clear inverse correlation between the frequency of CD4<sup>+</sup>PRF<sup>+</sup> T cells and LVEF, as well as a direct correlation between the frequency of these cells and the left atrium diameter was found. These correlations suggest that CD4CTLs might play a pathogenic role in the chronic phase of Chagas disease, although the alternative possibility remains that the higher levels of CD4CTLs reflect elevated parasite burden and/or inflammation in the heart, without a direct involvement of this cell subset in the pathology. Together, data obtained here in CC patients and in the mouse experimental model point to the heart as an important target-organ for CD4<sup>+</sup> T cells with cytolytic potential generated in response to infection with <italic>T. cruzi</italic>.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here we show for the first time that CD4CTLs are abundantly present in the spleen of mice infected with <italic>T. cruzi</italic> and that such phenotype predominates among CD4<sup>+</sup> T cells infiltrating the infected cardiac tissue. The expression of LAMP-1 degranulation marker by CD4<sup>+</sup>GzB<sup>+</sup> T cells in the heart and in the spleen indicates that these cells may play important effector functions in both organs. GzB<sup>+</sup>PRF<sup>+</sup>CD4<sup>+</sup> T cells present in the <italic>T. cruzi</italic>-infected hearts express CRTAM and NKG2D cytotoxicity markers, but differently from CD4CTLs found in the lungs of mice infected with IAV, do not express NKG2A/C/E molecules (<xref ref-type="bibr" rid="bib54">Marshall et al., 2017</xref>). This interesting dissimilarity requires further investigation and could be due to differential regulation exerted by tissue-specific factors or, alternatively, by different innate responses influencing CD4CTL differentiation, which would be distinctly triggered by viral and parasite pathogens.</p><p>CD4<sup>+</sup> T cells purified from the spleen of infected mice killed APCs presenting parasite-derived antigens in vitro, in a GzB- and PRF-dependent process. In vivo Ag-specific cytotoxicity against parasite-derived I-A<sup>b</sup>-restricted epitopes was also observed. It is expected that killing of infected APCs in the spleen should lead to a decrease in the activation of effector T cells, dampening the exuberant immune response against the parasite. Therefore, the cytotoxic action of CD4CTLs may contribute to immunoregulation<italic>,</italic> avoiding the development of exacerbated immunopathology that can cause mortality in the acute phase of the infection with <italic>T. cruzi</italic>. Favoring this hypothesis, we showed that adoptive transfer of CD4<sup>+</sup>GzB<sup>+</sup> T cells to susceptible <italic>Il18ra<sup>-/-</sup></italic> mice, which have lower levels of these cells, significantly increased their survival to infection without, however, affecting parasite loads. The incapacity of transferred CD4CTLs in decreasing parasite loads in the heart might be due to two facts: (i) cytotoxicity mediated by CD4CTLs is MHC class II-restricted, but only heart endothelial cells express MHC class II molecules, while the infected cardiac muscle cells remain MHC II<sup>-</sup> (<xref ref-type="bibr" rid="bib72">Reis et al., 1993</xref>); (ii) as shown here, only a small fraction of CD4<sup>+</sup> T cells with cytolytic phenotype produce IFN-γ, the main cytokine inducing trypanosomicidal function in macrophages and cardiomyocytes (<xref ref-type="bibr" rid="bib53">Machado et al., 2000</xref>). Accordingly, adoptive transfer of highly purified <italic>Ifng<sup>-/-</sup></italic> CD4<sup>+</sup> T cells (among which the same frequency of GzB<sup>+</sup> cells were found) also resulted in the significantly increase of the survival time of infected <italic>Il18ra<sup>-/-</sup></italic> mice, but did not decrease parasite levels (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>). The data discussed above, along with the fact that the parasite load is not decreased in the recipient mice indicate that IFN-γ is not involved in the extended survival granted by adoptive transfer of CD4<sup>+</sup>GzB<sup>+</sup> T cells and exclude a role for Th1 cells, which are known to exert an important microbicidal function through the production of IFN-γ (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>). Together with our previous work, the current results point to complementary roles exerted by CD4CTL and Th1 cells. Both cell types might be required for survival against infection with <italic>T. cruzi</italic>, working together to establish a balance between the Th1-dependent control of parasite load on one side, and CD4CTL-mediated dampening of the immunopathology resulting from this process, on the other. In fact, it is known that IFN-γ plays a central but dual role in Chagas disease, having both important microbicidal and pathogenic functions (<xref ref-type="bibr" rid="bib29">Ferreira et al., 2014</xref>). The equilibrium between anti-parasitic and anti-inflammatory responses underlies the establishment of the asymptomatic form of chronic infection (<xref ref-type="bibr" rid="bib64">Nunes et al., 2018</xref>), in which increased levels of CD4<sup>+</sup>GzB<sup>+</sup> T cells have been found in humans (<xref ref-type="bibr" rid="bib46">Keesen et al., 2012</xref>). Therefore, our results are in accordance with an immunoregulatory role played by CD4CTLs, likely through the GzB/PRF/FasL-mediated killing of infected APCs in an IFN-γ-independent manner, although it is not possible to formally attribute the beneficial role of adoptively transferred CD4CTLs exclusively to their cytolytic action.</p><p>Of note, we also show here that most CD4<sup>+</sup>GzB<sup>+</sup>PRF<sup>+</sup> T cells express surface co-inhibitory receptors, such as Lag-3 and Tim-3, as well as the ecto-ATPase CD39, at particularly high levels. These regulatory molecules, typically expressed by Treg, Tr1 cells and terminally differentiated or exhausted CD8<sup>+</sup> or CD4<sup>+</sup> T cells, have been implicated in the immunoregulatory functions of these cell subsets (<xref ref-type="bibr" rid="bib3">Anderson et al., 2016</xref>; <xref ref-type="bibr" rid="bib55">Mascanfroni et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Park et al., 2019</xref>). Although almost the totality of CD4<sup>+</sup>GzB<sup>+</sup> T cells express T-bet, only a minority of these cells produce IFN-γ. Most CD4<sup>+</sup>GzB<sup>+</sup> T cells also express Eomes and/or Blimp-1, two transcription factors, which are known to be involved in T cell exhaustion. Whether the repression of IFN-γ in CD4<sup>+</sup>GzB<sup>+</sup> T cells is mediated by Eomes and/or Blimp-1, as evidentiated in CD4<sup>+</sup> T cells during infection with <italic>Toxoplasma gondii</italic> (<xref ref-type="bibr" rid="bib39">Hwang et al., 2016</xref>), remains to be determined. Thus, the phenotype of a large fraction of CD4<sup>+</sup>GzB<sup>+</sup>PRF<sup>+</sup> T cells developing in response to infection with <italic>T. cruzi</italic> is typical of terminal differentiated/exhausted cells. Nevertheless, it is important to note that highly functional effector T cells can also express inhibitory receptors and despite exhaustion being often seen as a dysfunctional state, it has been shown that the expression of inhibitor molecules allows T cells to persist and to contribute to the contention of chronic viral infections without causing immunopathology (reviewed in <xref ref-type="bibr" rid="bib86">Wherry, 2011</xref>).</p><p>Chronic CC usually develops in around 30% of infected individuals after decades, probably reflecting an imbalance between parasite and host immune response (<xref ref-type="bibr" rid="bib64">Nunes et al., 2018</xref>). Although the exact mechanism remains to be elucidated, the association of NK, CD8CTL and GzA-expressing CD4<sup>+</sup> T cells with the development of chronic carditis has been indicated (<xref ref-type="bibr" rid="bib30">Ferreira et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Menezes et al., 2012</xref>; <xref ref-type="bibr" rid="bib64">Nunes et al., 2018</xref>). Since CD4CTLs recognize the cognate antigen in the context of MHC class II molecules, the lysis of infected MHC II<sup>+</sup> endothelial cells in the heart might trigger immunopathology in the chronic phase, in contrast to the possible immunoregulatory role due to the killing of infected APCs in the spleen, during the acute phase of infection, as discussed above. In the present study, we found that the frequency of parasite-specific CD4<sup>+</sup>PRF<sup>+</sup> T cells is increased in the circulation of chronic cardiac patients with Chagas disease (CC) when compared to HD. A correlation between the frequency of PRF<sup>+</sup>CD4<sup>+</sup> T cells and two echocardiographic parameters employed for evaluating myocarditis in CC patients was also encountered. It is tempting to speculate that the loss of regulatory function exerted by different CD4<sup>+</sup> T cell subsets, including CD4CTLs, might lead to the chronic pathology. Alternatively, the increased levels of CD4CTLs in chronic patients might be reflecting parasite burden and/or tissue inflammation without exerting a pathogenic function. Therefore, further studies are necessary for fully defining the role of tissue-infiltrating CD4CTLs in Chagas disease. Interestingly, NKG2D, expressed by most CD4CTLs in the heart, can mediate both activating and inhibitory signals (<xref ref-type="bibr" rid="bib85">Wensveen et al., 2018</xref>). Importantly, a polymorphism in one of the NKG2D ligands, the major histocompatibility complex class I–related chain A gene (MICA) molecule, was associated with left ventricular systolic dysfunction in patients with chronic Chagas myocarditis (<xref ref-type="bibr" rid="bib4">Ayo et al., 2015</xref>).</p><p>We have shown here that CD4<sup>+</sup>GzB<sup>+</sup> T cells originating in response to <italic>T. cruzi</italic> infection largely outnumber IFN-γ-producing CD4<sup>+</sup> T cells and that their appearance in the spleen follows the same kinetics of classic Th1 cells, indicating thereby that differentiation of CD4CTLs is not a late event during infection. Of note, more than 60% of CD4<sup>+</sup>GzB<sup>+</sup> T cells have downregulated CD27 expression in the spleen at day 14 pi, a characteristic of terminally differentiated T cells (<xref ref-type="bibr" rid="bib84">Takeuchi and Saito, 2017</xref>). We have also shown here that the majority of CD4<sup>+</sup>GzB<sup>+</sup> T cells express T-bet, Eomes and Blimp-1. Although Eomes seems not to be essential for CD4CTLs in certain studies (<xref ref-type="bibr" rid="bib24">Donnarumma et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Kotov et al., 2018</xref>), it was proposed to be the master regulator for CD4CTLs and Tr1 cells by others (<xref ref-type="bibr" rid="bib22">Curran et al., 2013</xref>; <xref ref-type="bibr" rid="bib27">Eshima et al., 2012</xref>; <xref ref-type="bibr" rid="bib71">Qui et al., 2011</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2017</xref>). The CD4<sup>+</sup>GzB<sup>+</sup> T cell population described herein presents some characteristics in common with Tr1 cells. However, we only detected a very low frequency of CD4<sup>+</sup>GzB<sup>+</sup> T cells co-expressing Lag-3 and CD49b (<xref ref-type="bibr" rid="bib32">Gagliani et al., 2013</xref>) or IL-10. In this regard, data from <italic>T. cruzi</italic> infection differs from those observed during infection with other intracellular parasites such as <italic>T. gondii</italic> and certain <italic>L. major</italic> strains, in which high frequencies of CD4<sup>+</sup> T cells producing both IL-10 and IFN-γ were described (<xref ref-type="bibr" rid="bib2">Anderson et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Jankovic et al., 2007</xref>). In contrast with ThPOK<sup>-</sup> CD4CTLs that accumulate in the gut (<xref ref-type="bibr" rid="bib18">Cheroutre and Husain, 2013</xref>; <xref ref-type="bibr" rid="bib61">Mucida et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Reis et al., 2013</xref>), CD4<sup>+</sup>GzB<sup>+</sup> T cells in the <italic>T. cruzi-</italic>infected spleen express ThPOK at the peak of infection. Interestingly, other studies observed the absence of ThPOK downregulation in mouse and human CD4CTLs (<xref ref-type="bibr" rid="bib59">Mittal et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Serroukh et al., 2018</xref>). On the other hand, we also detected <italic>Runx3d</italic> expression in GzB<sup>+</sup> CD4<sup>+</sup> T cells, although it was not possible to compare it to the levels found in the Th1 cell subset (<xref ref-type="bibr" rid="bib23">Djuretic et al., 2007</xref>). Thus, different subpopulations of CD4CTL possibly exist, in which the interplay between ThPOK and RUNX3 expression might be differentially regulated.</p><p>Although many authors consider CD4CTLs merely functional variants of Th1 cells, in some models CD4CTLs fail to fit Th1-defining criteria, such as the dependence on IL-12, STAT4 or T-bet for differentiation (<xref ref-type="bibr" rid="bib12">Brown et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Curran et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Hua et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Kotov et al., 2018</xref>). Nonetheless, in agreement with other studies (<xref ref-type="bibr" rid="bib19">Cooper et al., 2004</xref>; <xref ref-type="bibr" rid="bib49">Krueger et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Tagawa et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Xie et al., 2010</xref>), we showed here that CD4<sup>+</sup>GzB<sup>+</sup> T cells are scarcely generated in the absence of IL-12p40. Importantly, we demonstrated that the expansion/survival of CD4CTLs also depends on T-cell intrinsic IL-18R/MyD88 signaling, which we have previously shown to induce cell cycling, anti-apoptotic and Th1-signature transcripts (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>). Notably, several genes of the CD4CTL signature, which distinguishes this subset from Th1 and Tfh cells (<xref ref-type="bibr" rid="bib24">Donnarumma et al., 2016</xref>), were expressed by WT, but not by <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells from infected mix-BM chimeras. Therefore, analogous to its action on Th1 cells, we showed here that T-cell intrinsic IL-18R/MyD88 signaling contributes for the reinforcement and/or stabilization of CD4<sup>+</sup> T cell commitment into the CD4CTL phenotype. IFN-γ is another key cytokine involved in Th1 differentiation and <italic>Ifng<sup>-/-</sup></italic> mice are extremely susceptible to infection with <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="bib15">Campos et al., 2004</xref>). Interestingly, we found no difference in the frequency of CD4<sup>+</sup>GzB<sup>+</sup> T cells between WT and <italic>Ifng<sup>-/-</sup></italic> infected mice, in accordance with a study showing that IFN-γ had no impact on the ability of CD4 effectors to acquire cytolytic activity (<xref ref-type="bibr" rid="bib13">Brown et al., 2012</xref>). However, both GzB<sup>+</sup> and total CD4<sup>+</sup> T-cell numbers were significantly lower in the infected <italic>Ifng<sup>-/-</sup></italic> animals, indicating that IFN-γ might also play a role in the expansion/survival of both Th1 and CD4CTLs in our system. It is known that IFN-γ and IL-18R participate in a reciprocal positive feedback loop in Th1 differentiation process: while IFN-γ is required for IL-12-driven upregulation of IL-18R expression (<xref ref-type="bibr" rid="bib62">Nakahira et al., 2001</xref>; <xref ref-type="bibr" rid="bib79">Smeltz et al., 2001</xref>), IL-18 is a major IFN-γ-inducing factor. Therefore, the absence of IL-18R upregulation in CD4<sup>+</sup> T cells of <italic>Ifng<sup>-/-</sup></italic> mice would prevent the expansion of both CD4<sup>+</sup> T cell subpopulations. Thus, in <italic>T. cruzi</italic> infection model, IL-12, IFN-γ and IL-18R/MyD88 signaling act as key pathways at early check-points in the generation of CD4<sup>+</sup>GzB<sup>+</sup> T cells with cytotoxic potential, suggesting that these cells might share common early differentiating steps with the Th1 subset. It is not excluded, however, that different precursors of CD4CTL and Th1 cells might exist (<xref ref-type="bibr" rid="bib84">Takeuchi and Saito, 2017</xref>). A cartoon summarizing our results and cited works published by others is shown in <xref ref-type="fig" rid="fig7s6">Figure 7—figure supplement 6</xref>. Of note, in humans, the higher production of IL-18 due to gene polymorphisms has been correlated to protection against chronic CC (<xref ref-type="bibr" rid="bib51">Leon Rodriguez et al., 2016</xref>; <xref ref-type="bibr" rid="bib63">Nogueira et al., 2015</xref>).</p><p>It is possible that differentiation into CD4CTLs could also be influenced by pathogen-derived factors. Very recently, Krueger et al have shown that a subset of IL-12-dependent Th1-derived cytotoxic cells was present in the spleen of <italic>Il18<sup>-/-</sup></italic> mice at later stages of infection with <italic>Salmonella enterica</italic> (<xref ref-type="bibr" rid="bib49">Krueger et al., 2021</xref>). Whether that result was due to compensatory mechanisms, such as the known exacerbated IL-12 production by infected <italic>Il18<sup>-/-</sup></italic> mice (<xref ref-type="bibr" rid="bib60">Monteforte et al., 2000</xref>), or to distinct innate responses, differentially induced by phagosomal bacteria and cytosolic parasites, remains to be determined. Of note, other discrepancies between results obtained with <italic>Il18<sup>-/-</sup></italic> versus <italic>Il18ra<sup>-/-</sup></italic> mouse lineages have been described in different models in the past (<xref ref-type="bibr" rid="bib36">Gutcher et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">Lewis and Dinarello, 2006</xref>). It is known that different classes of pathogens can trigger diverse APC responses and, therefore, elicit pathogen-tailored Th programs (<xref ref-type="bibr" rid="bib45">Kara et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Kiner et al., 2021</xref>). Previous works have reported the immunoregulatory action of <italic>T. cruzi</italic>-derived PAMPs on CD4<sup>+</sup> T cell activation, either by directly acting as co-stimulatory signals for T cells or by modulating APC functions (<xref ref-type="bibr" rid="bib7">Bellio et al., 1999</xref>; <xref ref-type="bibr" rid="bib25">DosReis et al., 2002</xref>; <xref ref-type="bibr" rid="bib56">Medeiros et al., 2007</xref>). It would be interesting to test <italic>T. cruzi</italic>-derived molecules on their capacity to favor the generation of CD4CTLs.</p><p>In summary, the present work is the first to describe a CD4CTL subset abundantly present in the <italic>T. cruzi</italic>-infected cardiac tissue, bringing novel pieces to the scenario of the immune response against a major human intracellular parasite. Importantly, our data disclose a mechanistic framework involved in the generation of a robust CD4CTL response, whose control and optimization may provide new therapeutic and vaccination strategies to combat infection with intracellular pathogens and chronic diseases resulting thereof.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p>C57BL/6 (RID:IMSR_JAX:000664), B6.SJL (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:002014">IMSR_JAX:002014</ext-link>), and F1 (B6 × B6.SJL) mice were from the Universidade Federal Fluminense. <italic>Myd88<sup>-/-</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:5447806">MGI:5447806</ext-link>) mice were generated by Dr. S. Akira (Osaka University, Japan); <italic>Il12p40<sup>-/-</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:002693">IMSR_JAX:002693</ext-link>) and <italic>Ifng<sup>-/-</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:002287">IMSR_JAX:002287</ext-link>) mice were purchased from USP; <italic>Il18ra<sup>-/-</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004131">IMSR_JAX:004131</ext-link>) and <italic>Il1r1<sup>-/-</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:003245">IMSR_JAX:003245</ext-link>) mice from JAX Mice, USA. GzB reporter mice, GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP, previously described (<xref ref-type="bibr" rid="bib5">Bannard et al., 2009</xref>) were provided by Dr Ricardo Gazinelli (UFMG, BH, Brazil). Mice were on the C57BL/6 background, except GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP, which were on mixed Sv129/B6 background and backcrossed to B6 for 5 generations. In each experiment, only male mice of the same age (6- to 8-week-old) were used. Mice were housed at a maximum of 5 animals per cage, in forced-air-ventilated micro-isolation rack system, in a room at 21–23<sup>◦</sup>C under a 12/12 hr light/dark cycle and provided with sterilized water and chow ad libitum. All mouse experiments were conducted in accordance with guidelines of the Animal Care and Use Committee of the Federal University of Rio de Janeiro (Comitê de Ética do Centro de Ciências da Saúde CEUA - CCS/UFRJ, license: IMPPG022).</p></sec><sec id="s4-2"><title>Experimental infection</title><p>Bloodstream trypomastigotes of the Y strain of <italic>T. cruzi</italic> (2 × 10<sup>3</sup> cells/0.2 mL) were inoculated intraperitoneally (ip). Y-OVA strain trypomastigotes (<xref ref-type="bibr" rid="bib34">Gomes-Neto et al., 2018</xref>) were obtained from LLC-MK2 infected cultures and 2 × 10<sup>6</sup> trypomastigotes (in 0.2 mL phosphate-buffered saline; PBS) were inoculated ip. Rare outliers (mice in which the infection was not properly established) were identified by the lower size of the spleen (total cell number) and lower percentage of GzB<sup>+</sup>CD8<sup>+</sup> T cells (inferior of 50%) in the spleen. These outlier mice were excluded from all analyses. Mice found at the moribund condition (presenting unambiguous signals that the experimental endpoint has been reached), were euthanized.</p></sec><sec id="s4-3"><title>Generation of BM chimeras</title><p>Acidic drinking water (pH 2.5–3.0) was given for 8 days to recipient mice prior to irradiation with a lethal single dose of 800 rad (TH780C - Theratronics, Canada). The day after irradiation, BM cells were transferred and mice were treated with neomycin sulfate (2 mg/mL) in the drinking water for 15 days. Marrow was harvested from the femur and tibia of B6.SJL (CD45.1<sup>+</sup>) and B6, <italic>Myd88<sup>-/-</sup>, Il1r1<sup>-/-</sup></italic> or <italic>Il18ra<sup>-/-</sup></italic> (CD45.2<sup>+</sup>) mice. For mixed BM chimeras, CD45.1<sup>+</sup> and CD45.2<sup>+</sup> BM cells were transferred in a 1:1 ratio (2 × 10<sup>6</sup> cells each) to irradiated mice. In all experiments, mice were infected 6–8 weeks after cell transfer, when reconstitution was achieved.</p></sec><sec id="s4-4"><title>Human population</title><p>A total of thirteen volunteers were enrolled in this study. Nine volunteer patients had positive specific serology for <italic>T. cruzi</italic> and displayed the chronic CC with right and/or left ventricular dilation, global left ventricular dysfunction, alterations in the cardiac electric impulse generation and conduction upon electrocardiogram, chest x-rays and echocardiography; four individuals displayed negative specific serological tests for Chagas disease and were included as control group (HD). Patients were from Chagas disease endemic regions within Minas Gerais, Brazil, and were evaluated at the outpatient clinic of the Universidade Federal de Minas Gerais. HD were from Belo Horizonte, which is a non-endemic region for Chagas disease. We excluded from our study individuals with any other chronic inflammatory diseases, diabetes, heart/circulatory illnesses or bacterial infections. All individuals included in this work were volunteers and treatment and clinical care were offered to all patients, as needed, despite their enrollment in this research project. All participants provided written informed consent for participation in the study. This cross-sectional study is part of an extended project evaluating biomarkers of cardiomyopathy development in Chagas disease, which has the approval of the National Committee of Ethics in Research (CONEP#195/2007) and are in accordance with the Declaration for Helsinki.</p></sec><sec id="s4-5"><title>PBMC flow cytometry</title><p>Peripheral blood samples were collected in heparin tubes. PBMCs were obtained by separating whole blood over Ficoll (Sigma-Aldrich, St. Louis, MO), as previously described (<xref ref-type="bibr" rid="bib57">Menezes et al., 2012</xref>). Cells were washed and resuspended in RPMI 1640 medium (Gibco, Rockville, MD) supplemented with 5% heat-inactivated AB human serum, antibiotics (penicillin, 200 U/mL; and streptomycin, 0.1 mg/mL) and L-glutamine (1 mM) (Sigma-Aldrich) at a concentration of 1 × 10<sup>7</sup> cells/mL. Cells from each volunteer were cultured on 96-well plates (Costar, Corning Incorporated, Corning, NY) in 200 μL of medium alone (ctr) or containing 20 μg/mL of trypomastigote antigen (trypo) for 18 hr. Trypo was obtained from trypomastigotes purified from VERO cell cultures: parasites were washed, freeze-thawed for 3 cycles, followed by 5 cycles of 5 min each of sonication using 30 s between them. Samples were ultracentrifugated at 5000 g for 60 min, at 4°C. Supernatants were collected, dialyzed for 24 hr and protein quantification performed by Bradford method. Cells (2 × 10<sup>5</sup>) were incubated with PerCP-anti-CD4 (clone A161A1) antibody (Biolegend) for 15 min at 4°C, washed in PBS containing 1% bovine serum albumin, and fixed by a 20 min incubation with a 2% formaldehyde. After washing with PBS, cells were permeabilized with 0.5% saponin for 15 min and intracellularly stained with PE-anti-perforin (clone B-D48) antibody (Biolegend) for 20 min, washed twice with 0.5% saponin solution, resuspended in PBS and analyzed. A minimum of 100,000 gated events from each sample were collected and analyzed using FlowJo software.</p></sec><sec id="s4-6"><title>Flow cytometry of mouse cells</title><p>Reagents and antibodies: PB-anti-CD45.1, APC-Cy7-anti-CD45.2, FITC- PE- or BV-605-anti-CD4, PE-anti-CD8, PE-Cy7-anti-NK1.1, BV421-anti-TCRβ, PE-anti-2B4, FITC-anti-CD107a, PE-Cy7-anti-CD39, PE-anti-FasL, PE-Cy7-anti-CRTAM, PE-anti-NKG2D, PE-anti-NKG2A/C/E, FITC- or AlexaFluor647-anti-GzB, PE-anti-Eomes, PE- or A647-anti-T-bet, PE-anti-FoxP3, AlexaFluor647-anti-Blimp1, and PE-anti-PRF were used. All mAbs were purchased from Biolegend, BD Biosciences or eBioscience/Thermo Fisher Scientific. Spleen cells were stained after red blood cell lysis with ACK buffer. Hearts were perfused with 20 mL of cold PBS, minced into small fragments and treated with collagenase D (1.0 mg/mL) and DNAse I (0.1 mg/mL), for 1 hr at 37°C. Collagenase D, DNAse I, monensin and saponin were purchased from Sigma-Aldrich. Single cell suspensions were incubated with anti-CD16/CD32 (FcR block) for 5 min and then surface stained for 30 min on ice. For IL-10 and IFN-γ intracellular staining, 2 × 10<sup>6</sup> spleen cells were cultured in the presence of PMA (16 nM), ionomycin (0.5 μM), monensin (5 μM) and brefeldin A (3.0 μg/mL) for 4 hr. After staining for surface markers, cells were fixed with paraformaldehyde 1% for 1 hr, permeabilized with saponin 0.2% for 20 min and stained with PE-Cy7-anti-IFN-γ mAb and/or PE-anti-IL-10 mAbs (Biolegend). For TF and GzB/PRF staining, the FoxP3 staining buffer kit (eBioscience, ThermoFisher Scientific) was employed. At least 20,000 events gated on CD4<sup>+</sup> T cells were acquired. Analytical flow cytometry was conducted with MoFlo (Beckman Coulter/Dako-Cytomation), FacsCanto, FacsCalibur or BD LSRFortessa (BD Bioscience) and data analyzed with Summit V4.3 software (Dako Colorado, Inc).</p></sec><sec id="s4-7"><title>Cytotoxicity assays and cell lines</title><p>For redirected cytotoxic assay, sorted B cells (B220<sup>+</sup>), previously activated by LPS (InvivoGen), at 25 µg/mL for 48 hr and then incubated for 1 hr with anti-CD3ε antibody (10 μg/mL), were employed as target cells. FACS-sorted naïve (CD44<sup>low</sup>CD4<sup>+</sup>) and effector/memory (CD44<sup>hi</sup>CD4<sup>+</sup>) T cells were purified from the spleen of non-infected and infected mice, respectively. In some experiments, sorted T cells were treated for 1 h with GzB (Z-AAD-CMK, 10 μM) and PRF (Concamycin A, 0.5 μM) inhibitors (Biovision Inc, Milpitas, CA), before coincubation at different E:T ratios, with 10<sup>4</sup> target B cells (prepared as aforementioned) in round-bottom microplates (Costar-Corning) for 14 hr, at 37°C in a 5% CO<sub>2</sub> incubator and in triplicates. After incubation, living target cells were quantified by flow cytometry, after staining with propidium iodide at 0.5 μg/mL (Sigma-Aldrich). For <italic>T. cruzi</italic>-specific cytotoxicity assays, CD4<sup>+</sup> T cells were obtained from infected B6 mice, at day 14 pi, and purified by FACS sorting (MoFlo cell sorter, Beckman Coulter/Dako-Cytomation). IC-21 macrophage cell lineage (ATCC) were used as targets in vitro. For this, IC-21 cells were counted and split into two tubes: half of the target cells were incubated for 45 min at 37° C in 5% CO<sub>2</sub>, in RPMI containing <italic>T. cruzi</italic> amastigote protein extract (30 μg/mL) obtained as previously described (<xref ref-type="bibr" rid="bib65">Oliveira et al., 2010</xref>). For in vivo cytotoxic assays, Ag-loaded cells were then stained with 2.5 μM CFSE (CFSE<sup>Hi</sup>) (Invitrogen, Life Technologies), and control cells with 0.5 μM CFSE (CFSE<sup>Low</sup>) in 5 mL of warm PBS for 10 min at 37 ° C. After two washes in RPMI 1640 (10% FCS), cells were resuspended at a concentration of 2 × 10<sup>5</sup> cells/mL each and mixed at 1:1 ratio (CFSE<sup>Hi</sup>:CFSE<sup>Low</sup>). Purified CD4<sup>+</sup> T cells were added at different E:T ratios. Cells were seeded in duplicate to round-bottom 96-well plate in a final volume of 200 μL. After ON incubation, cells were harvested, incubated with 0.5 μg/mL of propidium iodide and PI<sup>+</sup> cells were excluded from FACS analysis. The percentage of specific lysis was calculated using the formula: % of specific lysis =100× [(CFSE<sup>Low</sup> / CFSE<sup>Hi</sup>) ctr − (CFSE<sup>Low</sup> / CFSE<sup>Hi</sup>) effector] × (CFSE<sup>Low</sup> / CFSE<sup>Hi</sup>) ctr<sup>−1</sup>. For in vivo cytotoxicity assays, splenocytes from non-infected B6 mice were employed as target cells after being divided in 3 subpopulations and stained with 10.0 (High), 2.5 (Int), and 0.625 (Low) μM of CFSE or of CTV (Invitrogen, Life Technologies). CFSE<sup>Int</sup> and CFSE<sup>Low</sup> cells were loaded with one of the following peptides: SA85c (SHNFTLVASVIIEEA), SA85d (LVASVIIEEAPSGNT), OVA<sub>323-339</sub>, OVA<sub>257-263</sub>, or PA8 (VNHRFTLV) at 2 μM, all from GenScript, EUA. CFSE<sup>Hi</sup> cells were not loaded with any peptide and used as internal control. For calculating the percentage of specific lysis, CFSE<sup>Hi</sup> and CFSE<sup>Int</sup> (or CFSE<sup>Low</sup>) were gated together in order to constitute 100% of cells. CFSE<sup>Hi</sup> and CFSE<sup>Int</sup> (or CFSE<sup>Low</sup>) populations were then individually gated and specific lysis was calculated using the following formula: % of specific lysis =100× [(CFSE<sup>Low or Int</sup> / CFSE<sup>Hi</sup>) ctr − (CFSE<sup>Low or Int</sup> / CFSE<sup>Hi</sup>) effector] × (CFSE<sup>Low or Int</sup> / CFSE<sup>Hi</sup>) ctr<sup>−1</sup>.</p></sec><sec id="s4-8"><title>Real time RT-PCR</title><p>RNA was extracted using the RNeasykit (QIAGEN). cDNA was synthesized using the High Capacity cDNA Reverse Transcription Kit (Invitrogen, Life Technologies), following the manufacturer’s instructions. Gene expression was analyzed using primers in combination with SYBR Green on a StepOneReal Time PCR System (Applied Biosystems, Life Technologies). The expression level of the genes of interest was determined relative to the expression of 18 S rRNA. Primers: <italic>Runx3</italic> Fwd.: 5’- ACA GCA TCT TTG ACT CCT TCC –3’; <italic>Runx3</italic> Rev.: 5- GTT GGT GAA CAC GGT GAT TG- 3’; <italic>Thpok</italic> Fwd: 5’- ATG GGA TTC CAA TCA GGT CA-3’; <italic>Thpok</italic> Rev.5’- TTCTTC CTA CAC CCT GTG CC –3’; <italic>CD8a</italic> Fwd: 5’ - ACT GCA AGG AAG CAA GTG GT – 3’; <italic>CD8a</italic> Rev: 5’-CAC CGC TAA AGG CAG TTC TC-3’; 18S-Fwd.: 5’- GGG CGT GGG GCG GAG ATA TGC - 3’ and 18S-Rev.: 5’- CG CGG ACA CGA AGG CCC CAA A –3’. For parasite load quantification, hearts of infected mice were perfused, minced and immediately homogenized in 1.0 mL of 4.0 M Guanidine thiocyanate (SIGMA-Aldrich) containing 8.0 μl/mL of β-mercaptoethanol and processed for DNA extraction. Generation of PCR standards and detection of parasite tissue load by real-time PCR was carried out as described (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>); briefly, primers amplify a repeated satellite sequence of <italic>T. cruzi</italic> DNA of 195 base-pairs: TCZ-Fwd.: (5’-<named-content content-type="sequence">GCTCTTGCCCACAAGGGTGC</named-content>-3’) and TCZ-Rev.: (5’-<named-content content-type="sequence">CCAAGCAGCGGATAGTTCAGG</named-content>-3’). Reactions with TNF-a-Fwd: (5’- <named-content content-type="sequence">CCTGGAGGAGAAGAGGAAAGAGA</named-content>-3’) and TNF-a-Rev.: (5’- <named-content content-type="sequence">TTGAGGACCTCTGTGTATTTGTCAA</named-content>-3’) primers for <italic>Mus musculus</italic> TNF-α gene were used as loading controls.</p></sec><sec id="s4-9"><title>Gene-expression analysis</title><p>Gene expression data were extracted with GeneSpring software GX 11.0 software using default parameters. Data were then normalized by subtracting the average from all genes from each gene intensity and dividing the result by the standard deviation of all gene intensities (i.e. z-score normalization). Z ratios were calculated as previously described (<xref ref-type="bibr" rid="bib17">Cheadle et al., 2003</xref>) and used to compare the difference in expression between WT samples and <italic>Myd88</italic><sup>-/-</sup> samples. Gene Set Enrichment Analysis (GSEA) (<ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/gsea/index.jsp">http://www.broadinstitute.org/gsea/index.jsp</ext-link>) was performed on the genes pre-ranked by Z ratios (1,000 permutations and Weighted Enrichment Statistic) using as data set 82 differentially expressed genes of sorted WT and <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells (GEO accession no. GSE57738) (<xref ref-type="bibr" rid="bib66">Oliveira et al., 2017</xref>); and using as gene set the CD4<sup>+</sup>GzmB<sup>+</sup> (CD4CTL) transcriptional signature (159 upregulated genes) previously described (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB14043">https://www.ebi.ac.uk/ena/data/view/PRJEB14043</ext-link>).</p></sec><sec id="s4-10"><title>Adoptive CD4<sup>+</sup> T cell transfer assay</title><p>Eight-week-old male GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP mice were infected with 2 × 10<sup>3</sup> trypomastigotes and treated with 4 mg/animal/day of tamoxifen citrate (Sandoz-Novartis) from day 7 to 11 pi by gavage. Spleen cells were harvested and treated with ACK for red blood cells lysis at day 13 pi. Alternatively, CD4<sup>+</sup> T cells were purified from the spleen of non-treated and infected <italic>Ifng<sup>-/-</sup></italic> mice. In both cases, spleen cells were labeled with biotinylated anti-B220, anti-CD11b, anti-NK1.1, anti-γδTCR, anti-CD8 and PE-conjugated anti-CD4 antibodies for 30 min on ice, followed by staining with PE-Cy7-conjugated Streptavidin for 20 min. Residual PE-Cy7<sup>+</sup> cells were excluded and EYFP<sup>+</sup>PE<sup>+</sup> (CD4<sup>+</sup>GzB<sup>+</sup> T cells) or PE<sup>+</sup>CD4<sup>+</sup> (<italic>Ifng<sup>-/-</sup></italic> CD4<sup>+</sup> T cells) were sorted using MoFlo cell sorter (Beckman Coulter/Dako-Cytomation). CD4<sup>+</sup>GzB<sup>+</sup> T cells (2.8 × 10<sup>5</sup> cells/animal) or <italic>Ifng<sup>-/-</sup></italic> CD4<sup>+</sup> T cells (1.3 × 10<sup>6</sup> cells/animal), both presenting purity higher than 98%, were adoptively transferred by iv injection into <italic>Il18ra<sup>-/-</sup></italic> recipient mice, previously infected with 1 × 10<sup>3</sup> trypomastigotes (day 7 pi). Control groups of <italic>Il18ra<sup>-/-</sup></italic> and <italic>Myd88<sup>-/-</sup></italic> infected mice received PBS. Survival was accompanied daily.</p></sec><sec id="s4-11"><title>Statistics</title><p>Statistical analyses were performed using GraphPad Prism version 6 for Mac OS (GraphPad Software, San Diego California USA, <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link>). Sample sizes were chosen to allow the detection of statistical differences with p&lt;0.5 using Student’s t test, or the Log-rank (Mantel-Cox) test for mouse survival curves. Correlation analysis employed Pearson correlation test. When comparing two groups, the minimum number was n=3 per group. In some experiments, the number was increased to n=9 to permit p&lt;0.05 even considering the possibility of a single outlier in a population. Data are expressed as mean ± SEM and considered statistically significant if p values were&lt;0.05.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Methodology, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Methodology, Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology, Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Methodology</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology, Formal analysis</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con10"><p>Methodology, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Validation, Writing – original draft, Writing – review and editing, Supervision</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: All individuals included in this work were volunteers and treatment and clinical care were offered to all patients, as needed, despite their enrollment in this research project. All participants provided written informed consent for participation in the study. This cross-sectional study is part of an extended project evaluating biomarkers of cardiomyopathy development in Chagas disease, which has the approval of the National Committee of Ethics in Research (CONEP#195/2007) and are in accordance with the Declaration for Helsinki.</p></fn><fn fn-type="other"><p>All mouse experiments were conducted in accordance with guidelines of the Animal Care and Use Committee of the Federal University of Rio de Janeiro (Comitê de Ética do Centro de Ciências da Saúde CEUA - CCS/UFRJ, license: IMPPG022).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-74636-transrepform1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Transcriptome data was uploaded to GEO and is already publicly available with the GEO accession no. GSE57738.</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>BS</given-names></name><name><surname>Bellio</surname><given-names>M</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Nóbrega</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>T cell-intrinsic MyD88 signaling in cognate immune response to intracellular parasite infection: crucial role for IL-18R</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57738">GSE57738</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Donnarumma</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Single-cell RNA sequencing of CD4 T cells 7 days after infection or immunisation</data-title><source>ENA</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB14043">PRJEB14043</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Dr Ricardo T Gazzinelli (Fiocruz, MG, Brazil) for enriching discussion and providing GzmbCreER<italic><sup>T2</sup></italic>/ROSA26EYFP mouse lineage, Dr Helder I Nakaya (University of São Paulo, SP, Brazil) for helping with Bioinformatics Analyses and Dr Hilde Cheroutre (La Jolla Institute for Immunology, CA, USA) for critically reading our manuscript and enriching discussion. Funding: this study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Pesquisas (CNPq) and by The National Institute for Vaccine Development and Technology (INCTV-CNPq). CDB and LMB received PhD fellowships from CNPq; AG and EGAN received PhD fellowships from CAPES; FBC and AG received PDJ-CNPq fellowships. GM received PIBIC-CNPq fellowship. AN, WOD and MB received PQ fellowship from CNPq; AN and MB received CNE grant from FAPERJ.</p><p>The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonina</surname><given-names>IS</given-names></name><name><surname>Cullen</surname><given-names>SP</given-names></name><name><surname>Martin</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B</article-title><source>Immunological Reviews</source><volume>235</volume><fpage>105</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1111/j.0105-2896.2010.00908.x</pub-id><pub-id pub-id-type="pmid">20536558</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>CF</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name><name><surname>Kuchroo</surname><given-names>VJ</given-names></name><name><surname>Sacks</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>285</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1084/jem.20061886</pub-id><pub-id pub-id-type="pmid">17283207</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>AC</given-names></name><name><surname>Joller</surname><given-names>N</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation</article-title><source>Immunity</source><volume>44</volume><fpage>989</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.05.001</pub-id><pub-id pub-id-type="pmid">27192565</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayo</surname><given-names>CM</given-names></name><name><surname>Oliveira</surname><given-names>AP</given-names></name><name><surname>Camargo</surname><given-names>AV</given-names></name><name><surname>Mattos</surname><given-names>CCB</given-names></name><name><surname>Bestetti</surname><given-names>RB</given-names></name><name><surname>Mattos</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Association of the Functional MICA-129 Polymorphism With the Severity of Chronic Chagas Heart Disease</article-title><source>Clinical Infectious Diseases</source><volume>61</volume><fpage>1310</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.1093/cid/civ540</pub-id><pub-id pub-id-type="pmid">26129751</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannard</surname><given-names>O</given-names></name><name><surname>Kraman</surname><given-names>M</given-names></name><name><surname>Fearon</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Secondary replicative function of CD8+ T cells that had developed an effector phenotype</article-title><source>Science (New York, N.Y.)</source><volume>323</volume><fpage>505</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1126/science.1166831</pub-id><pub-id pub-id-type="pmid">19164749</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname><given-names>C</given-names></name><name><surname>Bonilla</surname><given-names>WV</given-names></name><name><surname>Fröhlich</surname><given-names>A</given-names></name><name><surname>Helmstetter</surname><given-names>C</given-names></name><name><surname>Peine</surname><given-names>M</given-names></name><name><surname>Hegazy</surname><given-names>AN</given-names></name><name><surname>Pinschewer</surname><given-names>DD</given-names></name><name><surname>Löhning</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses</article-title><source>PNAS</source><volume>112</volume><fpage>4056</fpage><lpage>4061</lpage><pub-id pub-id-type="doi">10.1073/pnas.1418549112</pub-id><pub-id pub-id-type="pmid">25829541</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellio</surname><given-names>M</given-names></name><name><surname>Liveira</surname><given-names>AC</given-names></name><name><surname>Mermelstein</surname><given-names>CS</given-names></name><name><surname>Capella</surname><given-names>MA</given-names></name><name><surname>Viola</surname><given-names>JP</given-names></name><name><surname>Levraud</surname><given-names>JP</given-names></name><name><surname>Dosreis</surname><given-names>GA</given-names></name><name><surname>Previato</surname><given-names>JO</given-names></name><name><surname>Mendonça-Previato</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Costimulatory action of glycoinositolphospholipids from Trypanosoma cruzi: increased interleukin 2 secretion and induction of nuclear translocation of the nuclear factor of activated T cells 1</article-title><source>FASEB Journal</source><volume>13</volume><fpage>1627</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1096/fasebj.13.12.1627</pub-id><pub-id pub-id-type="pmid">10463955</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Sasson</surname><given-names>SZ</given-names></name><name><surname>Hu-Li</surname><given-names>J</given-names></name><name><surname>Quiel</surname><given-names>J</given-names></name><name><surname>Cauchetaux</surname><given-names>S</given-names></name><name><surname>Ratner</surname><given-names>M</given-names></name><name><surname>Shapira</surname><given-names>I</given-names></name><name><surname>Dinarello</surname><given-names>CA</given-names></name><name><surname>Paul</surname><given-names>WE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation</article-title><source>PNAS</source><volume>106</volume><fpage>7119</fpage><lpage>7124</lpage><pub-id pub-id-type="doi">10.1073/pnas.0902745106</pub-id><pub-id pub-id-type="pmid">19359475</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bern</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chagas’ Disease</article-title><source>The New England Journal of Medicine</source><volume>373</volume><fpage>456</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1410150</pub-id><pub-id pub-id-type="pmid">26222561</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossi</surname><given-names>G</given-names></name><name><surname>Griffiths</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells</article-title><source>Nature Medicine</source><volume>5</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1038/4779</pub-id><pub-id pub-id-type="pmid">9883845</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brien</surname><given-names>JD</given-names></name><name><surname>Uhrlaub</surname><given-names>JL</given-names></name><name><surname>Nikolich-Zugich</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>181</volume><fpage>8568</fpage><lpage>8575</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.12.8568</pub-id><pub-id pub-id-type="pmid">19050276</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DM</given-names></name><name><surname>Kamperschroer</surname><given-names>C</given-names></name><name><surname>Dilzer</surname><given-names>AM</given-names></name><name><surname>Roberts</surname><given-names>DM</given-names></name><name><surname>Swain</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells</article-title><source>Cellular Immunology</source><volume>257</volume><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2009.03.002</pub-id><pub-id pub-id-type="pmid">19338979</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DM</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Garcia-Hernandez</surname><given-names>M</given-names></name><name><surname>Swain</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection</article-title><source>Journal of Virology</source><volume>86</volume><fpage>6792</fpage><lpage>6803</lpage><pub-id pub-id-type="doi">10.1128/JVI.07172-11</pub-id><pub-id pub-id-type="pmid">22491469</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burel</surname><given-names>JG</given-names></name><name><surname>Apte</surname><given-names>SH</given-names></name><name><surname>Groves</surname><given-names>PL</given-names></name><name><surname>Klein</surname><given-names>K</given-names></name><name><surname>McCarthy</surname><given-names>JS</given-names></name><name><surname>Doolan</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production</article-title><source>PLOS Pathogens</source><volume>12</volume><elocation-id>e1005839</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005839</pub-id><pub-id pub-id-type="pmid">27662621</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>MA</given-names></name><name><surname>Closel</surname><given-names>M</given-names></name><name><surname>Valente</surname><given-names>EP</given-names></name><name><surname>Cardoso</surname><given-names>JE</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Alvarez-Leite</surname><given-names>JI</given-names></name><name><surname>Ropert</surname><given-names>C</given-names></name><name><surname>Gazzinelli</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>172</volume><fpage>1711</fpage><lpage>1718</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.3.1711</pub-id><pub-id pub-id-type="pmid">14734753</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canaday</surname><given-names>DH</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name><name><surname>Silver</surname><given-names>RF</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>167</volume><fpage>2734</fpage><lpage>2742</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.5.2734</pub-id><pub-id pub-id-type="pmid">11509617</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheadle</surname><given-names>C</given-names></name><name><surname>Vawter</surname><given-names>MP</given-names></name><name><surname>Freed</surname><given-names>WJ</given-names></name><name><surname>Becker</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Analysis of microarray data using Z score transformation</article-title><source>The Journal of Molecular Diagnostics</source><volume>5</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/S1525-1578(10)60455-2</pub-id><pub-id pub-id-type="pmid">12707371</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheroutre</surname><given-names>H</given-names></name><name><surname>Husain</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD4 CTL: living up to the challenge</article-title><source>Seminars in Immunology</source><volume>25</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2013.10.022</pub-id><pub-id pub-id-type="pmid">24246226</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>D</given-names></name><name><surname>Pride</surname><given-names>MW</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Cutler</surname><given-names>M</given-names></name><name><surname>Mester</surname><given-names>JC</given-names></name><name><surname>Nasar</surname><given-names>F</given-names></name><name><surname>She</surname><given-names>J</given-names></name><name><surname>Souza</surname><given-names>V</given-names></name><name><surname>York</surname><given-names>L</given-names></name><name><surname>Mishkin</surname><given-names>E</given-names></name><name><surname>Eldridge</surname><given-names>J</given-names></name><name><surname>Natuk</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responses</article-title><source>Vaccine</source><volume>23</volume><fpage>236</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2004.05.011</pub-id><pub-id pub-id-type="pmid">15531043</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro</surname><given-names>ZM</given-names></name><name><surname>Dahia</surname><given-names>AC</given-names></name><name><surname>Andrade</surname><given-names>ZA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Kinetics of Trypanosoma cruzi destruction in the mouse spleen</article-title><source>Revista Da Sociedade Brasileira de Medicina Tropical</source><volume>30</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1590/s0037-86821997000100002</pub-id><pub-id pub-id-type="pmid">8993104</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Guilloty</surname><given-names>F</given-names></name><name><surname>Pipkin</surname><given-names>ME</given-names></name><name><surname>Djuretic</surname><given-names>IM</given-names></name><name><surname>Levanon</surname><given-names>D</given-names></name><name><surname>Lotem</surname><given-names>J</given-names></name><name><surname>Lichtenheld</surname><given-names>MG</given-names></name><name><surname>Groner</surname><given-names>Y</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs</article-title><source>The Journal of Experimental Medicine</source><volume>206</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1084/jem.20081242</pub-id><pub-id pub-id-type="pmid">19139168</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>MA</given-names></name><name><surname>Geiger</surname><given-names>TL</given-names></name><name><surname>Montalvo</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name><name><surname>Al-Shamkhani</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Allison</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin</article-title><source>The Journal of Experimental Medicine</source><volume>210</volume><fpage>743</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1084/jem.20121190</pub-id><pub-id pub-id-type="pmid">23547098</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djuretic</surname><given-names>IM</given-names></name><name><surname>Levanon</surname><given-names>D</given-names></name><name><surname>Negreanu</surname><given-names>V</given-names></name><name><surname>Groner</surname><given-names>Y</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Ansel</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells</article-title><source>Nature Immunology</source><volume>8</volume><fpage>145</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/ni1424</pub-id><pub-id pub-id-type="pmid">17195845</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnarumma</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>GR</given-names></name><name><surname>Merkenschlager</surname><given-names>J</given-names></name><name><surname>Eksmond</surname><given-names>U</given-names></name><name><surname>Bongard</surname><given-names>N</given-names></name><name><surname>Nutt</surname><given-names>SL</given-names></name><name><surname>Boyer</surname><given-names>C</given-names></name><name><surname>Dittmer</surname><given-names>U</given-names></name><name><surname>Le-Trilling</surname><given-names>VTK</given-names></name><name><surname>Trilling</surname><given-names>M</given-names></name><name><surname>Bayer</surname><given-names>W</given-names></name><name><surname>Kassiotis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus</article-title><source>Cell Reports</source><volume>17</volume><fpage>1571</fpage><lpage>1583</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.013</pub-id><pub-id pub-id-type="pmid">27806296</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DosReis</surname><given-names>GA</given-names></name><name><surname>Peçanha</surname><given-names>LMT</given-names></name><name><surname>Bellio</surname><given-names>M</given-names></name><name><surname>Previato</surname><given-names>JO</given-names></name><name><surname>Mendonça-Previato</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Glycoinositol phospholipids from Trypanosoma cruzi transmit signals to the cells of the host immune system through both ceramide and glycan chains</article-title><source>Microbes and Infection</source><volume>4</volume><fpage>1007</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1016/s1286-4579(02)01616-7</pub-id><pub-id pub-id-type="pmid">12106795</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egawa</surname><given-names>T</given-names></name><name><surname>Tillman</surname><given-names>RE</given-names></name><name><surname>Naoe</surname><given-names>Y</given-names></name><name><surname>Taniuchi</surname><given-names>I</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>1945</fpage><lpage>1957</lpage><pub-id pub-id-type="doi">10.1084/jem.20070133</pub-id><pub-id pub-id-type="pmid">17646406</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshima</surname><given-names>K</given-names></name><name><surname>Chiba</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Kokubo</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Iizuka</surname><given-names>M</given-names></name><name><surname>Iwabuchi</surname><given-names>K</given-names></name><name><surname>Shinohara</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways</article-title><source>Immunology Letters</source><volume>144</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2012.02.013</pub-id><pub-id pub-id-type="pmid">22425747</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>M</given-names></name><name><surname>Siciliano</surname><given-names>NA</given-names></name><name><surname>Hersperger</surname><given-names>AR</given-names></name><name><surname>Roscoe</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Shamsedeen</surname><given-names>AR</given-names></name><name><surname>Eisenlohr</surname><given-names>LC</given-names></name><name><surname>Sigal</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection</article-title><source>PNAS</source><volume>109</volume><fpage>9983</fpage><lpage>9988</lpage><pub-id pub-id-type="doi">10.1073/pnas.1202143109</pub-id><pub-id pub-id-type="pmid">22665800</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>LRP</given-names></name><name><surname>Frade</surname><given-names>AF</given-names></name><name><surname>Baron</surname><given-names>MA</given-names></name><name><surname>Navarro</surname><given-names>IC</given-names></name><name><surname>Kalil</surname><given-names>J</given-names></name><name><surname>Chevillard</surname><given-names>C</given-names></name><name><surname>Cunha-Neto</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy</article-title><source>World Journal of Cardiology</source><volume>6</volume><fpage>782</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.4330/wjc.v6.i8.782</pub-id><pub-id pub-id-type="pmid">25228957</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>LRP</given-names></name><name><surname>Ferreira</surname><given-names>FM</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Cândido</surname><given-names>D</given-names></name><name><surname>de Oliveira</surname><given-names>LC</given-names></name><name><surname>Billaud</surname><given-names>JN</given-names></name><name><surname>Lanteri</surname><given-names>MC</given-names></name><name><surname>Rigaud</surname><given-names>VOC</given-names></name><name><surname>Seielstad</surname><given-names>M</given-names></name><name><surname>Kalil</surname><given-names>J</given-names></name><name><surname>Fernandes</surname><given-names>F</given-names></name><name><surname>Ribeiro</surname><given-names>ALP</given-names></name><name><surname>Sabino</surname><given-names>EC</given-names></name><name><surname>Cunha-Neto</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction</article-title><source>The Journal of Infectious Diseases</source><volume>215</volume><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw540</pub-id><pub-id pub-id-type="pmid">28003350</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frazer</surname><given-names>LC</given-names></name><name><surname>Sullivan</surname><given-names>JE</given-names></name><name><surname>Zurenski</surname><given-names>MA</given-names></name><name><surname>Mintus</surname><given-names>M</given-names></name><name><surname>Tomasak</surname><given-names>TE</given-names></name><name><surname>Prantner</surname><given-names>D</given-names></name><name><surname>Nagarajan</surname><given-names>UM</given-names></name><name><surname>Darville</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD4+ T cell expression of MyD88 is essential for normal resolution of Chlamydia muridarum genital tract infection</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>191</volume><fpage>4269</fpage><lpage>4279</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301547</pub-id><pub-id pub-id-type="pmid">24038087</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagliani</surname><given-names>N</given-names></name><name><surname>Magnani</surname><given-names>CF</given-names></name><name><surname>Huber</surname><given-names>S</given-names></name><name><surname>Gianolini</surname><given-names>ME</given-names></name><name><surname>Pala</surname><given-names>M</given-names></name><name><surname>Licona-Limon</surname><given-names>P</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Herbert</surname><given-names>DR</given-names></name><name><surname>Bulfone</surname><given-names>A</given-names></name><name><surname>Trentini</surname><given-names>F</given-names></name><name><surname>Di Serio</surname><given-names>C</given-names></name><name><surname>Bacchetta</surname><given-names>R</given-names></name><name><surname>Andreani</surname><given-names>M</given-names></name><name><surname>Brockmann</surname><given-names>L</given-names></name><name><surname>Gregori</surname><given-names>S</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Roncarolo</surname><given-names>M-G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells</article-title><source>Nature Medicine</source><volume>19</volume><fpage>739</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1038/nm.3179</pub-id><pub-id pub-id-type="pmid">23624599</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glimcher</surname><given-names>LH</given-names></name><name><surname>Townsend</surname><given-names>MJ</given-names></name><name><surname>Sullivan</surname><given-names>BM</given-names></name><name><surname>Lord</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Recent developments in the transcriptional regulation of cytolytic effector cells</article-title><source>Nature Reviews. Immunology</source><volume>4</volume><fpage>900</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1038/nri1490</pub-id><pub-id pub-id-type="pmid">15516969</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes-Neto</surname><given-names>JF</given-names></name><name><surname>Sartorius</surname><given-names>R</given-names></name><name><surname>Canto</surname><given-names>FB</given-names></name><name><surname>Almeida</surname><given-names>TS</given-names></name><name><surname>Dias</surname><given-names>AA</given-names></name><name><surname>Barbosa</surname><given-names>C-HD</given-names></name><name><surname>Melo</surname><given-names>GA</given-names></name><name><surname>Oliveira</surname><given-names>AC</given-names></name><name><surname>Aguiar</surname><given-names>P-HN</given-names></name><name><surname>Machado</surname><given-names>CR</given-names></name><name><surname>de Matos Guedes</surname><given-names>HL</given-names></name><name><surname>Santiago</surname><given-names>MF</given-names></name><name><surname>Nóbrega</surname><given-names>A</given-names></name><name><surname>De Berardinis</surname><given-names>P</given-names></name><name><surname>Bellio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Vaccination With Recombinant Filamentous <italic>fd</italic> Phages Against Parasite Infection Requires TLR9 Expression</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1173</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01173</pub-id><pub-id pub-id-type="pmid">29896197</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunturi</surname><given-names>A</given-names></name><name><surname>Berg</surname><given-names>RE</given-names></name><name><surname>Forman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The role of CD94/NKG2 in innate and adaptive immunity</article-title><source>Immunologic Research</source><volume>30</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1385/IR:30:1:029</pub-id><pub-id pub-id-type="pmid">15258309</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutcher</surname><given-names>I</given-names></name><name><surname>Urich</surname><given-names>E</given-names></name><name><surname>Wolter</surname><given-names>K</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Becher</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation</article-title><source>Nature Immunology</source><volume>7</volume><fpage>946</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1038/ni1377</pub-id><pub-id pub-id-type="pmid">16906165</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haring</surname><given-names>JS</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Interleukin-18-related genes are induced during the contraction phase but do not play major roles in regulating the dynamics or function of the T-cell response to Listeria monocytogenes infection</article-title><source>Infection and Immunity</source><volume>77</volume><fpage>1894</fpage><lpage>1903</lpage><pub-id pub-id-type="doi">10.1128/IAI.01315-08</pub-id><pub-id pub-id-type="pmid">19223481</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Pham</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Sawant</surname><given-names>D</given-names></name><name><surname>Dent</surname><given-names>AL</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name><name><surname>Kaplan</surname><given-names>MH</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection</article-title><source>Journal of Virology</source><volume>87</volume><fpage>11884</fpage><lpage>11893</lpage><pub-id pub-id-type="doi">10.1128/JVI.01461-13</pub-id><pub-id pub-id-type="pmid">23986597</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>S</given-names></name><name><surname>Cobb</surname><given-names>DA</given-names></name><name><surname>Bhadra</surname><given-names>R</given-names></name><name><surname>Youngblood</surname><given-names>B</given-names></name><name><surname>Khan</surname><given-names>IA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis</article-title><source>The Journal of Experimental Medicine</source><volume>213</volume><fpage>1799</fpage><lpage>1818</lpage><pub-id pub-id-type="doi">10.1084/jem.20151995</pub-id><pub-id pub-id-type="pmid">27481131</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Intlekofer</surname><given-names>AM</given-names></name><name><surname>Takemoto</surname><given-names>N</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Longworth</surname><given-names>SA</given-names></name><name><surname>Northrup</surname><given-names>JT</given-names></name><name><surname>Palanivel</surname><given-names>VR</given-names></name><name><surname>Mullen</surname><given-names>AC</given-names></name><name><surname>Gasink</surname><given-names>CR</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Miller</surname><given-names>JD</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Ryan</surname><given-names>K</given-names></name><name><surname>Russ</surname><given-names>AP</given-names></name><name><surname>Lindsten</surname><given-names>T</given-names></name><name><surname>Orange</surname><given-names>JS</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin</article-title><source>Nature Immunology</source><volume>6</volume><fpage>1236</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1038/ni1268</pub-id><pub-id pub-id-type="pmid">16273099</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>D</given-names></name><name><surname>Kullberg</surname><given-names>MC</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Goldszmid</surname><given-names>RS</given-names></name><name><surname>Collazo</surname><given-names>CM</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Kamanaka</surname><given-names>M</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1084/jem.20062175</pub-id><pub-id pub-id-type="pmid">17283209</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jellison</surname><given-names>ER</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cutting edge: MHC class II-restricted killing in vivo during viral infection</article-title><source>Journal of Immunology (Baltimore, Md</source><volume>174</volume><fpage>614</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.2.614</pub-id><pub-id pub-id-type="pmid">15634878</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joffre</surname><given-names>O</given-names></name><name><surname>Nolte</surname><given-names>MA</given-names></name><name><surname>Spörri</surname><given-names>R</given-names></name><name><surname>Reis e Sousa</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Inflammatory signals in dendritic cell activation and the induction of adaptive immunity</article-title><source>Immunological Reviews</source><volume>227</volume><fpage>234</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00718.x</pub-id><pub-id pub-id-type="pmid">19120488</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juno</surname><given-names>JA</given-names></name><name><surname>van Bockel</surname><given-names>D</given-names></name><name><surname>Kent</surname><given-names>SJ</given-names></name><name><surname>Kelleher</surname><given-names>AD</given-names></name><name><surname>Zaunders</surname><given-names>JJ</given-names></name><name><surname>Munier</surname><given-names>CML</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00019</pub-id><pub-id pub-id-type="pmid">28167943</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kara</surname><given-names>EE</given-names></name><name><surname>Comerford</surname><given-names>I</given-names></name><name><surname>Fenix</surname><given-names>KA</given-names></name><name><surname>Bastow</surname><given-names>CR</given-names></name><name><surname>Gregor</surname><given-names>CE</given-names></name><name><surname>McKenzie</surname><given-names>DR</given-names></name><name><surname>McColl</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tailored immune responses: novel effector helper T cell subsets in protective immunity</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1003905</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003905</pub-id><pub-id pub-id-type="pmid">24586147</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keesen</surname><given-names>TSL</given-names></name><name><surname>Gomes</surname><given-names>JAS</given-names></name><name><surname>Fares</surname><given-names>RCG</given-names></name><name><surname>de Araújo</surname><given-names>FF</given-names></name><name><surname>Ferreira</surname><given-names>KS</given-names></name><name><surname>Chaves</surname><given-names>AT</given-names></name><name><surname>Rocha</surname><given-names>MOC</given-names></name><name><surname>Correa-Oliveira</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Characterization of CD4</article-title><source>Scandinavian Journal of Immunology</source><volume>76</volume><fpage>311</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3083.2012.02730.x</pub-id><pub-id pub-id-type="pmid">22670682</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiner</surname><given-names>E</given-names></name><name><surname>Willie</surname><given-names>E</given-names></name><name><surname>Vijaykumar</surname><given-names>B</given-names></name><name><surname>Chowdhary</surname><given-names>K</given-names></name><name><surname>Schmutz</surname><given-names>H</given-names></name><name><surname>Chandler</surname><given-names>J</given-names></name><name><surname>Schnell</surname><given-names>A</given-names></name><name><surname>Thakore</surname><given-names>PI</given-names></name><name><surname>LeGros</surname><given-names>G</given-names></name><name><surname>Mostafavi</surname><given-names>S</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Aguilar</surname><given-names>O</given-names></name><name><surname>Allan</surname><given-names>R</given-names></name><name><surname>Astarita</surname><given-names>J</given-names></name><name><surname>Austen</surname><given-names>KF</given-names></name><name><surname>Barrett</surname><given-names>N</given-names></name><name><surname>Baysoy</surname><given-names>A</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>BD</given-names></name><name><surname>Buechler</surname><given-names>M</given-names></name><name><surname>Buenrostro</surname><given-names>J</given-names></name><name><surname>Casanova</surname><given-names>MA</given-names></name><name><surname>Choi</surname><given-names>K</given-names></name><name><surname>Chowdhary</surname><given-names>K</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Crowl</surname><given-names>T</given-names></name><name><surname>Deng</surname><given-names>T</given-names></name><name><surname>Desai</surname><given-names>JV</given-names></name><name><surname>Desland</surname><given-names>F</given-names></name><name><surname>Dhainaut</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Dominguez</surname><given-names>C</given-names></name><name><surname>Dwyer</surname><given-names>D</given-names></name><name><surname>Frascoli</surname><given-names>M</given-names></name><name><surname>Gal-Oz</surname><given-names>S</given-names></name><name><surname>Goldrath</surname><given-names>A</given-names></name><name><surname>Grieshaber-Bouyer</surname><given-names>R</given-names></name><name><surname>Jia</surname><given-names>B</given-names></name><name><surname>Johanson</surname><given-names>T</given-names></name><name><surname>Jordan</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Kapoor</surname><given-names>V</given-names></name><name><surname>Kenigsberg</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>wook Kim</surname><given-names>K</given-names></name><name><surname>Kiner</surname><given-names>E</given-names></name><name><surname>Kronenberg</surname><given-names>M</given-names></name><name><surname>Lanier</surname><given-names>L</given-names></name><name><surname>Laplace</surname><given-names>C</given-names></name><name><surname>Lareau</surname><given-names>C</given-names></name><name><surname>Leader</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Magen</surname><given-names>A</given-names></name><name><surname>Maier</surname><given-names>B</given-names></name><name><surname>Maslova</surname><given-names>A</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>McFarland</surname><given-names>A</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Meunier</surname><given-names>E</given-names></name><name><surname>Monach</surname><given-names>P</given-names></name><name><surname>Mostafavi</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>S</given-names></name><name><surname>Muus</surname><given-names>C</given-names></name><name><surname>Ner-Gaon</surname><given-names>H</given-names></name><name><surname>Nguyen</surname><given-names>Q</given-names></name><name><surname>Nigrovic</surname><given-names>PA</given-names></name><name><surname>Novakovsky</surname><given-names>G</given-names></name><name><surname>Nutt</surname><given-names>S</given-names></name><name><surname>Omilusik</surname><given-names>K</given-names></name><name><surname>Ortiz-Lopez</surname><given-names>A</given-names></name><name><surname>Paynich</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>V</given-names></name><name><surname>Potempa</surname><given-names>M</given-names></name><name><surname>Pradhan</surname><given-names>R</given-names></name><name><surname>Quon</surname><given-names>S</given-names></name><name><surname>Ramirez</surname><given-names>R</given-names></name><name><surname>Ramanan</surname><given-names>D</given-names></name><name><surname>Randolph</surname><given-names>G</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Rose</surname><given-names>SA</given-names></name><name><surname>Seddu</surname><given-names>K</given-names></name><name><surname>Shay</surname><given-names>T</given-names></name><name><surname>Shemesh</surname><given-names>A</given-names></name><name><surname>Shyer</surname><given-names>J</given-names></name><name><surname>Smilie</surname><given-names>C</given-names></name><name><surname>Spidale</surname><given-names>N</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Sylvia</surname><given-names>K</given-names></name><name><surname>Tellier</surname><given-names>J</given-names></name><name><surname>Turley</surname><given-names>S</given-names></name><name><surname>Vijaykumar</surname><given-names>B</given-names></name><name><surname>Wagers</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>PL</given-names></name><name><surname>Wroblewska</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yim</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><collab>The Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes</article-title><source>Nature Immunology</source><volume>22</volume><fpage>216</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-00836-7</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotov</surname><given-names>DI</given-names></name><name><surname>Kotov</surname><given-names>JA</given-names></name><name><surname>Goldberg</surname><given-names>MF</given-names></name><name><surname>Jenkins</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>200</volume><fpage>2004</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1700420</pub-id><pub-id pub-id-type="pmid">29436413</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname><given-names>PD</given-names></name><name><surname>Goldberg</surname><given-names>MF</given-names></name><name><surname>Hong</surname><given-names>SW</given-names></name><name><surname>Osum</surname><given-names>KC</given-names></name><name><surname>Langlois</surname><given-names>RA</given-names></name><name><surname>Kotov</surname><given-names>DI</given-names></name><name><surname>Dileepan</surname><given-names>T</given-names></name><name><surname>Jenkins</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Two sequential activation modules control the differentiation of protective T helper-1 (Th1) cells</article-title><source>Immunity</source><volume>54</volume><fpage>687</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.03.006</pub-id><pub-id pub-id-type="pmid">33773107</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaRosa</surname><given-names>DF</given-names></name><name><surname>Stumhofer</surname><given-names>JS</given-names></name><name><surname>Gelman</surname><given-names>AE</given-names></name><name><surname>Rahman</surname><given-names>AH</given-names></name><name><surname>Taylor</surname><given-names>DK</given-names></name><name><surname>Hunter</surname><given-names>CA</given-names></name><name><surname>Turka</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>T cell expression of MyD88 is required for resistance to <italic>Toxoplasma gondii</italic></article-title><source>PNAS</source><volume>105</volume><fpage>3855</fpage><lpage>3860</lpage><pub-id pub-id-type="doi">10.1073/pnas.0706663105</pub-id><pub-id pub-id-type="pmid">18308927</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leon Rodriguez</surname><given-names>DA</given-names></name><name><surname>Carmona</surname><given-names>FD</given-names></name><name><surname>Echeverría</surname><given-names>LE</given-names></name><name><surname>González</surname><given-names>CI</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>IL18 Gene Variants Influence the Susceptibility to Chagas Disease</article-title><source>PLOS Neglected Tropical Diseases</source><volume>10</volume><elocation-id>e0004583</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0004583</pub-id><pub-id pub-id-type="pmid">27027876</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>EC</given-names></name><name><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor</article-title><source>PNAS</source><volume>103</volume><fpage>16852</fpage><lpage>16857</lpage><pub-id pub-id-type="doi">10.1073/pnas.0607917103</pub-id><pub-id pub-id-type="pmid">17075045</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>FS</given-names></name><name><surname>Martins</surname><given-names>GA</given-names></name><name><surname>Aliberti</surname><given-names>JC</given-names></name><name><surname>Mestriner</surname><given-names>FL</given-names></name><name><surname>Cunha</surname><given-names>FQ</given-names></name><name><surname>Silva</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity</article-title><source>Circulation</source><volume>102</volume><fpage>3003</fpage><lpage>3008</lpage><pub-id pub-id-type="doi">10.1161/01.cir.102.24.3003</pub-id><pub-id pub-id-type="pmid">11113053</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>NB</given-names></name><name><surname>Vong</surname><given-names>AM</given-names></name><name><surname>Devarajan</surname><given-names>P</given-names></name><name><surname>Brauner</surname><given-names>MD</given-names></name><name><surname>Kuang</surname><given-names>Y</given-names></name><name><surname>Nayar</surname><given-names>R</given-names></name><name><surname>Schutten</surname><given-names>EA</given-names></name><name><surname>Castonguay</surname><given-names>CH</given-names></name><name><surname>Berg</surname><given-names>LJ</given-names></name><name><surname>Nutt</surname><given-names>SL</given-names></name><name><surname>Swain</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>198</volume><fpage>1142</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601297</pub-id><pub-id pub-id-type="pmid">28031335</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascanfroni</surname><given-names>ID</given-names></name><name><surname>Takenaka</surname><given-names>MC</given-names></name><name><surname>Yeste</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Kenison</surname><given-names>JE</given-names></name><name><surname>Siddiqui</surname><given-names>S</given-names></name><name><surname>Basso</surname><given-names>AS</given-names></name><name><surname>Otterbein</surname><given-names>LE</given-names></name><name><surname>Pardoll</surname><given-names>DM</given-names></name><name><surname>Pan</surname><given-names>F</given-names></name><name><surname>Priel</surname><given-names>A</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name><name><surname>Quintana</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α</article-title><source>Nature Medicine</source><volume>21</volume><fpage>638</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1038/nm.3868</pub-id><pub-id pub-id-type="pmid">26005855</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medeiros</surname><given-names>MM</given-names></name><name><surname>Peixoto</surname><given-names>JR</given-names></name><name><surname>Oliveira</surname><given-names>A-C</given-names></name><name><surname>Cardilo-Reis</surname><given-names>L</given-names></name><name><surname>Koatz</surname><given-names>VLG</given-names></name><name><surname>Van Kaer</surname><given-names>L</given-names></name><name><surname>Previato</surname><given-names>JO</given-names></name><name><surname>Mendonça-Previato</surname><given-names>L</given-names></name><name><surname>Nobrega</surname><given-names>A</given-names></name><name><surname>Bellio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Toll-like receptor 4 (TLR4)-dependent proinflammatory and immunomodulatory properties of the glycoinositolphospholipid (GIPL) from Trypanosoma cruzi</article-title><source>Journal of Leukocyte Biology</source><volume>82</volume><fpage>488</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1189/jlb.0706478</pub-id><pub-id pub-id-type="pmid">17540734</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>CAS</given-names></name><name><surname>Sullivan</surname><given-names>AK</given-names></name><name><surname>Falta</surname><given-names>MT</given-names></name><name><surname>Mack</surname><given-names>DG</given-names></name><name><surname>Freed</surname><given-names>BM</given-names></name><name><surname>Rocha</surname><given-names>MOC</given-names></name><name><surname>Gollob</surname><given-names>KJ</given-names></name><name><surname>Fontenot</surname><given-names>AP</given-names></name><name><surname>Dutra</surname><given-names>WO</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease</article-title><source>Clinical and Experimental Immunology</source><volume>169</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2012.04608.x</pub-id><pub-id pub-id-type="pmid">22774985</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millar</surname><given-names>AE</given-names></name><name><surname>Kahn</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen</article-title><source>Infection and Immunity</source><volume>68</volume><fpage>3574</fpage><lpage>3580</lpage><pub-id pub-id-type="doi">10.1128/IAI.68.6.3574-3580.2000</pub-id><pub-id pub-id-type="pmid">10816514</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>P</given-names></name><name><surname>Abblett</surname><given-names>R</given-names></name><name><surname>Ryan</surname><given-names>JM</given-names></name><name><surname>Hagymasi</surname><given-names>AT</given-names></name><name><surname>Agyekum-Yamoah</surname><given-names>A</given-names></name><name><surname>Svedova</surname><given-names>J</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name><name><surname>St Rose</surname><given-names>MC</given-names></name><name><surname>Hanley</surname><given-names>MP</given-names></name><name><surname>Vella</surname><given-names>AT</given-names></name><name><surname>Adler</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>200</volume><fpage>1513</fpage><lpage>1526</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1701039</pub-id><pub-id pub-id-type="pmid">29305435</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteforte</surname><given-names>GM</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Rodriguez-Sosa</surname><given-names>M</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>David</surname><given-names>JR</given-names></name><name><surname>Satoskar</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>164</volume><fpage>5890</fpage><lpage>5893</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.11.5890</pub-id><pub-id pub-id-type="pmid">10820270</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mucida</surname><given-names>D</given-names></name><name><surname>Husain</surname><given-names>MM</given-names></name><name><surname>Muroi</surname><given-names>S</given-names></name><name><surname>van Wijk</surname><given-names>F</given-names></name><name><surname>Shinnakasu</surname><given-names>R</given-names></name><name><surname>Naoe</surname><given-names>Y</given-names></name><name><surname>Reis</surname><given-names>BS</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Lambolez</surname><given-names>F</given-names></name><name><surname>Docherty</surname><given-names>M</given-names></name><name><surname>Attinger</surname><given-names>A</given-names></name><name><surname>Shui</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Lena</surname><given-names>CJ</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Miyamoto</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Honda</surname><given-names>K</given-names></name><name><surname>Ellmeier</surname><given-names>W</given-names></name><name><surname>Kronenberg</surname><given-names>M</given-names></name><name><surname>Taniuchi</surname><given-names>I</given-names></name><name><surname>Cheroutre</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transcriptional reprogramming of mature CD4</article-title><source>Nature Immunology</source><volume>14</volume><fpage>281</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/ni.2523</pub-id><pub-id pub-id-type="pmid">23334788</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakahira</surname><given-names>M</given-names></name><name><surname>Tomura</surname><given-names>M</given-names></name><name><surname>Iwasaki</surname><given-names>M</given-names></name><name><surname>Ahn</surname><given-names>HJ</given-names></name><name><surname>Bian</surname><given-names>Y</given-names></name><name><surname>Hamaoka</surname><given-names>T</given-names></name><name><surname>Ohta</surname><given-names>T</given-names></name><name><surname>Kurimoto</surname><given-names>M</given-names></name><name><surname>Fujiwara</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>An absolute requirement for STAT4 and a role for IFN-gamma as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>167</volume><fpage>1306</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.3.1306</pub-id><pub-id pub-id-type="pmid">11466347</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>LG</given-names></name><name><surname>Frade</surname><given-names>AF</given-names></name><name><surname>Ianni</surname><given-names>BM</given-names></name><name><surname>Laugier</surname><given-names>L</given-names></name><name><surname>Pissetti</surname><given-names>CW</given-names></name><name><surname>Cabantous</surname><given-names>S</given-names></name><name><surname>Baron</surname><given-names>M</given-names></name><name><surname>Peixoto</surname><given-names>G</given-names></name><name><surname>Borges</surname><given-names>A</given-names></name><name><surname>Donadi</surname><given-names>E</given-names></name><name><surname>Marin-Neto</surname><given-names>JA</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Dias</surname><given-names>F</given-names></name><name><surname>Saba</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>HTL</given-names></name><name><surname>Fragata</surname><given-names>A</given-names></name><name><surname>Sampaio</surname><given-names>M</given-names></name><name><surname>Hirata</surname><given-names>MH</given-names></name><name><surname>Buck</surname><given-names>P</given-names></name><name><surname>Mady</surname><given-names>C</given-names></name><name><surname>Martinelli</surname><given-names>M</given-names></name><name><surname>Lensi</surname><given-names>M</given-names></name><name><surname>Siqueira</surname><given-names>SF</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Rodrigues</surname><given-names>V</given-names></name><name><surname>Kalil</surname><given-names>J</given-names></name><name><surname>Chevillard</surname><given-names>C</given-names></name><name><surname>Cunha-Neto</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Functional IL18 polymorphism and susceptibility to Chronic Chagas Disease</article-title><source>Cytokine</source><volume>73</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2015.01.037</pub-id><pub-id pub-id-type="pmid">25743241</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>MCP</given-names></name><name><surname>Beaton</surname><given-names>A</given-names></name><name><surname>Acquatella</surname><given-names>H</given-names></name><name><surname>Bern</surname><given-names>C</given-names></name><name><surname>Bolger</surname><given-names>AF</given-names></name><name><surname>Echeverría</surname><given-names>LE</given-names></name><name><surname>Dutra</surname><given-names>WO</given-names></name><name><surname>Gascon</surname><given-names>J</given-names></name><name><surname>Morillo</surname><given-names>CA</given-names></name><name><surname>Oliveira-Filho</surname><given-names>J</given-names></name><name><surname>Ribeiro</surname><given-names>ALP</given-names></name><name><surname>Marin-Neto</surname><given-names>JA</given-names></name><collab>American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Stroke Council</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association</article-title><source>Circulation</source><volume>138</volume><fpage>e169</fpage><lpage>e209</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000599</pub-id><pub-id pub-id-type="pmid">30354432</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>AC</given-names></name><name><surname>de Alencar</surname><given-names>BC</given-names></name><name><surname>Tzelepis</surname><given-names>F</given-names></name><name><surname>Klezewsky</surname><given-names>W</given-names></name><name><surname>da Silva</surname><given-names>RN</given-names></name><name><surname>Neves</surname><given-names>FS</given-names></name><name><surname>Cavalcanti</surname><given-names>GS</given-names></name><name><surname>Boscardin</surname><given-names>S</given-names></name><name><surname>Nunes</surname><given-names>MP</given-names></name><name><surname>Santiago</surname><given-names>MF</given-names></name><name><surname>Nóbrega</surname><given-names>A</given-names></name><name><surname>Rodrigues</surname><given-names>MM</given-names></name><name><surname>Bellio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice</article-title><source>PLOS Pathogens</source><volume>6</volume><elocation-id>e1000870</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000870</pub-id><pub-id pub-id-type="pmid">20442858</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>A-C</given-names></name><name><surname>Gomes-Neto</surname><given-names>JF</given-names></name><name><surname>Barbosa</surname><given-names>C-HD</given-names></name><name><surname>Granato</surname><given-names>A</given-names></name><name><surname>Reis</surname><given-names>BS</given-names></name><name><surname>Santos</surname><given-names>BM</given-names></name><name><surname>Fucs</surname><given-names>R</given-names></name><name><surname>Canto</surname><given-names>FB</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Nóbrega</surname><given-names>A</given-names></name><name><surname>Bellio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Crucial role for T cell-intrinsic IL-18R-MyD88 signaling in cognate immune response to intracellular parasite infection</article-title><source>eLife</source><volume>6</volume><elocation-id>e30883</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30883</pub-id><pub-id pub-id-type="pmid">28895840</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Ryu</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Hwang</surname><given-names>ES</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Chung</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>IL-27 confers a protumorigenic activity of regulatory T cells via CD39</article-title><source>PNAS</source><volume>116</volume><fpage>3106</fpage><lpage>3111</lpage><pub-id pub-id-type="doi">10.1073/pnas.1810254116</pub-id><pub-id pub-id-type="pmid">30718407</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>EL</given-names></name><name><surname>Mullen</surname><given-names>AC</given-names></name><name><surname>Martins</surname><given-names>GA</given-names></name><name><surname>Krawczyk</surname><given-names>CM</given-names></name><name><surname>Hutchins</surname><given-names>AS</given-names></name><name><surname>Zediak</surname><given-names>VP</given-names></name><name><surname>Banica</surname><given-names>M</given-names></name><name><surname>DiCioccio</surname><given-names>CB</given-names></name><name><surname>Gross</surname><given-names>DA</given-names></name><name><surname>Mao</surname><given-names>C-A</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Cereb</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>SY</given-names></name><name><surname>Lindsten</surname><given-names>T</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>CA</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Control of effector CD8+ T cell function by the transcription factor Eomesodermin</article-title><source>Science (New York, N.Y.)</source><volume>302</volume><fpage>1041</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1126/science.1090148</pub-id><pub-id pub-id-type="pmid">14605368</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poholek</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tissue-Specific Contributions to Control of T Cell Immunity</article-title><source>ImmunoHorizons</source><volume>5</volume><fpage>410</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.4049/immunohorizons.2000103</pub-id><pub-id pub-id-type="pmid">34103371</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quezada</surname><given-names>SA</given-names></name><name><surname>Simpson</surname><given-names>TR</given-names></name><name><surname>Peggs</surname><given-names>KS</given-names></name><name><surname>Merghoub</surname><given-names>T</given-names></name><name><surname>Vider</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Blasberg</surname><given-names>R</given-names></name><name><surname>Yagita</surname><given-names>H</given-names></name><name><surname>Muranski</surname><given-names>P</given-names></name><name><surname>Antony</surname><given-names>PA</given-names></name><name><surname>Restifo</surname><given-names>NP</given-names></name><name><surname>Allison</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>637</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1084/jem.20091918</pub-id><pub-id pub-id-type="pmid">20156971</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qui</surname><given-names>HZ</given-names></name><name><surname>Hagymasi</surname><given-names>AT</given-names></name><name><surname>Bandyopadhyay</surname><given-names>S</given-names></name><name><surname>St Rose</surname><given-names>M-C</given-names></name><name><surname>Ramanarasimhaiah</surname><given-names>R</given-names></name><name><surname>Ménoret</surname><given-names>A</given-names></name><name><surname>Mittler</surname><given-names>RS</given-names></name><name><surname>Gordon</surname><given-names>SM</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name><name><surname>Vella</surname><given-names>AT</given-names></name><name><surname>Adler</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation</article-title><source>Journal of Immunology (Baltimore, Md</source><volume>187</volume><fpage>3555</fpage><lpage>3564</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101244</pub-id><pub-id pub-id-type="pmid">21880986</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>DD</given-names></name><name><surname>Jones</surname><given-names>EM</given-names></name><name><surname>Tostes</surname><given-names>S</given-names></name><name><surname>Lopes</surname><given-names>ER</given-names></name><name><surname>Chapadeiro</surname><given-names>E</given-names></name><name><surname>Gazzinelli</surname><given-names>G</given-names></name><name><surname>Colley</surname><given-names>DG</given-names></name><name><surname>McCurley</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas’ disease</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>49</volume><fpage>192</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1993.49.192</pub-id><pub-id pub-id-type="pmid">7689301</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>BS</given-names></name><name><surname>Rogoz</surname><given-names>A</given-names></name><name><surname>Costa-Pinto</surname><given-names>FA</given-names></name><name><surname>Taniuchi</surname><given-names>I</given-names></name><name><surname>Mucida</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4</article-title><source>Nature Immunology</source><volume>14</volume><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/ni.2518</pub-id><pub-id pub-id-type="pmid">23334789</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>D</given-names></name><name><surname>Shibuya</surname><given-names>K</given-names></name><name><surname>Mui</surname><given-names>A</given-names></name><name><surname>Zonin</surname><given-names>F</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Sana</surname><given-names>T</given-names></name><name><surname>Hartley</surname><given-names>SB</given-names></name><name><surname>Menon</surname><given-names>S</given-names></name><name><surname>Kastelein</surname><given-names>R</given-names></name><name><surname>Bazan</surname><given-names>F</given-names></name><name><surname>O’Garra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB</article-title><source>Immunity</source><volume>7</volume><fpage>571</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(00)80378-7</pub-id><pub-id pub-id-type="pmid">9354477</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>MM</given-names></name><name><surname>Oliveira</surname><given-names>AC</given-names></name><name><surname>Bellio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Immune Response to Trypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine Development</article-title><source>Journal of Parasitology Research</source><volume>2012</volume><elocation-id>507874</elocation-id><pub-id pub-id-type="doi">10.1155/2012/507874</pub-id><pub-id pub-id-type="pmid">22496959</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roncarolo</surname><given-names>MG</given-names></name><name><surname>Gregori</surname><given-names>S</given-names></name><name><surname>Bacchetta</surname><given-names>R</given-names></name><name><surname>Battaglia</surname><given-names>M</given-names></name><name><surname>Gagliani</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases</article-title><source>Immunity</source><volume>49</volume><fpage>1004</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.12.001</pub-id><pub-id pub-id-type="pmid">30566879</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenten</surname><given-names>D</given-names></name><name><surname>Nish</surname><given-names>SA</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Brodsky</surname><given-names>I</given-names></name><name><surname>Pasman</surname><given-names>L</given-names></name><name><surname>Yordy</surname><given-names>B</given-names></name><name><surname>Wunderlich</surname><given-names>FT</given-names></name><name><surname>Brüning</surname><given-names>JC</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells</article-title><source>Immunity</source><volume>40</volume><fpage>78</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.023</pub-id><pub-id pub-id-type="pmid">24439266</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serroukh</surname><given-names>Y</given-names></name><name><surname>Gu-Trantien</surname><given-names>C</given-names></name><name><surname>Hooshiar Kashani</surname><given-names>B</given-names></name><name><surname>Defrance</surname><given-names>M</given-names></name><name><surname>Vu Manh</surname><given-names>T-P</given-names></name><name><surname>Azouz</surname><given-names>A</given-names></name><name><surname>Detavernier</surname><given-names>A</given-names></name><name><surname>Hoyois</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>J</given-names></name><name><surname>Bizet</surname><given-names>M</given-names></name><name><surname>Pollet</surname><given-names>E</given-names></name><name><surname>Tabbuso</surname><given-names>T</given-names></name><name><surname>Calonne</surname><given-names>E</given-names></name><name><surname>van Gisbergen</surname><given-names>K</given-names></name><name><surname>Dalod</surname><given-names>M</given-names></name><name><surname>Fuks</surname><given-names>F</given-names></name><name><surname>Goriely</surname><given-names>S</given-names></name><name><surname>Marchant</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes</article-title><source>eLife</source><volume>7</volume><elocation-id>e30496</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30496</pub-id><pub-id pub-id-type="pmid">29488879</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smeltz</surname><given-names>RB</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Hu-Li</surname><given-names>J</given-names></name><name><surname>Shevach</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4</article-title><source>The Journal of Experimental Medicine</source><volume>194</volume><fpage>143</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1084/jem.194.2.143</pub-id><pub-id pub-id-type="pmid">11457889</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stojanovic</surname><given-names>A</given-names></name><name><surname>Correia</surname><given-names>MP</given-names></name><name><surname>Cerwenka</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>827</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00827</pub-id><pub-id pub-id-type="pmid">29740438</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagawa</surname><given-names>T</given-names></name><name><surname>Albanese</surname><given-names>M</given-names></name><name><surname>Bouvet</surname><given-names>M</given-names></name><name><surname>Moosmann</surname><given-names>A</given-names></name><name><surname>Mautner</surname><given-names>J</given-names></name><name><surname>Heissmeyer</surname><given-names>V</given-names></name><name><surname>Zielinski</surname><given-names>C</given-names></name><name><surname>Lutter</surname><given-names>D</given-names></name><name><surname>Hoser</surname><given-names>J</given-names></name><name><surname>Hastreiter</surname><given-names>M</given-names></name><name><surname>Hayes</surname><given-names>M</given-names></name><name><surname>Sugden</surname><given-names>B</given-names></name><name><surname>Hammerschmidt</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing</article-title><source>The Journal of Experimental Medicine</source><volume>213</volume><fpage>2065</fpage><lpage>2080</lpage><pub-id pub-id-type="doi">10.1084/jem.20160248</pub-id><pub-id pub-id-type="pmid">27621419</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Tsutsui</surname><given-names>H</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Adachi</surname><given-names>O</given-names></name><name><surname>Yoshida</surname><given-names>N</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Defective NK cell activity and Th1 response in IL-18-deficient mice</article-title><source>Immunity</source><volume>8</volume><fpage>383</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(00)80543-9</pub-id><pub-id pub-id-type="pmid">9529155</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Badr</surname><given-names>M</given-names></name><name><surname>Miyauchi</surname><given-names>K</given-names></name><name><surname>Ishihara</surname><given-names>C</given-names></name><name><surname>Onishi</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Ike</surname><given-names>H</given-names></name><name><surname>Takumi</surname><given-names>A</given-names></name><name><surname>Tsuji</surname><given-names>NM</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Katakai</surname><given-names>T</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>CRTAM determines the CD4+ cytotoxic T lymphocyte lineage</article-title><source>The Journal of Experimental Medicine</source><volume>213</volume><fpage>123</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1084/jem.20150519</pub-id><pub-id pub-id-type="pmid">26694968</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>A.</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CD4 CTL, a Cytotoxic Subset of CD4<sup>+</sup> T Cells, Their Differentiation and Function</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>194</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00194</pub-id><pub-id pub-id-type="pmid">28280496</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wensveen</surname><given-names>FM</given-names></name><name><surname>Jelenčić</surname><given-names>V</given-names></name><name><surname>Polić</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>NKG2D: A Master Regulator of Immune Cell Responsiveness</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>441</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00441</pub-id><pub-id pub-id-type="pmid">29568297</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>T cell exhaustion</article-title><source>Nature Immunology</source><volume>12</volume><fpage>492</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1038/ni.2035</pub-id><pub-id pub-id-type="pmid">21739672</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>TM</given-names></name><name><surname>Li</surname><given-names>CKF</given-names></name><name><surname>Chui</surname><given-names>CSC</given-names></name><name><surname>Huang</surname><given-names>AKY</given-names></name><name><surname>Perkins</surname><given-names>M</given-names></name><name><surname>Liebner</surname><given-names>JC</given-names></name><name><surname>Lambkin-Williams</surname><given-names>R</given-names></name><name><surname>Gilbert</surname><given-names>A</given-names></name><name><surname>Oxford</surname><given-names>J</given-names></name><name><surname>Nicholas</surname><given-names>B</given-names></name><name><surname>Staples</surname><given-names>KJ</given-names></name><name><surname>Dong</surname><given-names>T</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>McMichael</surname><given-names>AJ</given-names></name><name><surname>Xu</surname><given-names>X-N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans</article-title><source>Nature Medicine</source><volume>18</volume><fpage>274</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/nm.2612</pub-id><pub-id pub-id-type="pmid">22286307</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Akpinarli</surname><given-names>A</given-names></name><name><surname>Maris</surname><given-names>C</given-names></name><name><surname>Hipkiss</surname><given-names>EL</given-names></name><name><surname>Lane</surname><given-names>M</given-names></name><name><surname>Kwon</surname><given-names>E-KM</given-names></name><name><surname>Muranski</surname><given-names>P</given-names></name><name><surname>Restifo</surname><given-names>NP</given-names></name><name><surname>Antony</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>651</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1084/jem.20091921</pub-id><pub-id pub-id-type="pmid">20156973</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Gartlan</surname><given-names>KH</given-names></name><name><surname>Schuster</surname><given-names>IS</given-names></name><name><surname>Comerford</surname><given-names>I</given-names></name><name><surname>Varelias</surname><given-names>A</given-names></name><name><surname>Ullah</surname><given-names>MA</given-names></name><name><surname>Vuckovic</surname><given-names>S</given-names></name><name><surname>Koyama</surname><given-names>M</given-names></name><name><surname>Kuns</surname><given-names>RD</given-names></name><name><surname>Locke</surname><given-names>KR</given-names></name><name><surname>Beckett</surname><given-names>KJ</given-names></name><name><surname>Olver</surname><given-names>SD</given-names></name><name><surname>Samson</surname><given-names>LD</given-names></name><name><surname>Montes de Oca</surname><given-names>M</given-names></name><name><surname>de Labastida Rivera</surname><given-names>F</given-names></name><name><surname>Clouston</surname><given-names>AD</given-names></name><name><surname>Belz</surname><given-names>GT</given-names></name><name><surname>Blazar</surname><given-names>BR</given-names></name><name><surname>MacDonald</surname><given-names>KP</given-names></name><name><surname>McColl</surname><given-names>SR</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Engwerda</surname><given-names>CR</given-names></name><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name><name><surname>Kallies</surname><given-names>A</given-names></name><name><surname>Tey</surname><given-names>S-K</given-names></name><name><surname>Hill</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Eomesodermin promotes the development of type 1 regulatory T (T<sub>R</sub>1) cells</article-title><source>Science Immunology</source><volume>2</volume><elocation-id>eaah7152</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aah7152</pub-id><pub-id pub-id-type="pmid">28738016</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74636.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0145znz58</institution-id><institution>Walter Reed Army Institute of Research</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.10.21.465260" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.10.21.465260"/></front-stub><body><p>This is an interesting study, conducted in mice, that demonstrates for the first time the presence of a large population of cytotoxic CD4<sup>+</sup> T lymphocytes in infection with Trypanosoma cruzi, a relevant human pathogen. At present, the relevance of these cells in protective immunity engendered by the host remains unclear. Additional experiments are needed to characterize the functionality of these cytotoxic CD4 T cells vis-a-vis the canonical Th1 T cells. This paper can be of interest to scientists interested in immune responses to parasitic infections.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74636.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0145znz58</institution-id><institution>Walter Reed Army Institute of Research</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Donnarumma</surname><given-names>Tiziano</given-names></name><role>Reviewer</role><aff><institution>Crick</institution><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.10.21.465260">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.10.21.465260v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Cytotoxic CD4<sup>+</sup> T cells driven by T-cell intrinsic IL-18R/MyD88 signaling predominantly infiltrate <italic>Trypanosoma cruzi</italic>-infected hearts&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Satyajit Rath as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Tiziano Donnarumma (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors are encouraged to perform additional experiments in support of their claims:</p><p>(a) whether CD4 CTL cells are protective or pathological and</p><p>(b) how is their function is coordinated with or distinct from the role of &quot;classical&quot; Th1 cells that the authors previously showed play and essential role.</p><p>2) These experiments are necessary to establish &quot;functional&quot; and/or &quot;protective&quot; attributes of the CD4T CTL cells to determine if their killing capability is dependent on the phenotype described, namely Gzb-mediated killing.</p><p>3) A comparison over the state of activation/exhaustion of heart and lymphoid CD4 CTL cells will complement and link with the data on protection and functionality.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>– The y-axes on most of the bar graphs are rather complicated and duplicate information provided on the x-axes (e.g. Fig. 1F)</p><p>– Fig. 3 F-H is poorly explained. At best, 10% GzB+CD4+ T cells are positive for NKG2, NKGD2 or CRTAM. It is not clear whether the same subpopulation expresses all 3 markers (although in hearts at least the latter two are co-expressed on GzB+ CD4+ T lymphocytes).</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>It would be essential, in my view, for the authors to separate FasL-mediated from granzyme/perforin-mediated cytotoxicity (e.g. the use of granzyme substrates loaded on target cells or of perforin-deficient CD4 cells).</p><p>If IL-18R or MyD88 deficient CD4 cells, which clearly lack CD4CTL development and protective function, still express FasL and can kill in a FasL-dependent manner, perhaps this can be used to argue that FasL expression is not sufficient for protection in vivo by CD4CTLs.</p><p>In light of the authors' previous finding that the IL-18R/MyD88 signaling pathway is important for development of protective Th1 responses, the assertion that &quot;It is expected that pharmacological targeting of the IL-18R/MyD88 signaling pathway might contribute to the strategic development of new therapeutic and vaccine approaches aiming the control of the CD4CTL response&quot;, may need to be revised. Can such treatments be CD4CTL-specific and spare Th1 cells?</p><p>Also, the statement that correlations between levels of CD4CTLs and measures of heart dysfunction in chronic Chagas cardiomyopathy &quot;suggest that CD4CTLs may play a pathogenic role in the chronic phase of Chagas disease&quot; may need to be qualified, as the alternative possibility that both of these simply reflect parasite burden in the heart, without a causal link between them, would have to be entertained, if not excluded.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>– On Figure 1G the % of CD4 GzB+ is much lower than what shown in Figure 1B,D.</p><p>– The cytoxicity experiments are very convincing. Using GzB YFP+ CD4 could further demonstrate the superior cytolytic capability of the CDCTLs subset.</p><p>– FoxP3 does not correlate with GzB production in CD4 in the model and interestingly seems to be decreased in infected animal. Could the author comment on the possibility that lower Treg numbers could be favourable to CD4 CTLs development?</p><p>– In Fig2H the authors compare levels of ThPOK and RUNX3 in CD4 GzB vs naive cells showing a noticeable RunX3 upregulation in CD4CTLs. Instead of naive cells CD44H<sup>+</sup> GzB- cells (or the total CD4 population) should be used for the comparison.</p><p>– TCF7gene /TCF1 protein has been linked to CD4 and CD8 stemness and his loss is associated to a a terminally differentiated state. Loss of TCF1 is also the most recognizable feature of the CD4 CTLs gene signature used as a reference in the paper. Did the authors checked whether TCF1 levels are diminished in CD4CTLs in their model?</p><p>– The amount of CD4 CTLs found in the heart and the massive coexpression of NKG2D and CRTAM are striking and very promising in the view of future studies aimed at establishing the role of CD4CTLs in the pathology.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74636.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors are encouraged to perform additional experiments in support of their claims:</p><p>(a) whether CD4 CTL cells are protective or pathological and</p><p>(b) how is their function is coordinated with or distinct from the role of &quot;classical&quot; Th1 cells that the authors previously showed play and essential role.</p></disp-quote><p>Our results in the mouse model of infection with <italic>T. cruzi</italic>, employing the adoptive transfer of WT CD4<sup>+</sup>GzB+ T cells to the susceptible <italic>IL18ra<sup>-/-</sup></italic> mouse strain, clearly indicate a beneficial role of transferred CD4CTLs. Although the adoptive transfer of CD4<sup>+</sup>GzB+ T cells did not decrease the parasite load (Figure 6G, right panel), it resulted in a significant extent of survival of the transferred group (Figure 6G, left panel). Therefore, overall, CD4CTLs are exerting a protective effect in infected mice. Please see more details about this topic in our answer to Reviewer #1. In order to avoid possible misunderstanding, we changed “protective” for “beneficial” in our text. These data are evidence that the classical IFN-greleasing function of Th1, which has known microbicide action, is not being exerted by transferred CD4<sup>+</sup>GzB+ T cells. This result is in accordance to our finding that CD4<sup>+</sup>GzB+ T cells are for the great majority non-producers of IFN-g (Figure 1F). We also showed that <italic>IFNγ<sup>-/-</sup></italic> mice have the same percentage of GzB+ cells among CD4<sup>+</sup> T lymphocytes compared to WT mice (Figure 4B) and that, similarly, the adoptive transfer of <italic>IFNγ<sup>-/-</sup></italic> CD4<sup>+</sup> T cells significantly extend survival of susceptible mice (Figure 6Supp.Figure 2), albeit it does not diminish parasite levels (Oliveira <italic>et al.</italic>, <italic>eLife</italic>, 2017). Therefore, these data strongly suggest that the transferred-CD4<sup>+</sup>GzB+ T cells are extending survival of recipient mice, independently of classic Th1 function. It would be interesting to have a GzB-reporter mice lacking the <italic>IFNγ</italic> gene in CD4 T cells only, in order to obtain purified CD4<sup>+</sup>GzB+IFNγ-negative cells for adoptive transfer experiments. Unfortunately, we are not aware of the existence of such a mouse strain. As discussed in the manuscript, together with our previous work, the current results point to complementary roles exerted by CD4CTL and Th1 cells. Both cell types might be beneficial against infection with <italic>T. cruzi</italic>, working together to establish a balance between the Th1-dependent control of parasite load on one side, and CD4CTLmediated dampening of the immunopathology resulting from this process, on the other. Please see our revised discussion on the function of CD4CTLs and Th1 cells on pages 20-21 of the revised manuscript.</p><p>Concerning a possible pathological function for CD4CTLs: The correlation found between the percentage of circulating PRF+CD4<sup>+</sup> T cells and the severity of chronic myocarditis in patients with Chagas Disease raises the possibility of a detrimental role of this cell subset during the chronic phase of the infection. Clearly, this correlation does not prove that CD4CTLs are directly involved in the immunopathology, although at present this possibility cannot be excluded. Although speculative, this hypothesis deserves discussion. Thus, we improved the discussion on this point, please see pages 18 and 19 (lines 445-448) and page 22 (lines 535-539) of the revised manuscript. Assessing the exact role of this human cytotoxic CD4<sup>+</sup> T subpopulation in Chagas disease requires further investigation. Of note, in humans, myocarditis is also uniformly present during acute infection, although difficult to diagnose (Henao-Martínez et al., 2012, Trans R Soc Trop Med Hyg 106(9):521). The mechanism linking the acute to the chronic myocardial process, however, are not known yet. Please also note that a beneficial or pathological function of any T cell subset can vary in different phases (acute x chronic) of a disease. In fact, many groups, including ours, have shown the protective role of Th1 cells in the acute phase of infection with <italic>T. cruzi</italic>, while, on the other hand, the Th1 response has also been associated with a pathogenic role in Chagas chronic myocarditis (Oliveira et al., 2017, and reviewed in Ferreira et al., 2014 World J Cardiol 2014 6(8): 7820 and in Fresno and Girones, 2018, Front.Immunol. 9;351). Hypothetically, extensive tissue damage might be a consequence of a failure in the regulatory circuits, which would otherwise control effector T cell subsets, avoiding pathology. The persistence of a long lasting response in infected tissues, without adequate immunoregulation, could lead to the pathogenesis observed in the chronic phase of Chagas Disease.</p><disp-quote content-type="editor-comment"><p>2) These experiments are necessary to establish &quot;functional&quot; and/or &quot;protective&quot; attributes of the CD4T CTL cells to determine if their killing capability is dependent on the phenotype described, namely Gzb-mediated killing.</p></disp-quote><p>In order to determine if CD4CTL killing capability is dependent on GzB and PRF mediated killing, we have now performed the cytotoxic assays in the presence of GzB and PRF inhibitors, (Z-AAD-CMK and Concamycin A). As shown in Figure 2 – Figure supp. 1A, the killing of target cells was totally inhibited in this condition. Therefore, the new data added to the revised manuscript demonstrate that the killing capability of the CD4CTL subset in <italic>T. cruzi-</italic>infection model is dependent on GzB- and PRFmediated action, as previously shown for tumor-specific CD4CTLs (Quezada et al., 2010).</p><disp-quote content-type="editor-comment"><p>3) A comparison over the state of activation/exhaustion of heart and lymphoid CD4 CTL cells will complement and link with the data on protection and functionality.</p></disp-quote><p>In our present study we shown that the great majority of CD4 T cells with cytotoxic phenotype expresses high levels of the activation/memory marker CD44 in the spleen (Figure 2—figure supplement 2). We now added to the revised version of the manuscript the information that the totality of CD4<sup>+</sup> T cells in the heart express the CD44 marker (Figure 7—figure supplement 2). We also added new cytometry data showing the frequencies of CD4CTLs (GzB+PRF+) that express the activation/exhaustion markers PD-1, Tim-3, Lag-3 and CD39, and their corresponding MFI, in the spleen and in the heart, compared to other activated CD4<sup>+</sup>T cells (CD44<sup>hi</sup>) expressing neither GzB nor PRF (Figure 7—figure supplement 3). Furthermore, the comparison of the level of expression of these markers on CD4CTLs and on CD8CTLs, as well as the frequency of activation/exhaustion marker-positive cells among these subsets in the spleen and in the heart of infected mice were also added to the revised manuscript (Figure 7—figure supplement 4). Please note that this point is further commented in the detailed response to Reviewer # 1, on pages 6-8, below.</p><p>We believe that, taken together, the new data and discussion included in the revised manuscript address to the Reviewers’ concerns and add for the better comprehension of CD4CTL biology in the model of acute infection with <italic>T. cruzi</italic>, which is being described for the first time by our work.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>– The y-axes on most of the bar graphs are rather complicated and duplicate information provided on the x-axes (e.g. Fig. 1F)</p></disp-quote><p>Thank you for the observation. Duplicated information on Fig.1 F graph axes was corrected.</p><disp-quote content-type="editor-comment"><p>– Fig. 3 F-H is poorly explained. At best, 10% GzB+CD4+ T cells are positive for NKG2, NKGD2 or CRTAM. It is not clear whether the same subpopulation expresses all 3 markers (although in hearts at least the latter two are co-expressed on GzB+ CD4+ T lymphocytes).</p></disp-quote><p>With the scope of obtaining brighter staining and due to limitations of our flow cytometry facility at the time, we employed PE-linked mAbs for both NKG2D and NKG2A/C/E staining, which were thus used in different panels. For CRTAM staining, a PE-Cy7 mAb was employed, allowing the analysis of double positive CRTAM+NKG2D+ and CRTAM+NKG2A/C/E+ CD4+ T cells. Our results (Figure 7E and Figure 7-figure supplement 1D) clearly show that in the heart the vast majority of GzB+CD4+ T cells express both CRTAM and NKG2D (but not NKG2A/C/E). We have now analyzed the co-expression of CRTAM and NKG2D or CRTAM and NKG2A/C/E in the GzB+CD4+ T cells of the spleen and these data were added to new Figure 3-figure supplement 3. We found that while half of the CRTAM+ cells among CD4+GzB+ T splenocytes also express NKG2D, only a minority of CD4+GzB+ T cells co-express CRTAM and NKG2A/C/E. It is true that, in the spleen, the expression of these markers is limited to a lower frequency of cells, although both NKG2A/C/E+ and NKG2D+ cells are present at a similar ratio among CD4+GzB+ T cells. These data indicate that only one of the subpopulations present in the spleen, that is, double-positive CRTAM+NKG2D+ GzB+CD4+ T cells, migrate and/or are retained as infiltrating cells in the infected cardiac tissue. The difference observed on the expression of NKG2A/C/E or NKG2D by CD4CTLs infiltrating IAV infected lungs (Marshall et al., 2017, JI) or parasite infected hearts (our ms), respectively, is discussed on page 19, lines 457-464.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>It would be essential, in my view, for the authors to separate FasL-mediated from granzyme/perforin-mediated cytotoxicity (e.g. the use of granzyme substrates loaded on target cells or of perforin-deficient CD4 cells).</p></disp-quote><p>Previous studies in viral infection models have investigated the killing mechanism of CD4CTLs and have established that this population can employ both FasL/Fas- and Perforin/GzB-mediated killing mechanisms (reviewed in Brown, 2010). Of note, FasL/Fas-mediated cytotoxicity is not incompatible with the simultaneous action of Perforin and GzB in the target-cell killing process. In fact, it was shown that the CTL’s ‘kiss of death’ stems from the complementary action of FasL- and Perforin- mediated lytic mechanisms (Hassin et al., 2011, Immunology 133(2):190). In that study, the authors suggested that the complementary FasL/Fas pathway would be particularly important in cells with lower expression of Perforin/GzB, as it is known to be the case of CD4<sup>+</sup>GzB+ T cells, when compared to CD8CTLs. We have now addressed this question by performing the cytotoxic assay in the presence of GzB and PRF inhibitors, (Z-AAD-CMK and Concamycin A, respectively). As shown in new Figure 2 – Figure supp. 1A, the killing of target cells was totally abolished in the presence of these inhibitors, as previously shown for tumor-specific CD4CTLs (Quezada et al., 2010). Therefore, the new data added to the revised manuscript demonstrate that the lytic capability of the CD4CTL subset differentiating in the murine <italic>T. cruzi-</italic>infection model is dependent on GzB- and PRF-mediated action.</p><disp-quote content-type="editor-comment"><p>If IL-18R or MyD88 deficient CD4 cells, which clearly lack CD4CTL development and protective function, still express FasL and can kill in a FasL-dependent manner, perhaps this can be used to argue that FasL expression is not sufficient for protection in vivo by CD4CTLs.</p></disp-quote><p>Whether IL-18R- or MyD88-deficient CD4<sup>+</sup> T cells express FasL or not is an interesting question. Our study shows that, in the absence of T-cell intrinsic IL18R/MyD88 signaling, fewer CD4CTLs are found in infected mice, probably reflecting the lower expansion of these cells (or of their precursor) as a consequence of decreased transcription levels of cell-cycle and anti-apoptotic genes in MyD88-/- CD4<sup>+</sup> T cells, as reported in our previous work (Oliveira et al., 2017). In the present study, however, we did not focus on the killing capability of the few CD4CTLs present in IL18R- and MyD88-deficient mice. Nonetheless, the new results employing GzB and PRF inhibitors (please see Figure 2 – Figure supp. 1A and answer above), indicate that Fas/FasL contribution to the killing of target cells in our system occurs in coordination with PRF/GzB release at the cytotoxic synapsis, as previously described (Hassin et al., 2011, Immunology 133(2):190). Further investigation of the details on how the lack of IL-18R/MyD88 signaling can affect CD4CTL activity, including the expression of the FasL molecule, is undoubtedly an interesting question, but it cannot be addressed in a suitable time at the present.</p><disp-quote content-type="editor-comment"><p>In light of the authors' previous finding that the IL-18R/MyD88 signaling pathway is important for development of protective Th1 responses, the assertion that &quot;It is expected that pharmacological targeting of the IL-18R/MyD88 signaling pathway might contribute to the strategic development of new therapeutic and vaccine approaches aiming the control of the CD4CTL response&quot;, may need to be revised. Can such treatments be CD4CTL-specific and spare Th1 cells?</p></disp-quote><p>Together, our present and past results (Oliveira et al., 2017) show that the T-cell intrinsic IL-18R/MyD88 signaling pathway is important for the development of both Th1 and CD4CTL responses. While our data indicate that CD4CTLs, as well as Th1 cells, are beneficial in the acute phase of infection with <italic>T. cruzi</italic>, it might be that, at the chronic stage of infection, CD4CTLs could have a detrimental role, as suggested by our data in humans (Figure 7G-J), and as discussed above. At present, the knowledge about CD4CTL function in cancer, infection and autoimmune diseases is still very limited. In our statement, we were referring to a hypothetical situation in which the enhancement (or inhibition) of CD4CTLs activity could be highly beneficial, independently of being simultaneously affecting the Th1 response. We believe that discovering how to specifically target the differentiation of CD4CTL or Th1 cell responses would probably be of high medical interest. However, we agree with Reviewer #2 that this statement might lead to misunderstanding and, thus, it was removed from the text of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Also, the statement that correlations between levels of CD4CTLs and measures of heart dysfunction in chronic Chagas cardiomyopathy &quot;suggest that CD4CTLs may play a pathogenic role in the chronic phase of Chagas disease&quot; may need to be qualified, as the alternative possibility that both of these simply reflect parasite burden in the heart, without a causal link between them, would have to be entertained, if not excluded.</p></disp-quote><p>We would like to thank Reviewer #2 for this comment. We totally agree that the correlation between the levels of CD4CTLs in the circulation and the echocardiographic parameters employed for evaluating myocarditis in Chagas cardiomyopathy patients is not a prove of causal link. We have now better presented these results, citing the alternative hypothesis on pages 18 and 19 (lines 445-448). However, please note that although a link between parasite persistence and the pathogenesis of Chagas heart disease has been established, the quantitative correlation between parasite load in the heart and myocarditis has not been fully demonstrated yet (reviewed in Lewis and Kelly, 2016, Trends in Parasitol.32(11):899). On the other side, although still debated, several studies have provided evidence for a role of autoimmunity in the clinical progression of chronic Chagas cardiomyopathy (reviewed in De Bona, 2018, Front Immunol 6;9:1842). Regardless of the mechanisms involved in the development of Chagas myocarditis, we agree that the higher levels of CD4CTLs found in Chagas patients might reflect not only elevated parasite burden but also inflammation in the heart, without necessarily implying a direct involvement of this cell subset in the pathology. Please see the revised discussion of this point on page 22 (lines 537-539).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>– On Figure 1G the % of CD4 GzB+ is much lower than what shown in Figure 1B,D.</p></disp-quote><p>It is common to have a certain variation in the frequency of GzB+CD4<sup>+</sup> T cells in the spleen in different experiments, within the approximate range of 10 to 40% at day 14 pi. The kinetic experiments shown in Figure 1G were performed in the beginning of our study, years ago, when we were employing an anti-GzB mAb conjugated to FITC. After changing to A647-conjugated mAb, the percentage of detected GzB+ positive cells increased. Thereafter, we have been using the A647-conjugated mAb for detecting GzB, obtaining better results (at least 25% in the spleen at day 14 pi). With the exception of data shown in Figure 1G, all the other experiments showed in the manuscript were performed with an anti-GzB A647-conjugated mAb.</p><disp-quote content-type="editor-comment"><p>– The cytoxicity experiments are very convincing. Using GzB YFP+ CD4 could further demonstrate the superior cytolytic capability of the CDCTLs subset.</p></disp-quote><p>As explained above and in our answer to Reviewer #2, it is not possible to sort bona-fide GzB-negative cells to use as controls in a comparison experiment between GzB+ and GzB- CD4 T cells. However, our new results employing GzB and PRF inhibitors (Figure 2 – Figure supp. 1A), clearly show the dependency on these proteins for killing.</p><disp-quote content-type="editor-comment"><p>– FoxP3 does not correlate with GzB production in CD4 in the model and interestingly seems to be decreased in infected animal. Could the author comment on the possibility that lower Treg numbers could be favourable to CD4 CTLs development?</p></disp-quote><p>The role of Tregs in <italic>T. cruzi</italic> infection is still a controversial question. Some studies found that (i) Treg cells are not necessary for <italic>T. cruzi</italic> evasion of immune responses during acute or chronic infection; (ii) Tregs have limited role on host resistance; (iii) Treg cells do not play a major role in regulating CD8 T cell effector responses and pathogenesis (Kotner J. and Tarleton, R., 2007, IAI 75:861; Sales, PA. et al., 2008 Microbes Infect10(6):680). On the other hand, other works reported that (i) Treg depletion leads to reduced cardiac parasitism and inflammation accompanied by an augmented Th1 response; (ii) reduced Treg frequency inversely correlated with the magnitude of the effector immune response, as well as with emergence of acute immunopathology and the emergence of protective anti-parasite CD8<sup>+</sup> T cell immunity (Bonney KM, 2015, Parasitol Res.114(3): 1167; Furlan, CLA, 2018, Front Immunol. 9: 2555.). Interestingly, in our study we also found that the ratio of spleen Tregs among CD4<sup>+</sup> T cells decrease in mice infected with <italic>T. cruzi</italic> (Figure 2E). Therefore, it is possible that, indeed, the observed lower Treg ratios favor the CD4CTL response in T. cruzi-infected mice. However, for the moment, we have no data to address this question in more details and, thus, no information or insights for further comments on this subject.</p><disp-quote content-type="editor-comment"><p>– In Fig2H the authors compare levels of ThPOK and RUNX3 in CD4 GzB vs naive cells showing a noticeable RunX3 upregulation in CD4CTLs. Instead of naive cells CD44H<sup>+</sup> GzB- cells (or the total CD4 population) should be used for the comparison.</p></disp-quote><p>In the experiment shown in Figure 2H, we employed total naïve CD4 T cells as negative control for the expression of Runx3. Besides the impossibility of obtaining purified bona fide GzB-negative cells from the mouse reporter strain (as explained above and in answers to Reviewer #2, an important consideration here is that Runx3 is also known to be expressed by Th1 cells (Djuretic et al., 2007). Therefore, since Runx3 expression is not an exclusive feature of CD4CTLs, some level of Runx3 mRNA would also be probably detected in the subset of CD44hi GzB-negative cells (which includes Th1 cells). However, an important result of the experiment shown in Figure 2H concerns the finding that CD4<sup>+</sup> GzB+ T cells in the spleen do not downmodulate ThPOK, as opposed to what has been shown for IEL CD4CTLs in a non-infectious context (Mucida, D. et al., 2013, Nat Immunol). Please find the discussion on this point on page 23, lines 562-568 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>– TCF7gene /TCF1 protein has been linked to CD4 and CD8 stemness and his loss is associated to a a terminally differentiated state. Loss of TCF1 is also the most recognizable feature of the CD4 CTLs gene signature used as a reference in the paper. Did the authors checked whether TCF1 levels are diminished in CD4CTLs in their model?</p></disp-quote><p>Recent findings have redefined a role for T cell factor 1 (TCF1), which is not only involved in T cell development and T cell memory formation but also has functions in the differentiation pathways of effector CD4<sup>+</sup> T lymphocytes. While Blimp1 suppresses Tcf7 expression, it is, in turn, negatively regulated by TCF-1. Accordingly, Donnarruma et al., 2016, have shown the loss of Tcf7 (TCF1) expression and the concomitant gain of Prdm1 (Blimp-1) expression in CD4CTLs developing in response to viral infection. In our present work, we show the higher frequency of cells expressing Blimp-1 among GzB+CD4<sup>+</sup> T lymphocytes by flow cytometry (Figure 5D), as well as the higher expression of its coding gene, Prdm1, among WT compared to <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells by bioinformatics analysis of microarray data (Figure 5C). Therefore, one would expect to find lower levels of Tcf7 expression in WT CD4<sup>+</sup> T cells, among which higher numbers of CD4CTLs are present, relative to <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells. On the other hand, however, <italic>Tcf7</italic> is associated with central T cell memory. We and others have shown the crucial role of T-cell intrinsic MyD88 signaling for the acquisition of memory cell signatures by CD4 T cells in response to infection or to immunization with Ag/adjuvant, respectively (Oliveira, 2017, <italic>eLife</italic> and Schenten, D. et al., 2014, Immunity 40:78). Two different specific probes for <italic>Tcf7</italic> were employed in the RNA microarray. For both probes, the analysis indicated a higher expression among Myd88 CD4<sup>+</sup> T cells, but the fold change was lower than 1.5, the cut-off value we employed. Therefore, we did not include the result of the analysis of Tcf7 transcripts in RNA microarrays in the present manuscript. We believe that the result obtained reflects the fact that both CD4CTLs and memory CD4<sup>+</sup> T cells are more abundant among WT than among <italic>Myd88<sup>-/-</sup></italic> CD4<sup>+</sup> T cells, but opposite results concerning the expression of Tcf7 in CD4CTLs and memory CD4<sup>+</sup> T cell subsets are expected.</p><disp-quote content-type="editor-comment"><p>– The amount of CD4 CTLs found in the heart and the massive coexpression of NKG2D and CRTAM are striking and very promising in the view of future studies aimed at establishing the role of CD4CTLs in the pathology.</p></disp-quote><p>We thank Reviewer #3 for this comment. We agree that this can be very promising for understanding chronic Chagas myocarditis, as discussed on pages 22-23 (lines 541545) of the revised manuscript. We believe that investigating the interaction between CRTAM and/or NKG2D on T cells and their respective ligands expressed by the cardiac tissue might also bring novel insights for studies on other cardiac pathologies that involve infiltrating CD4<sup>+</sup> T cells in this organ.</p></body></sub-article></article>